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Vestibular compensation (VC) is the process of behavioural recovery that
follows damage to the vestibular receptors of one inner ear or vestibular nerve; it is
an attractive model of adult central nervous system plasticity. The first, rapid phase
of compensation has been associated with the recovery of a spontaneous resting
activity in the ipsilateral vestibular nucleus complex. The mechanisms involved in
this compensation are controversial, and a number of theories such as an up-
regulation of ipsilateral excitatory postsynaptic receptors, substitution of non-
vestibular sensory inputs, reactive synaptogenesis and modifications of the intrinsic
properties of the deafferented neurones have been postulated. Vestibular
compensation is a complex, heterogeneous process; rapidly developing
compensatory mechanisms may be quite distinct from the longer term molecular and
neuronal remodelling needed to sustain VC.
In the early stages of vestibular compensation in rat, neurons in the medial
vestibular nucleus (MVN) on the lesioned side develop a sustained up-regulation of
their excitability and a significant down-regulation of the functional efficacy of
inhibitory GABA receptors. These adaptations are in the appropriate direction to
promote the recovery of the resting activity of the deafferented MVN neurons in
vivo, an essential first step in VC. The up-regulation of ipsilesional MVN neuronal
excitability is dependent on the activation of glucocorticoid receptors (GR) which
presumably occurs during the acute stress response that accompanies the vestibular
deafferentation symptoms.
This thesis describes a series of experiments in rats, designed to investigate the
underlying molecular causes of VC. The role of the stress system in the adaptive
down-regulation of GABA receptors during compensation was investigated using
biochemical and in vitro electrophysiological techniques. The results demonstrate
that the down-regulation of GABA receptor efficacy in ipsilesional MVN neurones
observed after 4h of compensation following a unilateral labyrinthectomy (UL) is
dependent on activation of glucocorticoid receptors. The enzyme, 11(3-
hydroxysteroid dehydrogenase type 1 (11(3-HSD1) regenerates active glucocorticoids
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from inert forms, and is found to be present in the central vestibulo-oculomotor
centres of the brainstem and cerebellum. This suggests that this modulatory enzyme
is likely to be involved in regulating the exposure of these centres to circulating
glucocorticoids. The results show that the levels of 11P-HSD1 activity in the
vestibulo-cerebellum and MVN are stable over the 4h period after UL, disproving the
hypothesis that changes in enzyme modulatory activity may occur in parallel with the
deafferentation induced changes in the properties of the ipsilesional MVN neurones
over this time.
The relative importance of intrinsic membrane properties versus synaptic inputs
to the spontaneous firing rate of ipsilateral MVN neurones was investigated at
varying times following UL. The endogenous activity of MVN neurones was
assessed by their spontaneous activity recorded in brainstem slices perfused with a
cocktail of neurotransmitter antagonists to block synaptic transmission. The results
demonstrate a significant increase in excitability of lesioned rostral MVN neurones at
4h post-UL, which is maintained primarily by changes in the intrinsic pacemaker
properties of these neurones. At 48h and lwk post-UL the significant increase in
excitability of lesioned rostral MVN neurones is sustained, however by this time it is
maintained by an increased excitatory synaptic input onto the neurones. Thus
different mechanisms are utilised in the initiation and maintenance of processes
involved in VC.
Finally, the powerful techniques of quantitative two-dimensional gel analysis
and mass spectroscopy were used to assess changes in protein expression in the
MVN and vestibulo-cerebellum during VC. The results indicate changes between the
ipsilesional and contralesional MVN, in the expression of several proteins at lwk
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INTRODUCTION
The maintenance of a stable gaze and controlled orientation of the body in space
are essential aspects of survival. The vestibular system is the sensorimotor system
concerned with the sensation of head movement and with generation of reflexes for
stabilising gaze (vestibulo-ocular reflexes, VORs) and body posture (vestibulo-colic
reflexes, VCRs; vestibulo-spinal reflexes, VSRs). The vestibular nuclei in the
brainstem are the core of vestibular information processing; they receive inputs from
the peripheral vestibular organs, visual system, somatosensory system, cerebellum
and spinal cord and process appropriate motor commands. The vestibular nucleus
complex (VNC) consists of four main nuclei: the medial, lateral, superior and
inferior nuclei. Of these, the medial (MVN) and lateral vestibular nuclei (LVN) are
most extensively studied.
The complex and often convergent processing of several types of sensory inputs
requires the vestibular system to learn and adapt to often conflicting sensory cues
following lesions or alteration of the subject's environment. A remarkable example
of vestibular plasticity occurs after damage to one vestibular labyrinth (unilateral
labyrinthectomy, UL) or nerve (unilateral vestibular deafferentation, UVD). This
results in a severe syndrome of oculomotor and postural symptoms. These symptoms
are divided into two categories: static symptoms persist in the absence of head
movement (e.g. spontaneous ocular nystagmus, yaw and roll head tilts); and dynamic
symptoms occur as a result of head movement (e.g. abnormal gain and phase of the
VORs and VCRs) (for review, see Smith and Curthoys, 1989). Remarkably, many of
the static symptoms of unilateral vestibular damage disappear over a few days in
most species, as part of a process termed vestibular compensation. Vestibular
compensation is independent of functional regeneration of the deafferented vestibular
nerve and is therefore ascribed to central nervous system plasticity.
The study of vestibular compensation is important for a number of reasons.
Firstly, understanding how the vestibular system functions following damage lends
us information on how the system functions normally. Secondly, research into the
components of vestibular compensation may contribute to the development of
effective treatments for vestibular disorders in humans. Thirdly, vestibular
Introduction 6
compensation represents an interesting model of central nervous system plasticity in
adults: it has well defined and relatively simple inputs and outputs, which can be
quantified both on neuronal and behavioural levels. It seems likely that mechanisms
of plasticity defined in the vestibular system could extrapolate to plasticity in other
brain regions. For these reasons vestibular compensation has been the focus of a
large amount of research over the last 40 years. However, despite documentation of
many behavioural, anatomical and physiological aspects of compensation, the
mechanisms underlying functional recovery, and the position in CNS where they
reside are not well understood.
The aim of this thesis is to investigate some of the neuronal, molecular and
biochemical substrates underlying vestibular compensation, as outlined below. The
thesis will be divided into 6 main chapters:
1) The general anatomy, pharmacology, electrophysiological properties and function
of the vestibular system.
2) The neuronal, pharmacological and structural components of vestibular
compensation, and a discussion of possible mechanisms of compensation.
3) An electrophysiological investigation into the role of the stress axis in the down-
regulation of GABA receptors in the ipsilesional MVN during vestibular
compensation.
4) An investigation into the presence of the glucocorticoid metabolising enzyme,
liP-hydroxysteroid dehydrogenase type 1, in the vestibular system.
5) An electrophysiological and pharmacological investigation into the mechanisms
underlying changes in the neuronal discharge rates ofMVN neurones in vitro, during
vestibular compensation.






1.1 VESTIBULAR SYSTEM: ANATOMY AND FUNCTION
The vestibular system is the sensorimotor system which senses the position and
movement of the head and body in space, and uses that information to control
posture and stabilise vision. The peripheral vestibular organs are situated in the bony
labyrinth of the temporal bone, and consist of the semicircular canals and otolith
organs. There are three semicircular canals; horizontal, anterior and posterior,
orientated approximately in each plane of three dimensional space, detecting angular
(up-down, tilting and side to side) rotations of the head. The otolith organs consist of
the utricle and saccule; they are orientated perpendicular to each other and signal
linear acceleration and head orientation relative to earth's gravity. The arrangement
of the semicircular canals and otolith organs allows the most efficient signalling of
head position in three-dimensional space. Vestibular hair cells in the peripheral
vestibular organs detect movement and position of the head. This information is
relayed via the vestibular portion of the eighth cranial nerve to the vestibular nuclei
in the brainstem. The primary vestibular afferents carried by the eighth nerve are
bipolar cells, their cell bodies located in Scarpa's ganglion. There are four main
vestibular nuclei on either side of the brainstem: the superior, inferior, medial and
lateral vestibular nuclei. Each vestibular nucleus receives at least some primary
afferent fibre input, which is partly endorgan specific. For example, the medial
vestibular nucleus (MVN) receives afferents mainly from the horizontal canal and
utricle, the superior vestibular nucleus (SVN) from the anterior and posterior canals,
and the lateral vestibular nucleus (LVN) and inferior vestibular nucleus (IVN) from
the otolith organs. This primary vestibular information converges in the vestibular
nuclei with visual and somatosensory information to provide an internal 3-D
representation of body position and movement in space.
The function of the vestibular system is the maintenance of a stable gaze and
body posture, essential in many behaviours such as visuo-motor co-ordination,
spatially orientated tasks and visual tracking of objects in the external world. In
addition, the vestibular system appears to contribute to a cognitive perception of
spatial orientation via a hippocampal projection which provides information on
spatial environment and self-movement (Russell et ai, 2003). The vestibular nuclei
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also provide efferent connections to target oculomotor and spinal motorneurones,
which give rise to inter-related families of reflexes; the vestibulo-ocular reflexes
(VORs), vestibulo-colic reflexes (VCRs) and the vestibulo-spinal reflexes (VSRs).
VORs help stabilise the retinal image during head rotation, by rotation of the eyes in
the orbits by a nearly equal and opposite amount to head movement. The most direct
pathway from the peripheral vestibular organs to the eye muscles in the vertebrate, is
the three-neurone VOR arc.
This three-neurone arc, schematically represented in figure 1.1 consists of:
1) First order canal afferents located in Scarpa's ganglion, connecting the sensory
hair cells with neurones in the vestibular nuclei.
2) Second order vestibular afferents located in the vestibular nuclei, sending their
axons via the medial longitudinal fasciculus to the oculomotor nuclei.
3) The motorneurones located in the oculomotor nuclei, innervating the various
extra-ocular muscles.
Vestibular nuclei, with the exception of the SVN, project to the spinal cord via
the lateral, caudal and medial vestibulospinal tracts. Vestibulo-spinal reflexes give
rise to the reflex excitation of motorneurones of postural and extensor muscles to
control the trunk and limbs against gravity during movement. Vestibulo-colic
reflexes give rise to the reflex excitation of the appropriate groups of neck muscles to
resist and counteract head displacement, thus acting to stabilise the head on the trunk.
The integrated stabilisation of eyes, head and trunk through VORs, VCRs and VSRs
provides and essential base on which to execute co-ordinated eye, head and body
movements.
Figure1.1Schematicdiagr moft eneuronaltworkmed tingthhorizo talves ibul -o ular reflex(hVOR) A.Schematicdiagr moftheeesynapsesmediatingt n uroneVORarc. B.Simplifiedschematicdiagramofo etpathw ysinv lv dnthorizontalVOR.Tmedialv stibular nucleustypIIeurone(MVN)exhibitanincr asfi i gateorhorizo talangul rc el ationt contralateralsid ,andMVNIexhibitsnincre sefi gahorizo t la gul rccelerationtip il t r l side.LR,lateralr ctusmusc e;VN,l vestib larnucleus;MRedi lre tuuscleIIINoculomotor nucleus;VIN,abduc nsI Ieightherve.Opetrianglrep es ntx i atorysynap es,fill dci representinhibitorysynaps s.M noth rproj ctio sactivated,i h rdi ec lri d rectlybyv stibulaaff r nt inputsandotherat ways,w ichrnotsh nthimplifieddi gram.(Ad efrS tndD rli g on, 1996)
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1.1.1 Afferent Connections of the Vestibular Nuclei
Primary vestibular afferents, originating from the vestibular organs and carried by
the eight nerve, connect to the vestibular nuclei in the brainstem. There is a
differential distribution of vestibular afferents within parts of each vestibular
nucleus; portions not considered to receive primary vestibular afferents include the
dorsal half of the LVN, peripheral parts of the SVN and caudal and medial parts of
the MVN (see Figure 1.2B). Primary vestibular afferents bifurcate as they enter the
brainstem into ascending and descending pathways. Ascending pathways project
dorsomedially and rostrally through parts of the LVN to terminate in the SVN,
rostral MVN and cerebellum; descending pathways project to the IVN issuing
collaterals to the ventral LVN and the MVN (see Figure 1.2A) (Brodal, 1974; Korte,
1979; Mehler and Rubertone, 1985; Carpenter, 1988a; Sato et al., 1989; Newlands
and Perachio, 2003). Anatomical studies using axon degeneration or anterograde
labelling have demonstrated that the VNC receives an endorgan specific distribution
of primary vestibular afferents: ipsilateral semicircular canal afferents terminate
predominantly in the rostral MVN and SVN, and otolith afferents terminate in the
IVN, LVN and lateral MVN (Stein and Carpenter, 1967; Gacek, 1969; Brodal, 1972,
1974; Carleton and Carpenter, 1983; Sato et al., 1989). Precht and Shimazu (1965)
were the first to demonstrate that second order neurones in the MVN were
monosynaptically and polysynaptically activated by electrical stimulation of the
ipsilateral eighth nerve. Subsequently, Wilson et al. (1967) showed that cells
responding monosynaptically to vestibular nerve stimulation were mainly
concentrated in the rostral MVN, correlating with the anatomical data. Although the
vestibular nerve provides a large portion of afferents to the vestibular nuclei, inputs
to these nuclei are also derived from other sensory systems such as visual and
somatosensory systems and other brain regions such as the cerebellum and brainstem
nuclei (for reviews, see Brodal, 1974; Barmark, 2003). Indeed the cerebellum
provides a major tract projecting to the vestibular nuclei (see Section 1.1.5).
Figure1.2Projectionfprimaryv stibul rafferentstohestibularn cl usco plexandcere e m A.Primaryvestibularafferentsbifurcatesthnterra ns min oa c ndingnddes e dipa hways. B.Anillustrationoftheerminalfi ldsivprimaryestibul rafferentsca ,intr -axonallyab ll dw thHRP. Theterminalsarmappedontoschem ticaepresentshorizontalsecti nthr ughv stibularom lex.IVN, inferiorvestibularnucleus;LVN,lat ral ;MVmedi lv st l rl sPpa aso itarynucleus; SVN,superiorvestibulan cleus.(Ada tedfromBarmack,2003;nki199 )
From Scarpa' ganglion Vestibular nuclei
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1.1.2 Efferent Connections from the Vestibular Nuclei
Vestibulo-ocularpathways
Physiological and anatomical studies have shown that efferent fibres from the
vestibular nuclei, particularly the MVN and SVN, ascend in the medial longitudinal
fasciculus (MLF) to the motomeurones in the oculomotor nuclei (Wilson et al,
1968; Gacek, 1969, 1974; Tarlov, 1970; Isu and Yokota, 1983; Langer et al., 1986).
The six extraocular muscles of each eye are innervated by motorneurones in the
oculomotor, trochlear and abducens nuclei via the Illrd, IVth and Vlth cranial nerves
respectively (Wilson and Melvill Jones, 1979). The abducens and trochlear nuclei
each supply only one muscle, the ipsilateral lateral rectus muscle and contralateral
superior oblique respectively. The oculomotor nucleus innervates the ipsilateral
inferior and medial recti, and inferior oblique, and the contralateral superior rectus.
Fibres from the SVN enter the ipsilateral MLF and branch to the ipsilateral trochlear
and oculomotor nuclei, and the contralateral oculomotor nucleus. Fibres from the
MVN enter the ipsilateral and contralateral MLF and project bilaterally to the
abducens and oculomotor nuclei and contralaterally to the trochlear nucleus (Baker et
al., 1969; Wilson and Melvill Jones, 1979). Electrical stimulation of the eighth nerve
or horizontal canal afferents, causes a disynaptic excitatory postsynaptic potential
(EPSP) in the contralateral abducens motorneurones and a disynaptic inhibitory
postsynaptic potential (IPSP) in the ipsilateral abducens motomeurones (Precht et al.,
1969; Highstein, 1973; Schwindt et al., 1973; Babalian et al., 1997). Similar
potentials, but monosynaptic in their latency could be evoked in the abducens by
stimulation of the rostral MVN (Baker et al., 1969). Thus the anatomical and
physiological data indicate that one aspect of the horizontal VOR reflex, the three
neurone VOR arc, originates in the horizontal canal, relays in the rostral MVN,
which then projects to the oculomotor nuclei causing contractions of the extraocular
muscles sufficient to rotate the eyes in an equal and opposite manner to head
movement (see Figure 1.1).
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Vestibulospinal pathways
Activation of the vestibular organs leads to various reflexes of the body and
limbs sufficient to result in the stabilisation of head position and visual field.
Afferents from the vestibular organs are processed in the vestibular nuclei and
relayed to the spinal cord by vestibular efferents. The major links between the VNC
and the spinal motor centres consists of the lateral vestibulospinal tract (LVST) and
medial vestibulospinal tract (MVST), although activity is also relayed by the
reticulospinal tract and the caudal vestibulospinal tract (Wilson and Melvill Jones,
1979). The LVST originates from the LNV and IVN and projects ipsilaterally to all
segments of the spinal cord where it synapses on extensor motorneurone pools
(Brodal et al., 1962). The MVST originates primarily in the MVN, but the LVN and
IVN also contribute. It projects bilaterally, predominantly to the ventral horn of the
cervical spinal cord from CI to C6 (Nyberg-Hansen, 1964; Wilson et al., 1967).
There are also fibres from the MVN innervating neck motorneurones (Wilson, 1972).
These motorneurones receive disynaptic excitation and inhibition from all 6
semicircular canals and constitute the short latency pathway for the vestibulo-colic
reflex.
1.1.3 Commissural connections
Anatomical studies using axonal degeneration techniques and anterograde and
retrograde labelling techniques have demonstrated the presence of a commissural
pathway that interconnects the bilateral MVN, SVN and IVN, but only the
ventromedial portions of the LVN (Cat: Ladpli and Brodal, 1968; Gacek, 1978;
Carleton and Carpenter, 1983; Ito et al., 1985; Monkey: Carleton and Carpenter,
1983; Rat: Rubertone et al., 1983; Rabbit: Epema et al., 1988; Gerbil: Newlands et
al., 1989). Horseradish peroxidase (HRP) retrograde labelling techniques have
identified commissural pathways linking contralateral vestibular nuclei, the MVN
having the most extensive commissural network, projecting to the SVN, LVN and
IVN (Rubertone et al., 1983; Ito et al., 1985; Epema et al., 1988).
Electrophysiological studies demonstrated that stimulation of the contralateral
vestibular nerve evokes field potentials in the ipsilateral vestibular nuclei (Shimazu
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and Precht, 1966; Nakao et al., 1982; Furuya et al., 1992). Midline incision which
interrupted the commissural fibres, abolished this response (Precht et al., 1966). In
mammals the majority of commissural neurones are GABAergic (Furuya et al.,
1992; Holstein et al., 1999b). Babalian et al. (1997) showed that in the guinea pig,
contralateral vestibular nerve stimulation produced inhibitory synaptic potentials
with either di- or trisynaptic latencies in 75% of second order MVN neurones. The
remaining 25% of neurones responded with excitatory, or mixed excitatory and
inhibitory synaptic potentials. In commissural pathways with disynaptic latencies, an
inhibitory second order neurone in the contralateral MVN sends its axon in the
commissural pathway to inhibit second order ipsilateral MVN neurones; in the
trisynaptic pathway, excitatory commissural afferents (MVN I in Fig. 1.1) stimulate
inhibitory interneurones in the ipsilateral MVN (MVN II in Fig. 1.1) which inhibit
second order MVN neurones.
1.1.4 Intrinsic connections
lontophoretic microinjections of HRP into individual vestibular nuclei have
revealed highly organised and extensive internuclear connections between individual
vestibular nuclei in rat (Rubertone et al., 1983), cat, monkey (Carleton and
Carpenter, 1983), and rabbit (Epema et al., 1988). The SVN, IVN and MVN are
reciprocally connected (Epema et al., 1988). The IVN projects to the LVN and the
LVN projects to the SVN but these connections are not reciprocated (Ito et al.,
1985); the MVN is reciprocally connected to the LVN (Rubertone et al., 1983). In
addition to the connections between individual subnuclei, there are reciprocal




The vestibular nuclei receive extensive afferent projections from the area of the
cerebellum known as the vestibulo-cerebellum, consisting of the uvula-nodulus,
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flocculus, paraflocculus and fastigial nuclei. The uvula and nodulus differ in some
respects in their vestibular projections. The uvula and nodulus both send fibres to the
peripheral SVN, the ventrocaudal IVN and some sparse fibres to the LVN. The MVN
receives no uvula fibres whereas the nodulus sends a dense projection of fibres to the
caudal MVN (see Figure 1.3) (Brodal, 1974; Carleton and Carpenter, 1984; Shojaku
et al., 1987; Walberg and Dietrichs, 1988). Immunohistochemical tracing studies
show that fibres from the flocculus terminate ipsilaterally, mainly in the central SVN
and rostral region of the MVN, with some sparse labelling in the LVN and IVN (Fig.
1.3) (Anguat and Brodal, 1967; Brodal, 1974; Carleton and Carpenter, 1984; Langer
et al., 1985; Nagao et al., 1997). The areas of the MVN and SVN that receive
floccular fibres approximately coincide with the areas that receive primary vestibular
afferents and that are involved in the VOR pathways (compare Figs. 1.2 and 1.3).
Figure 1.3 A schematic diagram summarising connections between the vestibulo-
cerebellum and vestibular nuclei. Cells projecting to the floccular region are
represented as filled circles, cells projecting to the nodulus and uvula as open circles.
Areas where cerebellar efferents from the floccular region terminate are indicated by
fine dots, and inputs from the nodulus and uvula are depicted by cross hatching.






Electrophysiological experiments have identified floccular Purkinje cells that
inhibit both the excitatory and inhibitory branches of the VOR pathways to various
oculomotor muscles. These actions are mediated through inhibitory monosynaptic
projections to vestibular nucleus neurones called "flocculus target neurones" (FTNs).
Babalian and Vidal (2000) used an in vitro whole brain study in guinea pig to assess
floccular modulation of the horizontal VOR pathway. Stimulation of the ipsilateral
flocculus significantly decreased the inhibitory field potential evoked in the abducens
nucleus by ipsilateral vestibular nerve stimulation, but had no effect on responses
evoked in abducens nuclei after contralateral nerve stimulation. Thus the flocculus
exerts inhibitory actions on inhibitory second order vestibular neurones activated by
the ipsilateral vestibular nerve and projecting to the ipsilateral abducens nucleus.
Projections of the flocculus do not converge with vestibular afferent inputs on
excitatory second order vestibular neurones projecting to the contralateral abducens
nucleus. FTNs, identified electrophysiologically by the monosynaptic IPSPs
recorded after ipsilateral floccular stimulation, constitute around 15 to 20% of all
recorded second order rostral MVN neurones (Stahl and Simpson, 1995; Babalian
and Vidal, 2000). Recently, a technique has emerged which enables the visualisation
of FTNs in vitro, allowing an investigation of the electrophysiological properties of
FTNs. Sekirnjak et al. (2003) used the Purkinje cell specific L7 protein promoter to
express a green fluorescent protein (GFP) fusion protein, selectively in Purkinje
cells. GFP positive axons and terminals were sparse in the MVN projecting onto just
1% of all MVN neurones, all of which were concentrated in the rostral region.
Ipsilateral flocculectomy abolished the expression of GFP in rostral MVN neurones,
indicating a floccular rather than nodular origin of these fibres. The intrinsic firing
properties of the identified FTNs differed markedly from non-FTNs (the surrounding
non-GFP labelled MVN neurones). FTNs had exceptionally high spontaneous firing
rates, lower action potential thresholds and significantly smaller after-
hyperpolarisations than non-FTNs. After a membrane hyperpolarisation, FTNs
displayed dramatic postinhibitory rebound firing, whereas non-FTNs exhibit little or
no rebound firing (Sekirnjak et al., 2003).
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Vestibulo-cerebellar afferents
Vestibular information is fed to the cerebellum through primary and secondary
vestibulo-cerebellar projections. Primary vestibular projections consist of eighth
nerve afferents (Fig. 1.2A). Several folia of the cerebellum receive scattered
projections from primary vestibular afferents, however more than 90% of terminals
are restricted to the ipsilateral uvula-nodulus (Korte and Mugnaini, 1979; Gerrits et
al, 1989; Barmack, 2003). Dow (1936) originally showed that the uvula-nodulus,
but not the flocculus or paraflocculus receive primary vestibular afferent projections.
Subsequent studies in monkey (Carleton and Carpenter, 1983; Nagao et al., 1997)
and cat (Brodal and Hoivik, 1964) using silver impregnation, retrograde axonal
transport and autoradiography techniques, revealed a direct primary vestibular
projection to the flocculus and paraflocculus. However the use of similar techniques
in rabbit, failed to find any projections to the paraflocculus and either very sparse or
no projections were observed to the flocculus (Gerrits et al., 1989; Barmack et al.,
1993). In all studies, the projections to the uvula-nodulus terminated as mossy fibres
exclusively on the ipsilateral side of the brain.
Secondary vestibulo-cerebellar afferents project to the uvula-nodulus, flocculus,
paraflocculus and folia 1 of the anterior lobe (Carleton and Carpenter, 1984; Gerrits
et al., 1989; Barmack et al., 1992c). The granule cell layer of the uvula-nodulus
receives a bilateral vestibular projection from the MVN, IVN and SVN, a major
fraction of which originates in the caudal MVN and is cholinergic (Barmack et al.,
1992a; Jaarsma et al., 1997). Rubertone and Haines (1981) reported that in monkey,
the ventromedial MVN projects to the ventral paraflocculus, and the dorsomedial
MVN and dorsal IVN project to the dorsal paraflocculus. The flocculus receives
secondary vestibular fibres from discrete regions of the vestibular nucleus. In cat,
projections to the flocculus were traced from the ventromedial and dorsomedial
MVN, the ventromedial rostral IVN and the central area of the SVN (Sato et al.,
1983). This and another study in cat could find no vestibular nucleus projection to
the paraflocculus (Kotchabhakdi and Walberg, 1978; Sato et al., 1983). The
discrepancies of vestibulo-paraflocculus projections could be due to species
differences between cat and monkey. Electrophysiological studies have demonstrated
that rostral MVN neurones send fibres to either the ipsilateral or contralateral
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flocculus, with a strong contralateral preference (Shinoda and Yoshida, 1975; Cheron
et al., 1996).
1.1.6 Inferior olive
The inferior olive (IO) is proposed to be involved in the learning and timing of
motor behaviour. It is the sole source of climbing fibres innervating Purkinje cells in
the cerebellum, while the Purkinje cells are themselves the sole source of the output
signals from the cerebellum to the vestibular nuclei (for review, see De Zeeuw et al,
1998b). The mammalian inferior olive is divided into very specific functional
subgroups, composed of: the principle olive, the dorsal and medial accessory olives
and several smaller subnuclei such as the ventrolateral outgrowth, dorsal cap of
Kooy, (3 nucleus and the dorsomedial cell column (Whitworth and Haines, 1986). In
general, each olivary subnuclei projects contralaterally to one or more cerebellar
zones of Purkinje cells, which in turn project to a particular set of cerebellar or
vestibular nuclei. Anatomical studies using HRP injections have mapped climbing
fibre projections from the contralateral dorsal cap and ventrolateral outgrowth to the
flocculus, and from the contralateral dorsal cap, dorsomedial cell column and (3
nucleus to the uvula-nodulus (Yamamoto, 1979; Sato and Barmack, 1985; Bernard,
1987; Maekawa et al., 1989). Cerebellar nuclei project reciprocally to the olivary
subnucleus from which they receive collaterals, but also have an additional variable
ipsilateral component (Ruigrok, 1997). The olivary projections to the cerebellum are
excitatory, probably glutamatergic, whereas the cerebellar projections to the IO are
GABAergic (Barmack, 2000).
The vestibular nuclear complex and IO are connected, although the only direct
connection from the four main vestibular nuclei is from the LVN to IO (Matesz et
al., 2002). The MVN and IVN provide secondary vestibular afferent projections into
the ipsilateral parasolitary nucleus (Psol; a small GABAergic nucleus that receives a
primary vestibular afferent projection), this projects ipsilaterally to the (3-nucleus and
dorsomedial cell column of the IO (Barmack, 1996). The (3-nucleus and dorsomedial
cell column project to the contralateral uvula-nodulus, which in turn provides an
ipsilateral GABAergic projection to the Psol (Barmack and Yakhnitsa, 2000).
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1.2 ELECTROPHYSIOLOGICAL PROPERTIES OF VESTIBULAR
NEURONES
1.2.1 In vivo properties of vestibular nucleus neurones
Both primary vestibular afferents and second order vestibular neurones display
spontaneous resting activity in the absence of head movement, enabling neurones to
respond bi-directionally. MVN neurones in vivo, can be activated monosynaptically
and polysynaptically by electrical stimulation of the vestibular nerve (Precht and
Shimazu, 1965; Goldberg and Fernandez, 1971). In addition, many neurones in the
rostral region of the MVN respond to angular acceleration of the head in both the
horizontal and vertical plane (Shimazu and Precht, 1965; Markham, 1968; Curthoys
and Markham, 1971). Neurones responding to canal stimulation have been divided
into two main types according to whether it is the ipsilateral or contralateral canal
that evokes them: a type I neurone increases its discharge frequency with ipsilateral
canal stimulation and decreases it with contralateral stimulation whereas type II
neurones have the opposite response. Shimazu and Precht (1965) recorded neuronal
responses in the VNC of decerebrate cats after stimulation of the canals; 67% of
neurones examined showed type I responses and 29% type II responses. Two smaller
subsets of responses were recorded; type III neurones increased their discharge
frequency with rotation in either direction, and constituted 3% of recorded neurones,
and type IV neurones decreased firing with rotation in either direction and
constituted 1% of recorded neurones. Melvill Jones and Milsum (1970) reported
similar proportions of type I and type II responses in vivo in the cat, yet in the awake
monkey, Fuchs and Kimm (1975) showed equal proportions of type I and II
responses. Different nuclei show different proportions of type I and type II cells: the
MVN is mostly type I whereas the LVN is mostly type II (Carpenter, 1988b).
Shimazu and Precht (1965; Precht and Shimazu, 1965) further classified type I
neuronal responses into tonic and kinetic. Kinetic neurones comprised 20% of type I
cells and were characterised by no resting discharge, monosynaptic excitation by
ipsilateral vestibular nerve stimulation and an increase or decrease in their discharge
frequencies along steep slopes during rotational stimulation. Tonic neurones
comprised 80% of type I cells and were characterised by spontaneous activity at rest,
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polysynaptic activation in response to a single electric shock to the ipsilateral
vestibular nerve and less steep response sensitivities to activation or cessation of
rotational stimulation.
1.2.2 In vitro properties of vestibular nucleus neurones
Gallagher et al. (1985), using extracellular and intracellular recording techniques
in rat, were the first to demonstrate that MVN neurones fire spontaneous action
potentials in brainstem slices in vitro, where all inputs to the nucleus are cut.
Subsequent studies in the MVN have confirmed these findings, recording in vitro
firing rates ranging from 0.5-60 spikes/s, with a mean firing frequency between 10-
25 spikes/s (Lewis et al., 1987; Ujihara et al., 1988, 1989; Darlington et al., 1989;
Doi et al., 1990; Smith et al., 1990; Serafin et al., 1991a,b; Dutia et al., 1992;
Johnston et al., 1994). These firing rates are comparable with those recorded in vivo
(Precht and Shimazu, 1965; Shimazu and Precht, 1965; Goldberg and Fernandez,
1971; Hamann and Lannou, 1987; Ris et al., 1995), which was initially surprising as
it was assumed that a large component of the resting activity of MVN neurones was
provided by excitatory vestibular nerve afferents.
A major component of the spontaneous activity is generated by an intrinsic
mechanism, evidenced by its persistence after blockage of synaptic transmission with
calcium blocking agents or by perfusion of the slice with low Ca2+/ high Mg2+
medium. From their intracellular recordings in rat, Gallagher et al. (1985) identified
two spontaneously active subtypes of MVN neurones, distinguished by their
differing after-hyperpolarisation potential (AHP) profiles: one group showing a
single AHP the other a double (See Figure 1.4). Subsequently Serafin and colleagues
(1991a,b), using intracellular recordings from guinea pig brainstem slices, classified
three subtypes of MVN neurones on the basis of their AHP profiles. Type 'A' MVN
neurones constituted about 30% of the spontaneously recorded cells and were
characterised by a broad action potential and a single deep AHP. Type 'B' MVN
neurones comprised about 50% of recorded cells and displayed a narrow action
potential with an initial fast AHP followed by a delayed slow AHP. A third subtype






Figure 1.4 Intracellular recordings of spontaneous action potentials in type A and
type B MVN neurones. Spontaneous action potentials arise from a gradual
membrane depolarisation preceding the spike (arrows).
A. Type 'A' neurone, displaying a single deep AHP
B. Type 'B' neurone, displaying an initial fast, followed by delayed slower, AHP
(Adapted from the PhD thesis of A.R. Johnston (1995), University ofEdinburgh)
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AHP profiles indicated an intermediate subtype, unable to be classed as type A or
type B (Serafin et al, 1991a, b).
In confirmation of Gallagher's original observations, subsequent detailed
intracellular experiments using spike shape averaging, indicated the existence of only
two subtypes of MVN neurones in rat (Johnston et al., 1994; Him and Dutia, 2001).
Type A neurones (33% neurones recorded by Johnston et al., 1994) exhibit a single
deep AHP mediated by an apamin-insensitive Ca2+ activated K+ conductance and a
tetra-ethyl ammonium (TEA)-sensitive K+ conductance. Type B neurones (67%
neurones recorded by Johnston et al., 1994) exhibit an early fast AHP and a delayed
slow AHP, mediated by a TEA-sensitive K+ conductance and an apamin sensitive
Ca2+ activated K+ conductance respectively (see Fig. 1.4).
There is no difference between the firing rates of type A and type B neurones in
vitro. As mentioned above the two MVN cell subtypes differ in their active
membrane conductances, therefore different mechanisms regulate their tonic firing.
Type A neurones have a TEA sensitive K+ conductance (probably Ik), which is
responsible for action potential repolarisation. An A-like outwardly rectifying K+
conductance may also play a part in spike repolarisation as 4-aminopyridine slows
the rate of repolarisation. The single deep AHP is mediated by a Ca2+ dependent
outward conductance (perhaps Ic), evidenced by the fact that Ca2+ free Cd2+ medium
has only a small effect on the initial rate of repolarisation but greatly reduces the
AHP amplitude (Johnston et al 1994). In this medium, cells fire regularly indicating
that a Ca2+ activated membrane conductance is not essential for the regularity of their
tonic discharge. Depolarisation of the membrane between successive action
potentials involves a non-inactivating persistent Na+ conductance (iNap) (Serafin et
al., 1991a, b; Johnston et al., 1994) although the rate of depolarisation and the tonic
discharge may depend more on the rate of inactivation of K+ channels.
In type B neurones TEA blocks the initial fast AHP and slows the rate of
repolarisation. Rate of repolarisation was not much affected in a Ca2+ free medium,
indicating that as in type A neurones normal repolarisation of type B neurones is
largely mediated by a TEA sensitive K+ conductance (Johnston et al., 1994). The
delayed slow AHP is TEA insensitive, abolished in Ca2+ free medium and blocked
by apamin, and is probably due to a Ca2+ activated K+ current, maybe involving K+
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influx through small conductance K+ channels (SK channels). Blockage of SK
channels leads to an irregular pattern of firing, thus the Ca2+ mediated interspike
hyperpolarisation is important in regulating the timing of successive spikes. A non-
inactivating sodium conductance (lNap) which is active near the resting membrane
potential and continually depolarises the neurone towards firing threshold mediates
the spontaneous activity of type B neurones. (Serafin et al., 1991a, b; Johnston et al.,
1994). Around 30% these neurones exhibit a low threshold Ca2+ conductance that
may contribute to membrane depolarisation between successive spikes (Johnston et
al., 1994). A small component of the resting activity of MVN neurones in vitro may
come from synaptic inputs from within the same nucleus, since various
neurotransmitters and neuromodulators can modulate the spontaneous firing rates of
these neurones.
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1.3 PHARMACOLOGY OF THE VESTIBULAR SYSTEM
Neurotransmission and neuromodulation within the central vestibular system is
mediated through a range of amino acids, monoamines and neuropeptides.
Behavioural, biochemical and electrophysiological methods have been employed to
study the pharmacology of the vestibular system.
1.3.1 Amino acids
The amino acids glutamate, GABA and glycine are mediators of fast excitatory
and inhibitory transmission in the central nervous system, acting mainly through
ionotropic receptors. These amino acids regulate the majority of neurotransmission
and also have neuromodulatory roles in the central vestibular system.
Glutamate
The central nervous system contains two distinct groups of glutamatergic
receptors: ionotropic and metabotropic receptors. The ionotropic receptors are
subdivided into three groups: alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionate (AMPA), kainite, and N-methyl-D-aspartate (NMDA) glutamate
receptor subtypes. Metabotropic glutamate receptors (mGluRs) are G-protein
coupled receptors and regulate the production of intracellular messengers (Ozawa et
al., 1998). Both ionotropic and metabotropic glutamate receptors have been
identified in the vestibular nucleus complex (VNC) (for review, see de Waele et al.,
1995).
A large body of evidence has accumulated to suggest that glutamate and/or
aspartate is the major transmitter used between the primary vestibular nerve and the
second order vestibular nuclei neurones. Raymond et al. (1984), showed that
presynaptic primary vestibular nerve terminals in cat take up glutamate, and this
uptake is significantly decreased after nerve section. Ligand binding studies have
demonstrated high levels of glutamate binding sites in all vestibular nuclei, with the
highest density observed in the MVN (Touati et al., 1989; Walberg et al., 1990).
Glutamate receptor immunoreactivity is observed in vestibular afferents, and in cell
bodies in all parts of the VNC in frog and rat (Reichenberger and Dieringer, 1994;
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Reichenberger et al., 1997). All four vestibular nuclei are densely stained with
specific antibodies for AMPA-type glutamate receptors (Petralia and Wenthold,
1992), NMDA and kainite-type glutamate receptors (Petralia et al., 1994a, b; for
review of NMDA receptors, see Vidal et al., 1996). In situ hybridisation studies have
observed mRNA for a range of NMDA, non-NMDA and metabotropic glutamate
receptor subunits in the VNC (Horii et al., 2001). Microdialysis studies show that
glutamate is released from the eighth nerve, and electrical stimulation of this nerve
increases glutamate levels in the MVN (Yamanaka et al., 1995b, 1997).
In vitro electrophysiological studies corroborate the biochemical evidence
implicating glutamate as the major neurotransmitter between primary vestibular
afferents and second order vestibular nuclei neurones, and have further been used to
elucidate the glutamate receptor subtypes involved in this transmission. Extracellular
and intracellular studies in brainstem slices have shown that synaptic responses
evoked in neurones assumed to be second order MVN neurones, by electrical
stimulation of the eighth nerve are blocked by AMPA or kainite receptor antagonists,
but not by NMDA receptor antagonists (Cochran et al., 1987; Lewis et al., 1989; Doi
et al., 1990; Carpenter and Hori, 1992). However, subsequent patch clamp studies
using slices from young rats (postnatal days 4-25), showed that excitatory
postsynaptic potentials (EPSPs) induced in the MVN by electrical stimulation of the
eighth nerve can be blocked by NMDA receptor antagonists at high levels of
depolarisation (Kinney et al., 1994; Takahashi et al., 1994). These results may reflect
the presence of NMDA receptor mediated transmission in response to high frequency
vestibular nerve stimulation. However the discrepancy between the two groups of
data may be due to the age of animals used, as developmental difference exist in the
CNS in the expression of NMDA receptors (e.g. Tremblay et al., 1988).
Using in vitro whole brain preparation of young adult guinea pigs, Babalian et al.
(1997) reported that about a third of second order MVN neurones displayed NMDA
receptor mediated transmission. Most of the field potentials in the MVN, and the
EPSPs recorded from individual neurones were blocked by the AMPA/kainite
receptor antagonist CNQX, but any remaining components were blocked with the
NMDA receptor antagonist APV. Apart from their role in synaptic transmission,
NMDA receptors probably play a role in information processing in the VNC as there
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is evidence that they mediate commissural inputs from the contralateral VN, and
inputs from the spinal cord (Cochran et al., 1987; Knopfel, 1987).
Glutamate may also modulate the activity of vestibular nucleus neurones.
Application of NMDA receptor antagonists to in vitro brainstem slices, decreased the
firing rates of extracellularly recorded MVN neurones (Smith et al., 1990; Smith and
Darlington, 1992; Lin and Carpenter, 1993). This indicates that the tonic release of
glutamate, acting on NMDA receptors, modulates the spontaneous firing of MVN
neurones in vitro. MVN neurones recorded intracellularly from brainstem slices were
depolarised by both NMDA and AMPA/kainite receptor agonists, with an increase in
spontaneous discharge and an apparent decrease in membrane resistance (Lewis et
al., 1987, 1989; Serafin et al., 1992). A behavioural study in alert guinea pig
recorded that chronic infusion of the specific NMDA receptor antagonist D-APV into
the vestibular nuclei on one side of the brain induced a postural and oculomotor
syndrome similar to the one observed following acute vestibular deafferentation (de
Waele et al., 1990). The authors concluded that NMDA receptors contribute to the
resting discharge of VN neurones and consequently may be involved in static
vestibular reflexes.
GABA and glycine
Glycine and Y-arnin°butyaric acid (GABA) are the main inhibitory
neurotransmitters in the CNS. There are two types of GABA receptors in the
vestibular nuclei. GABAa receptors are ligand-gated receptors which are directly
associated with CI" ion channels in the membrane. GABAb receptors are linked to G-
proteins, or intracellular effector systems, and inhibit adenylate cyclase activity.
GABAb activation can also cause an increase in K+ conductance, or a decrease in
voltage-dependent Ca2+ currents resulting in neuronal inhibition (Bowery et al.,
2002). Glycine receptors are ligand-gated receptor channels that have similar
permeability and conduction properties to the GABAa receptor channel (Barry et al.,
1999).
Immunohistochemical studies using antibodies raised against GABA, glycine or
glutamic acid decarboxylase (GAD; the GABA synthesising enzyme), have
identified GABA and glycine containing cells, fibres and granules throughout the
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VNC in a range of species (Houser et al., 1984; Nomura et al., 1984; Kumoi et al.,
1987; Walberg et al., 1990; Spencer and Baker, 1992; Zanni et al., 1995;
Reichenberger et al., 1997; Holstein et al., 1999a). In addition, GABA and glycine
have been shown to co-localise in some MVN neurones (Walberg et al., 1990;
Lahjouji et al., 1996; Russier et al., 2002). GABA-immunoreactive (-ir) cells are
mostly small and lie scattered throughout the VNC with highest levels observed in
the MVN, where medium sized GABA-ir cells are also observed (Kumoi et al.,
1987; Walberg et al., 1990). In agreement with these data, in situ hybridisation with
probes for GAD and GABAa alpha 1 receptor subunit mRNA, localised these
mRNAs throughout the VNC with highest levels of GAD mRNA in the MVN
(Hironaka et al., 1990; de Waele et al., 1994; Zanni et al., 1995). GABAa, GABAb
and glycine receptors are widely distributed post-synaptically on vestibular neurones,
and GABAb receptors are also presynaptically located (Holstein et al., 1992; Lapeyre
and De Waele, 1995).
GABA and glycine mediate synaptic transmission at a number of inhibitory
synapses in the vestibular nucleus complex. The tonic discharge of ipsilateral
vestibular neurones in mammals is inhibited by stimulation of the contralateral eighth
nerve via a commissural system linking the two vestibular nuclei (see Section 1.1.3).
Precht et al. (1973) demonstrated that the ipsilateral IPSPs, generated by electrical
stimulation of the contralateral eighth nerve in cat in vivo, were blocked by systemic
injection of the GABAa agonist, bicuculline, or the glycine agonist, strychnine, but
not by both. This suggested that commissural inhibition is mediated by either
GABAa, or glycine receptors. In contrast, more recent experiments in cat suggest
that glycine only plays a minor role in commissural inhibition, the majority of this
inhibition being GABAergic (Furuya and Koizumi, 1998). Furuya and Koizumi
observed that bicuculline, applied iontophoretically to the ipsilateral vestibular nuclei
neurones, abolished the field potential evoked by contralateral vestibular nerve
stimulation, whereas strychnine did not. The discrepancy between the two studies
may be due to the location of drug administration, as the systemic administration of
Precht et al. (1973) could have affected other CNS regions. However, it is possible
that both GABA and glycine together are involved in mediating the commissural
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inhibition since both neurotransmitters co-localise in some MVN neurones as
discussed below.
The vertical and horizontal canal vestibulo-ocular reflex (VOR) neurones are
located in the SVN and MVN, respectively (see Section 1.1.2). The vertical VOR is
mediated primarily via GABAa receptors, as vestibulo-evoked inhibition of trochlear
motorneurones is blocked by intravenous bicuculline; in addition, lesioning of the
medial longitudinal fasciculus (MLF) which carries all the inhibitory vertical VOR
fibres causes a significant reduction in the concentration of GABA in the trochlear
and oculomotor nuclei (Precht et al., 1973). The short relay pathway of the
horizontal VOR is a disynaptic pathway: first order vestibular neurones from the
horizontal semicircular canal stimulate second order neurones in the MVN, which
inhibit ipsilateral or stimulate contralateral, motorneurones in the abducens nuclei.
Early electrophysiological data indicated that glycine was the inhibitory transmitter
used in the horizontal VOR pathway: Glycinergic but not GABAergic antagonists
blocked the disynaptic IPSP recorded in the ipsilateral abducens nucleus following
stimulation of the ipsilateral vestibular nerve. In addition, immunohistochemical data
revealed high levels of glycine-ir in the abducens nuclei with low levels in the
oculomotor and trochlear nuclei, and high levels of GABA-ir in the oculomotor and
trochlear nuclei with low levels in the abducens nuclei (Spencer et al., 1989).
However more recent studies have indicated that GABA and glycine may be co-
localised in the vestibular and oculomotor nuclei (Walberg et al., 1990).
Immunocytochemical techniques revealed that 9% of individual synaptic terminals
impinging on rat abducens nucleus motorneurones were immunoreactive for both
GABA and glycine (Lahjouji et al., 1996). In corroboration of this data, a whole cell
patch clamp study in young rat abducens nucleus motorneurones, recorded a
proportion miniature IPSP responses indicative of single evoked vesicles containing
both neurotransmitters (Russier et al., 2002). This GABA and glycine co-release was
also identified during transmitter release evoked after stimulation of the ipsilateral
MVN. Thus there may be a co-operation between GABA and glycine in the
inhibitory transmission at the abducens nucleus, and perhaps in other efferent
pathways from the MVN.
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The majority of inhibitory vestibulo-spinal neurones are glycinergic but
GABAergic projections exist in some species. Felpel (1972) demonstrated that
intravenous injection of glycine, but not GABA antagonists, depressed the amplitude
of the IPSP recorded in neck motorneurones in cat, after electrical stimulation of the
vestibular nerve. Immunohistochemistry for GAD, combined with retrograde tracing
from the spinal cord have identified GAD-ir neurones in the MVN, LVN and IVN
which project to the spinal cord in rabbit and rat (Blessing et al., 1987; Valla et al.,
2003). The above findings point to the involvement of both the GABAergic and
glycinergic systems in the control of vestibulo-ocular and vestibulo-spinal pathways.
In addition to their involvement in efferent projections from the VN, GABA and
glycine are likely to contribute to inhibitory interactions within specific vestibular
nuclei. Using ultrastructural visualisation of neurones in the MVN, Holstein et al.
(1999a) observed GABAergic cells which were involved in complex local synaptic
interactions which they concluded may represent a class of vestibular interneurones.
In vitro, electrophysiological experiments in brainstem slices containing the MVN
have confirmed the presence of locally acting GABA and glycine within this region.
Exogenous application of GABA or glycine to guinea pig MVN slices, inhibited the
tonic firing rate in around 50% of neurones tested (Smith et al., 1991). In contrast,
Dutia et al. (1992) observed an inhibition in the firing rate of all MVN neurones in
response to GABA or its agonists. This inhibition could be blocked by both GABAa
and GABAb receptor antagonists, indicating that both receptor subtypes are present
on MVN neurones (Dutia et al., 1992). The discrepancy in GABA actions between
the two experiments may be due to differences in the thickness of slices used. Dutia
and colleagues found that low micromolar doses of GABA were less efficient at
inhibiting neurones in thicker slices (350-500pM), but inhibited all neurones in slices
of less that 350pM, probably due to a greater uptake and metabolism of GABA in
thicker slices. The slices used by Smith and colleagues ranged from 400-600pM in
thickness.
Intracellular studies by Vibert et al. (1995b,c), demonstrated that both type A and
type B MVN neurones were hyperpolarized by the GABAa agonist, muscimol and
the GABAb agonist, baclofen in the presence of tetrodotoxin (TTX); while in normal
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medium some cells were hyperpolarized and some depolarised. This suggests that
local inhibitory interneurones are spontaneously active in vitro and can modulate the
activity of MVN neurones via GABAa and GABAb receptors. While the brainstem
slice study of Smith et al. (1991) showed that 50% of MVN neurones were inhibited
by exogenous glycine, Lapeyre and de Waele (1995) demonstrated that all MVN
neurones in vitro were inhibited by glycine in a dose dependant manner. This
inhibition persisted in low Ca2+/high Mg2+ solution, indicating a postsynaptic site of
action.
1.3.2 The cholinergic system
The cholinergic system is one of the most important modulatory transmitter
systems in the brain. Acetylcholine (ACh) acts through two types of receptors:
nicotinic and muscarinic. Nicotinic receptors are ligand gated ion channels, which act
by directly regulating the opening of cation channels. Muscarinic receptors belong to
the family of G-protein coupled receptors, and act through a range of second
messenger systems (Pompeiano, 2000). Acetylcholine receptors are located both pre-
and postsynaptically, including on presynaptic terminals of cholinergic neurones
where they can inhibit ACh release via muscarinic receptors or enhance ACh release
via nicotinic receptors.
Receptor binding and immunohistochemistry studies have revealed the presence
of both muscarinic and nicotinic receptors throughout the VNC, particularly in the
MVN. (Rotter et al., 1979; Wamsley et al., 1981; Schwartz, 1986; Swanson et al.,
1987; Calza et al., 1992). In situ hybridisation studies have identified cells containing
mRNA coding for the m2 subunit type of muscarinic receptors (Vilaro et al., 1992)
and different types of nicotinic receptor subunits (Wada et al., 1989) in the vestibular
nuclei of rats. All vestibular nuclei have been shown to display choline-
acetyltransferase (ChAT; the ACh synthesising enzyme) immunoreactivity, with
highest levels found in the MVN (Carpenter et al., 1987; Barmack et al., 1992b).
Indeed studies of ChAT localisation have been widely used to identify ACh as one of
the main efferent neurotransmitter in the VNC (Barmack et al., 1992c; Goldberg et
al., 2000).
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Application of ACh to LVN and MVN neurones in vivo, modulates their activity,
increasing the extracellularly recorded spontaneous firing rates of these cells (Kirsten
and Schoener, 1973; Kirsten and Sharma, 1976a,b). These effects were blocked by
muscarinic but not nicotinic receptor antagonists. The results of these in vivo
experiments were confirmed using extracellular recordings in vitro in vestibular
nucleus neurones (Ujihara et al., 1988, 1989; Dutia et al, 1990; Carpenter and Hori,
1992). Ujihara and colleagues showed that 66.7% of extracellularly recorded MVN
neurones exhibit a dose dependant increase in spontaneous activity after application
of the ACh agonist carbachol; 22.2% of neurones showed a decrease in spontaneous
activity, with no change in the remaining neurones. The excitatory or inhibitory
effects of carbachol were mimicked by muscarine, not nicotine, and were
antagonised by atropine, indicating a role for muscarinic but not nicotinic receptors
in modulation of vestibular neuronal activity. Other studies have recorded similar
results (Dutia et al., 1990; Caipenter and Hori, 1992).
In contrast, intracellular experiments recording from MVN neurones, have shown
that ACh acts through both muscarinic and nicotinic receptors in the MVN (Phelan
and Gallagher, 1992; Sun et al., 2002). MVN neurones responded to ACh or
carbachol with membrane depolarisation, and similar results were obtained with
application of selective nicotinic or muscarinic agonists. The muscarinic induced
depolarisations were linked to a decrease in conductance due to closure of K+
channels, whereas the nicotinic induced depolarisations were linked to an increase in
conductance due to the opening of cation channels. Both types of depolarisation
persisted in low Ca2+/high Mg2+ solution indicating a postsynaptic site of action
(Phelan and Gallagher, 1992; Sun et al., 2002). In addition to the excitatory effects, a
minority of MVN neurones show a transient hyperpolarisation during muscarinic
receptor agonist application (Dutia et al., 1990; Phelan and Gallagher, 1992). This
hyperpolarisation was blocked by antagonists of GABAa receptors, indicating that
activation of muscarinic receptors either postsynaptically on GABA intemeurones, or
presynaptically on GABA terminals, causes an increase in this inhibitory
neurotransmitter (Phelan and Gallagher, 1992).
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1.3.3 The monoaminergic system
Monoamines are modulatory transmitters in the central nervous system. The five
monoamines (histamine, serotonin, dopamine, noradrenaline and adrenaline) have
more dispersed and moderate effects on neurones than amino acids. Most only
activate metabotropic receptors through second messenger systems and therefore
have much slower effects upon neuronal activity.
Histamine
In mammals, all histaminergic neurones of the central nervous system are located
in the tuberomammillary nucleus of the posterior hypothalamus, and their fibres are
found in almost all regions of the brain. Three types of metabotropic histaminergic
receptors have been identified. H) and H2 receptors are located postsynaptically and
generally induce neuronal excitability through positive coupling to phospholipase C
and adenylate cyclase respectively. H3 receptors are located on presynaptic terminals,
predominantly of histaminergic neurones, where they exert a negative control on the
synthesis and release of histamine (Vibert et al., 2000b).
There are several lines of evidence suggesting that the histaminergic system
modulates the function of central vestibular neurones. A direct projection from the
tuberomammillary nucleus to the VNC is observed in rat (Takeda, 1987; Panula et
al., 1989; Steinbusch, 1991), guinea pig (Airaksinen and Panula, 1988), and cat
(Tighilet and Lacour, 1996, 1997). Ligand binding and in situ hybridisation studies
have located Hi, H2, and H3 binding sites in all vestibular nuclei, with highest levels
observed in the SVN and MVN (Bouthenet et al., 1988; Ruat et al., 1991; Pillot et
al., 2002). Early in vivo electrophysiological studies by Kirsten and colleagues
reported that iontophoretic application of histamine caused a decrease in firing rate in
the majority of vestibular neurones in cat (Kirsten and Sharma, 1976a; Satayavivad
and Kirsten, 1977). This inhibitory action of histamine was blocked by the H2
receptor antagonist, metiamide but not by the Hi receptor antagonist,
diphenhydramine.
In contrast, in vitro electrophysiological studies in guinea pig using intracellular
recording techniques, demonstrated that application of histamine predominantly
produced membrane depolarisation and an increase in the tonic firing rate of MVN
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neurones (Serafin et al., 1993). These effects of histamine could be mimicked by the
H2 agonist, impromidine and were inhibited by the H2 antagonist, cimetidine. The
histamine induced depolarisations persisted in high Ca2+/low Mg2+ solution, and
were unaffected by application of a Hi receptor antagonist or H3 agonists or
antagonists (Serafin et al., 1993). The authors concluded that histaminergic
depolarisation of MVN neurones is mediated through postsynaptic H2 receptors.
However, extracellular recordings in brainstem slices from rats demonstrated that
histamine acts postsynaptically through both Hi and H2 receptors (Inverarity et al.,
1993; Wang and Dutia, 1995). The discrepancy between these studies may be due to
species differences in either the anatomical distribution or the pharmacological
properties ofHi receptors.
The presence of H3 receptors within the MVN, which may modulate vestibular
neuronal activity was demonstrated by in vivo studies in the alert guinea pig (de
Waele et al., 1992; Yabe et al., 1993). Unilateral perfusion of the H3 agonist, alpha-
methylhistamine, or the H2 antagonist, cimetidine caused a postural and oculomotor
syndrome directed towards the side of the infusion, similar to the syndrome observed
after unilateral labyrinthine destruction. This suggests that histaminergic fibres
reaching the vestibular nuclei are endowed with presynaptic H3 receptors, the
activation of which inhibits tonic histamine release inducing a decrease in firing rate
of ipsilateral vestibular neurones.
Serotonin
Serotonergic neurones of the CNS are located within the brainstem reticular
formation. Serotonin receptors are classified into 4 main groups: 5-HTi, 5-HT2 and
5-HT4 are metabotropic receptors, and 5-HT3 is an ionotropic receptor. 5-HTi
receptors have a high affinity for serotonin and are divided into three subtypes (5-
HTia, 5-HTib and 5-HTiD), which are located pre- and postsynaptically and are
generally negatively coupled to adenylate cyclase. 5-HT2 receptors are also divided
into three subtypes (5-HT2A, 5-HT2C and 5-HT2c), the receptors are located both pre-
and postsynaptically and are positively coupled to phospholipase C.
Immunohistochemical studies have demonstrated that the vestibular nuclei receive a
dense serotonergic innervation, probably originating from the dorsal raphe nucleus
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(Steinbusch, 1981; Giuffrida et al., 1991; Zanni et al., 1995; Halberstadt and
Balaban, 2003). A recent in vivo microdialysis study has demonstrated the release of
serotonin from nerve terminals within the MVN (Inoue et al., 2002). Accordingly,
several autoradiographic and in situ hybridisation studies have detected 5-HTia, 5-
HTjb and 5-HT2 receptors (or corresponding mRNA) located in all vestibular nuclei
(Pazos et al., 1985; Pazos and Palacios, 1985; Zanni et al., 1995).
Serotonin may modulate the function of central vestibular neurones. Intra-
cerebroventricular injection of serotonin has been shown to increase the gain of the
vestibulo-ocular reflex in rat (Ternaux and Gambarelli, 1987). In vivo
electrophysiological studies have demonstrated excitatory, inhibitory or biphasic
responses to iontophoretically applied serotonin in the MVN and SVN (Licata et al.,
1993a). In vitro, serotonin mainly depolarises MVN neurones in rat brainstem slices
(Gallagher et al., 1992; Johnston et al., 1993). The observed depolarisation was
mediated via 5-HT2 receptors as application of a range of 5-HT2 receptor antagonists
blocked the depolarisation. A minority of cells in vitro were depolarised by serotonin
acting through 5-HT]A receptor subunits (Johnston et al., 1993).
Dopamine
Dopamine can activate at least five distinct subtypes of metabotropic receptors.
These five receptors are grouped into two classes according to their pharmacological
properties (Civelli et al., 1993). Di-like receptors (Di and D5) are located pre- and
postsynaptically and are generally positively coupled to adenylate cyclase; the
presynaptically located receptors mainly stimulate neurotransmitter release. D2-like
receptors (D2, D3 and D4) are also pre- and postsynaptically located and are generally
negatively coupled to adenylate cyclase; the presynaptically located receptors mainly
inhibit neurotransmitter release (Starke et al., 1989).
The vestibular nuclei have not been shown to receive any specific dopaminergic
innervation (Moore and Bloom, 1978). However an autoradiography study in rat has
identified D2 receptors in the vestibular nuclei, with highest levels in the MVN
(Yokoyama et al., 1994), and an in situ hybridisation study has located D2 receptor
mRNA in the MVN (Bouthenet et al., 1991). Electrophysiological experiments
support the notion of dopaminergic modulation of the vestibular system. Application
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of dopamine in vitro, depolarised MVN neurones in rat (Gallagher et al., 1992) and
guinea pig (Vibert et al., 1995a). The dopamine induced depolarisations in the guinea
pig MVN were mimicked by a selective D2-like receptor agonist, but not by a Dj-like
receptor agonist. When synaptic transmission was blocked in this preparation using
low Ca2+/high Mg2+ solution, the depolarising effect of the D2-like receptor agonist
was reversed to a hyperpolarisation. This hyperpolarizing effect was also observed in
the presence of the GABAa receptor antagonist, bicuculline, indicating that
dopamine may have a postsynaptic hyperpolarizing effect on MVN neurones, and
can also act to depolarise MVN neurones by presynaptically inhibiting the tonic
release of GABA.
Noradrenaline
Most noradrenergic neurones in the CNS originate from the locus coeruleus and
the nucleus subcoeruleus. Adrenergic receptors can be classified into three main
groups: cti, a2 and (3 receptors. Alphat receptors (consisting of four distinct subtypes;
ctiA to 0CiD) are generally presynaptically located and are positively coupled to
phospholipase C, increasing intracellular calcium. Alpha2 receptors have at least
three distinct receptor subtypes, are pre- and postsynaptically located and are
generally negatively coupled to adenylate cyclase, decreasing transmitter release and
hyperpolarising membranes. Beta receptors (consisting of three distinct subtypes; (3i,
P2 and (33) are pre- and postsynaptically located, are generally positively coupled to
adenylate cyclase, stimulating transmitter release and depolarising membranes.
It has been postulated that the noradrenergic system could play and important
role in regulation of vestibulo-spinal and vestibulo-ocular reflexes (Pompeiano,
1989; Tan et al., 1991), yet only recently has a noradrenergic projection to the VNC
been found. Schuerger and Balaban (1993) demonstrated projections from the locus
coeruleus and the A4 region of the nucleus subcoeruleus to all regions of the VNC
using antibodies raised against tyrosine hydroxylase and dopamine (3-hydroxylase.
The highest densities of noradrenergic fibres were found in the superior and lateral
vestibular nuclei. Autoradiographic and immunocytochemical studies have revealed
the presence of (3 and a2 noradrenergic receptors in the VNC (Wanaka et al., 1989;
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Fernandez-Lopez et al., 1990). While (3 receptors are abundant in the SVN and LVN,
a2 receptors are mostly concentrated in the MVN (Talley et al., 1996). In situ
hybridisation studies have located mRNA for the ai, a2A and a2c receptor subtypes
in all vestibular nucleus subnuclei (Nicholas et al., 1993; Pieribone et al., 1994).
Electrophysiological data support a role for noradrenergic modulation of
vestibular neurones. In vivo, iontophoretic application of noradrenaline in
cerebellectomised cats generally increased the resting activity of LVN neurones,
whereas it mostly decreased it in MVN neurones (Yamamoto, 1967; Kirsten and
Sharma, 1976b). In contrast, an in vivo study in rat found that iontophoretically
applied noradrenaline inhibited most SVN and LVN neurones, acting through a2
receptors (Licata et al., 1993b). The discrepancy between these results may be due to
the different in vivo preparations used. In vitro electrophysiological experiments have
sought to elucidate the noradrenergic receptor subtypes present on vestibular
neurones. Podda et al. (2001), recording extracellularly in MVN neurones from rats,
found that the majority of neurones were responsive to application of noradrenaline,
and in 87% of noradrenaline sensitive neurones excitatory responses were recorded.
The excitatory effects were mimicked by ai and (3 receptor agonists and were
antagonised by ai and (3 receptor antagonists. Inhibitory responses were antagonised
by a2 receptor antagonists. This data is in accordance with intracellular recordings
from guinea pig MVN neurones (Vibert et al., 2000b). The (3 receptor agonist,
isoproterenol, depolarised 60% of MVN neurones while decreasing their membrane
resistance. The ai receptor agonist, L-phenylephrine depolarised 60% of MVN
neurones while increasing their membrane resistance and the a2 receptor agonist,
clonidine hyperpolarized most MVN neurones while decreasing their membrane
resistance (Podda et al., 2001). The hyperpolarizing effects of clonidine persisted in
synaptic uncoupling conditions, indicating a postsynaptic site for a2 mediated
inhibitions, while most ai and (3 responses were indirectly modulated.
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1.3.4 The neuropeptide system
Numerous neuropeptides have been identified in the central nervous system, most
of which act through specific metabotropic receptors. Pharmacological and
electrophysiological studies have provided evidence that several neuropeptides act as
modulators of central vestibular neurones, including the opioid peptides,
somatostatin, substance P and adrenocorticotropin (for review, see Saxon and Beitz,
2000).
The opioid peptides
Opioid peptides are classified into three different families; enkephalins, (3-
endorphins and dynorphins. These peptides act on three different types of opioid
receptor; jll, 5 and k. Enkephalins have the highest affinity for 8 receptors but can
also bind to p receptors, (3-endorphins bind equally well to p and 8 receptors,
whereas dynorphins have a high affinity for K opioid receptors but can also bind to p
and 8 receptors. All opioid receptors are coupled to G-proteins; p and 8 receptors
mediate the inhibition of adenylate cyclase and the activation of inwardly rectifying
potassium channels, and k and 8 receptors can also inhibit the opening of voltage
dependant Ca2+ channels (Brownstein, 1993).
Enkephalin terminals and enkephalin immunoreactive cell bodies have been
detected within the vestibular nucleus complex (Hokfelt et al., 1977; Finley et al.,
1981a; Nomura et al., 1984; Merchenthaler et al., 1986). Cells positive for
preproenkephalin (the precursor for Met- and Leu-enkephalin) mRNA were observed
in the MVN and IVN (Saika et al., 1993), and the proenkephalin peptide is found in
the fibre plexuses of these same regions (Balaban et al., 1989). Accordingly, the
MVN contains neurones expressing both enkephalin mRNA and peptide, and is rich
in opiate receptors (Zanni et al., 1995). There is little evidence for the presence of
endorphins within the vestibular nuclei, whereas low levels of dynorphins have been
observed in the MVN and IVN using immunohistochemical techniques (Zamir et al.,
1983).
Electrophysiological studies have provided conflicting evidence relating to the
physiological effects of opioids on vestibular neurones. Carpenter and colleagues
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reported that 30% of tonically active rat MVN neurones in vitro were excited by
iontophoretic application of both the specific p. receptor agonist, morphine, and by
the 8 receptor agonist, ala-leu-enkephalin (Carpenter and Hori, 1992; Lin and
Carpenter, 1994). The excitation was blocked by the p and 8 receptor antagonist
naloxone, and persisted in synaptic uncoupling conditions indicating the presence of
postsynaptic p and 8 receptors on MVN neurones. In contrast, studies by Kawabata
et al. (1990) and Sulaiman and Dutia (1998) observed mainly inhibitory effects of
opiates on MVN neurones. Kawabata et al. (1990) demonstrated that enkephalin,
applied iontophoretically to anaesthetised cats in vivo, inhibited the firing of type I
MVN neurones responding to horizontal rotation. Using extracellular and whole cell
patch clamp recordings in vitro, Sulaiman and Dutia (1998) observed that the large
majority of MVN neurones were inhibited by the 8 receptor agonists [D-Ala2, D-
Leu5]-enkephalin (DADLE), and [D-Pen2, D-Pen3]-enkephalin (DPLPE). This
inhibition persisted in synaptic uncoupling conditions and was blocked by the
selective 8 receptor antagonist naltrindole, indicating that it was mediated by
postsynaptic 8 receptors. Selective p and k opioid receptor agonists had no effect on
the discharge of any MVN neurones tested. The discrepancy between these findings
may be due to the method of opiate agonist application, as the iontophoretic
application of Lin and Carpenter (1994) cannot calibrate the applied drug to the pH
of the perfusing aCSF.
Somatostatin
There are four different types of somatostatin receptor, SS1.4. They are
negatively coupled via G-proteins to adenylate cyclase and can modulate Ca2+ and
K+ channels to cause a decrease in neuronal excitability. Somatostatin
immunoreactive cell bodies and axons have been demonstrated throughout the
vestibulo-cerebellum and VNC, with highest densities of fibres observed in the MVN
(Finley et al., 1981b; Johansson et al., 1984; Vincent et al., 1985; Zanni et al., 1995).
The vestibular nuclei display intermediate to high concentrations of high affinity
binding sites for somatostatin, with greatest binding in the MVN (Uhl et al., 1985).
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Behaviourally, intraventricular injection of somatostatin in rat results in a
postural syndrome similar to that seen after unilateral labyrinthine destruction, the
effect of which is blocked by antimuscarinic drugs, suggesting an indirect action of
somatostatin on vestibular function (Balaban et al., 1989). Despite this, Chan-Palay
et al. (1982) recorded that iontophoretic application of somatostatin in rabbits
depressed the resting activity of LVN neurones. LVN neurones receive a large
Purkinje cell input from the cerebellar vermis and these cells are somatostatin
immunoreactive (Chan-Palay et al., 1982), thus somatostatin may be released as a
co-transmitter with GABA in vestibulo-cerebellar pathways.
Substance P
Substance P was the first neuropeptide discovered in the body and is now
recognised as a neurotransmitter and neuromodulator in the central and peripheral
nervous systems. Substance P is one of three tachykinins in the CNS, the others
being neurokinin A and neurokinin B. These molecules act on receptors named NK-
1, NK-2 and NK-3 respectively, all of which are G-protein coupled receptors. Many
substance P immunoreactive (-ir) fibres and cell bodies have been demonstrated in
the vestibular complex. Whilst substance P -ir fibres are found in all four main
vestibular nuclei (Nomura et al., 1984), substance P -ir cell bodies have been
visualised exclusively in the caudal region of the MVN and throughout the IVN
(Ljungdahl et al., 1978; Nomura et al., 1984). Since there are no substance P -ir cell
bodies in the SVN and LVN, the immunoreactive fibres probably originate from the
MVN, IVN or from primary vestibular neurones which are substance P -ir (Usami et
al., 1991). Receptor autoradiography and in situ hybridisation techniques have
located substance P binding sites and NK-1 mRNA in the MVN (Maeno et al., 1993;
Zanni et al., 1995).
Only one electrophysiological study has examined the effect of substance P on
vestibular neurones in vitro. Vibert et al. (1996) recording intracellularly from guinea
pig MVN neurones, demonstrated that bath application of substance P caused a
depolarisation and increase in membrane resistance in around 50% of the neurones,
while it inhibited and caused a decrease in membrane resistance in 10% of neurones.
Both responses persisted under synaptic uncoupling conditions indicating a
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postsynaptic site of action. The substance P induced depolarisations could not be
reproduced with agonists of the three tachykinin receptor subtypes, nor was it
blocked by specific NK-1 receptor antagonists, suggesting the involvement of a new,
pharmacologically distinct 'NK-l-like' receptor. The observed hyperpolarisations
were mimicked by specific NK-1 receptor agonists, suggesting that hyperpolarising
effects are mediated via the typical NK-1 receptors observed in the MVN (Vibert et
al., 1996).
Adrenocorticotropic hormone
Adrenocorticotropic hormone (ACTH) belongs to the melanocortin family of
peptides. Melanocortin receptors can be divided into 5 subtypes (MRC1-5), all are
G-protein associated, and are positively coupled to adenylate cyclase (Tatro, 1996).
Radioimmunoassay and immunocytochemical studies have failed to find ACTH
binding sites or ACTH containing fibres in the VNC (Palkovits, 1984). Despite this,
electrophysiological studies of MVN neurones in vitro have indicated that around
50% of these neurones respond to the 4-9 or 4-10 fragments of ACTH, mostly with a
decrease in their resting discharge (Darlington et al., 1992; Gilchrist et al., 1994,
1996a). In vivo, ACTH4_i0 has been shown to accelerate behavioural recovery from
unilateral labyrinthine destruction in a range of species (Flohr and Luneburg, 1982;
Igarashi et al., 1985; Gilchrist et al., 1990; Gilchrist et al., 1994). Thus ACTH
fragments appear to have a significant effect on the vestibular system despite the lack
of evidence for its presence in the vestibular system. It may be that ACTH4.10 acts
allosterically on non-melanocortin receptors, such as the glutamate NMDA receptor
(Darlington et al., 1996), or, as ACTH can be secreted directly into the CSF via the
choroids plexus, it could be reaching the MVN via the CSF of the IVth ventricle
(Saxon and Beitz, 2000).
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Summary
The vestibular system is involved with both sensing and controlling movement
and orientation in space. The peripheral vestibular organs detect angular and linear
accelerations of the head in three dimensions, and this information is conveyed to the
central vestibular nuclei. Here it converges with visual and somatosensory
information from centres such as the cerebellum and inferior olive, and information
is further modulated by the intrinsic properties of vestibular nucleus neurones
themselves. Multiple neurotransmitter systems and neuromodulators converge on the
vestibular nuclei, thus are involved in control of movement and posture. Excitatory
and inhibitory amino acids and their receptors play a major role in vestibular function
while acetylcholine, monoamines and neuropeptides play to some extent secondary






Unilateral damage to the peripheral vestibular system, as a consequence of
destruction of the vestibular receptor cells (unilateral labyrinthectomy, UL) or
transection of the vestibular nerve itself (unilateral vestibular deafferentation, UVD),
results in a characteristic syndrome of ocular motor and postural symptoms. These
symptoms can be divided into two categories on the basis of their relationship to
head movement. Static symptoms are those present in the absence of head movement,
affecting posture and eye movements (e.g. spontaneous nystagmus, yaw and roll
head tilts), whereas dynamic symptoms are elicited by head movements, and result in
deficits in the amplitude and timing of vestibulo-ocular and vestibulo-colic reflexes.
Over time many of these symptoms subside in a process of behavioural recovery
known as vestibular compensation (VC). Vestibular compensation is a complex,
heterogeneous process, with wide varieties in the time course and ultimate level of
compensation for different symptoms, and strong inter-species variability regarding
all aspects of compensation. Generally static symptoms undergo a remarkable degree
of recovery, many symptoms disappearing within a few days following UL, while
compensation of dynamic symptoms is much slower and often incomplete.
Vestibular compensation is independent of any regeneration of the peripheral
vestibular receptors, or any functional recovery of the cells in Scarpa's ganglion, and
therefore is attributed to central nervous system (CNS) plasticity. Vestibular
compensation is a valuable model of CNS plasticity for two main reasons: First, the
extent of the peripheral lesions can be precisely controlled and easily reproduced;
second, the neuronal networks underlying the vestibular system are relatively simple,
with input and output relations that can be quantified on both behavioural and
neuronal levels.
Despite a tremendous amount of research over the last 40 years into the
behavioural and neural correlates of compensation in different species, the exact
mechanisms of vestibular compensation, and where they reside in the CNS, are
poorly understood.
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2.2 BEHAVIOURAL COMPONENTS OF VESTIBULAR COMPENSATION
2.2.1 Static Symptoms
The first description of the static oculomotor and postural symptoms resulting
from unilateral labyrinthine destruction, and their gradual recovery, was recorded in
1823 by Flourens (cited in Schaeffer and Meyer, 1974). Sixty years later, Bechtrew
(1883) provided evidence for the hypothesis that the symptoms of labyrinthine
lesions are due to the loss of resting activity in one vestibular nucleus, and
rebalancing of this neural activity is responsible for the disappearance of the static
symptoms (cited in Schaeffer and Meyer, 1974). Bechtrew reported that if a second
labyrinthectomy was performed on the remaining intact labyrinth of an animal a few
days or weeks after the first, a reappearance of the original symptoms of UL are
observed but are reversed in their direction. This phenomenon is known as
"Bechtrew compensation" and indicates that neural rebalancing must have taken
place in the interval between the two labyrinthectomies.
Spontaneous nystagmus
In mammals, the most easily quantified effect of UL is a high frequency
sustained horizontal ocular nystagmus (SN) seen as a slow drift of the eyes towards
the lesioned side (slow phase) followed by a fast beat towards the intact side (quick
phase). It is the direction of the quick phase that is most easily observed, and
frequency of SN is recorded as quick phase beats per minute. Soon after UL, the
frequency of SN in rat and guinea pig is around 80-180 beats per minute (Schaefer
and Meyer, 1974; Sirkin et al., 1984; Magnusson et al., 2002). In submammalian
species such as frogs, SN does not occur (Dieringer, 1995). The frequency of SN
begins to decrease immediately after UL, with the time required for the
disappearance of SN remaining similar between mammalian species with complete
disappearance observed from around 15 hours in rat to a few days in human (Maioli
et al., 1983; Maioli and Precht, 1984; Sirkin et al., 1984; Curthoys et al., 1988; Fetter
and Zee, 1988; Cass et al., 1992; Hamann et al., 1998).
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Ocular skew deviation
UL results in disturbances in the position of the eyes. In humans, this ocular
skew deviation results in the eye on the affected, side moving down in its orbit
relative to the eye on the intact side, which remains in a normal position (Curthoys
and Halmagyi, 1999). In guinea pigs and rats, the eye on the side of the lesion
deviates down, and the other eye deviates up (Schaefer and Meyer, 1974; Sirkin et
al., 1984). A comparable deviation is found in rabbits and frogs: the eye on the
lesioned side bulges out while the eye on the intact side sinks into its orbit (Baarsma
and Collewijn, 1975; Dieringer, 1995)
Head tilts
Most species exhibit disturbances of head and body posture after UL. Humans
show relatively little head and body deviations, but common to many other species is
a tilt of the head towards the lesioned side in the roll plane (roll head tilt; RHT), and
a tilt of the head towards the lesioned side in the yaw plane (yaw head tilt; YHT)
(Schaefer and Meyer, 1974; Curthoys et al., 1988; Fetter and Zee, 1988; de Waele et
al, 1989; Hamann et al., 1998). Other static symptoms of UL include a yaw
curvature of the spine towards the lesioned side, circular walking and barrel rolling
towards the lesioned side, head nystagmus and extension of the contralateral
forelimbs (for a review, see Schaefer and Meyer, 1974).
2.2.2 Dynamic symptoms
Unlike the recovery of static symptoms, the recovery of dynamic symptoms is
slow and incomplete. Dynamic symptoms result from abnormalities in the vestibulo-
ocular and vestibulo-spinal reflexes in response to head movement. In all mammals,
UL results in severe abnormalities in the gain, symmetry and phase of the horizontal
vestibulo-ocular reflex (hVOR) (Baarsma and Collewijn, 1975; Maioli et al., 1983;
Fetter and Zee, 1988; Gilchrist et al., 1998; Hamann et al., 1998; Curthoys and
Halmagyi, 1999). In normal animals, the gain of the hVOR (the ratio of eye velocity
response to a given head movement) is around 1.0; thus the eye moves in an equal
and opposite manner to head movement, stabilising the image of the world on the
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fovea (see Figure 1.1). After UL, the eye velocity response to horizontal head
rotation in either direction is decreased. There is also asymmetry in the gain of the
horizontal VOR: there is a slower eye velocity gain in response to rotations towards
the lesioned side than towards the intact side. In humans, during rotations towards
the lesioned side, the VOR gain falls to <0.4 (Curthoys and Halmagyi, 1999) and in
guinea pigs it falls to <0.3 (Gilchrist et al., 1998). During rotations towards the intact
side, the VOR gain falls to around 0.7 in humans and around 0.8 in guinea pig.
Although there may be some recovery of VOR gain and symmetry in response to low
velocity and low frequency rotational stimuli (Lasker et al., 1999), VOR responses to
higher frequency stimulation such as that which occurs during natural head
movement appear to be impaired in the long term as they can be observed months
and years following labyrinthectomy (Gilchrist et al., 1998; Hamann et al., 1998;
Curthoys and Halmagyi, 1999).
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2.3 NEURAL COMPONENTS OF VESTIBULAR COMPENSATION
In a groundbreaking study into the mechanisms of VC Precht et al. (1966),
recording in the decerebrate cat showed that the appearance of the static symptoms
following UL correlated with the loss of spontaneous resting activity in type I
neurones ipsilateral to the lesion, and compensation of the static symptoms correlated
with a restoration of activity in these neurones. This loss of spontaneous resting
activity in VN neurones on the lesioned side and its gradual recovery over time as
VC develops has subsequently been recorded in vivo in many different species
(McCabe and Ryu, 1969; McCabe et al., 1972; Dieringer and Precht, 1977, 1979a;
Ried et al., 1984; Hamann and Lannou, 1987; Smith and Curthoys, 1988a, b;
Newlands and Perachio, 1990; Zennou-Azogui et al., 1993; Ris et al., 1995, 1997).
These experiments suggest that the return of resting activity to ipsilesional VN
neurones is important for the recovery from the static symptoms of UL.
Type I vestibular nucleus neurones are excited by ipsilateral horizontal canal
afferents. Following UL an immediate reduction in the number of type I neuronal
responses, and a reduction in the resting discharge of these neurones is recorded in
the ipsilesional MVN. In the anaesthetised guinea pig, for up to 8 hours following
UL, the ipsilesional MVN is almost devoid of type I neuronal activity (Smith and
Curthoys, 1988a); however, by 52-60 hours post-UL type I neurones were
encountered more frequently and their resting discharge had recovered to levels not
significantly different from normal. In contrast, type I neurones in the contralesional
MVN showed an increase in their resting discharge, probably due to disinhibition
from the ipsilesional type I neurones (Smith and Curthoys, 1988b).
Type II vestibular neurones are excited by contralateral horizontal canal afferents
via the commissural pathway, therefore ipsilesional type II neurones do not lose their
main source of excitation following UL. Ipsilesional type II neurones, recorded up to
8 hours following UL in anaesthetised guinea pig, were encountered more frequently
and their average resting discharge was significantly higher than normal (Smith and
Curthoys, 1988a). This is presumably due to increased commissural activation of
these neurones from the intact MVN. At 52-60 hours post-UL ipsilesional type II
responses were encountered less frequently than in the 0-8 hour group and their
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resting discharge rate was lower. In the contralateral nucleus at 0-8 hours post-UL,
type II neurones were more difficult to find and their resting discharge rate was
lower than in control animals (Smith and Curthoys, 1988b).
In a series of detailed studies in the alert guinea pig, Ris et al. (1995, 1997)
demonstrated that immediately after UL, 69% of monosynaptic ipsilesional MVN,
SVN and LVN neurones were silent and the remaining active units had a very low
resting discharge. Recovery of this resting activity was first observed 12-16 hours
post-UL (Ris et al., 1997). One week after UL there were no silent units and the
resting discharge had recovered to preoperative levels.
In addition to electrophysiological studies, experiments using [14C]2-
deoxyglucose (2-DG) uptake as an indicator for metabolic activity demonstrated
large decreases of 2-DG uptake within the lesioned VNC from within a few hours
after UL in rat, which persisted for up to 20 days post-UL (Patrickson et al., 1985;
Luyten et al., 1986). Similar results have been recorded in frogs indicating that soon
after UL neuronal activity is significantly decreased in the lesioned VNC (Flohr et
al., 1981; Flohr and Luneburg, 1989).
In parallel with the loss of resting activity in ipsilesional MVN neurones, their
sensitivity to angular head accelerations is significantly decreased after UL (Precht et
al., 1966; Hamann and Lannou, 1987; Smith and Curthoys, 1988a; Ris et al., 1995).
However, in contrast with the recovery of resting activity, the sensitivity of
ipsilateral MVN neurones to horizontal rotation remains decreased up to one year
after UL, which correlates with the incomplete recovery of the horizontal VOR
(Maioli et al., 1983; Smith and Curthoys, 1988a).
Whilst the return of resting activity to once silent VNC neurones is assumed to be
partly responsible for the compensation of static behavioural deficits following UL, it
is unlikely to be the only mechanism because some discrepancies exist in the time
course of neuronal and static behavioural recovery. For example in guinea pig,
during the first 90 min following UL, animals are able to stand up and maintain their
balance, while neuronal activity in the ipsilesional VNC in low or absent. During the
first 10 hours post-UL before neuronal recovery has started in vivo, SN diminishes
markedly (Ris et al., 1995, 1997).
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Summary
The development of VC for the static behavioural symptoms has been causally
related to the recovery of spontaneous resting activity in the VNC ipsilateral to the
lesion. This is evidenced by an approximate correlation between recovery of resting
activity in ipsilesional VNC neurones and compensation of static symptoms post-UL.
In addition, VNC neurones project directly to motorneurones controlling the
oculomotor and skeletal muscles involved in the manifestation of static symptoms.
While there may be an early phase of compensation which is not due to recovery of
the resting activity in the ipsilesional VNC, it is generally assumed that recovery of
this activity is essential for the maintenance of VC. The mechanisms that cause the
return of resting activity to the lesioned VNC neurones are widely researched, and
while many structural and neurochemical changes have been implicated there is no
clear evidence favouring any one cause.
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2.4 STRUCTURES INVOLVED IN VESTIBULAR COMPENSATION
Modulation of compensation may occur through areas of the CNS other than the
VNC. Structures implicated in the compensation process include the vestibulo-
cerebellum and inferior olive.
2.4.1 Role ofthe cerebellum in vestibular compensation
An important functional role for the cerebellum in VC is suggested by results
from lesion studies. During the initial 90min following labyrinthectomy,
compensation of SN in cat (Haddad et al., 1977) and guinea pig (Schaefer et al,
1979) was significantly reduced in animals with lesions of the flocculi, nodulus and
uvula. In these studies, the long-term compensation of SN was not significantly
different from cerebellar intact animals, implicating the cerebellum in only the rapid
early recovery of static symptoms. This contrasts with subsequent studies in cat and
squirrel monkey, which record significant long-term retardations in the compensation
of SN following lesions of the flocculus (Jeannerod et al., 1981; Courjon et al.,
1982), uvula and nodulus (Igarashi and Ishikawa, 1985). A more recent clinical study
supports the importance of the vestibulo-cerebellum for compensation in humans
(Furman et al., 1997). Although the role of the cerebellum in recovery of static
symptoms is unclear, it seems likely that it is involved in compensation of dynamic
symptoms as cerebellar lesions affect the response of vestibular nucleus neurones to
head movement during compensation, and retard recovery of certain postural
symptoms (Haddad et al., 1977; Schaefer et al., 1979; Smith and Curthoys, 1989).
Biochemical studies have shown that the immediate early gene c-fos and its
protein product Fos, are expressed in the uvula, nodulus, flocculus and ventral
paraflocculus 3-24 hours following UL (Kaufman et al., 1992; Cirelli et al., 1993,
1996). Immediate early genes such as c-fos are rapidly induced in neurones in
response to cell stimulation and are involved in the first wave of gene transcription
(Hughes and Dragunow, 1995). Thus their presence in the vestibulo-cerebellum
indicates that the imbalance in activity between the vestibular nuclei is rapidly
detected in these regions.
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Kitahara et al. (1997a,b; 1999) used a range of morphological and
immunohistochemical techniques to demonstrate the importance of the flocculus in
the initial stages of VC. Using immunoreactivity for Fos as a marker of neuronal
activation, the ipsilateral flocculus was found to inhibit the contralateral MVN, and
these inhibitory effects were up-regulated following ipsilateral labyrinthectomy.
Correspondingly, the inhibition of ipsilateral MVN neurones by the contralateral
flocculus decreased after an ipsilateral labyrinthectomy (Kitahara et al., 1997b).
Hence, the bilateral flocculus could restore the balance of vestibular nucleus
activities after UL, by an increased inhibition of the overexcited contralesional MVN
neurones and a disinhibition of the suppressed ipsilesional MVN neurones.
Nitric oxide is a free radical gas that is released from neurones by simple
diffusion and directly activates intracellular second messenger systems in other
neurones. Kitahara et al. (1997a) demonstrated that in rats, at 12 hours post-UL, NO
synthase (NOS; the enzyme which synthesises NO from arginine) immunoreactivity
was significantly increased in unipolar brush cells of the ipsilateral flocculus and
ventral paraflocculus, with no change in NOS immunoreactivity seen in the uvula,
nodulus or vestibular nuclei. NOS immunoreactivity reached its maximum intensity
in the flocculus at 24 hours post-UL and gradually disappeared 7 days after surgery.
In the second part of this study, rats were treated with a continuous perfusion of the
NOS inhibitor L-NAME into the bilateral flocculi from 2 hours before a UL. These
rats displayed a significantly higher frequency of SN and a delayed recovery of SN
compared to UL animals that had received a saline perfusion. L-NAME perfusion
also leads to an induction of Fos-like immunoreactivity in the contralateral MVN,
indicating that the suppression of NO leads to the activation of the contralateral
MVN, causing a more severe imbalance in neuronal activities after UL (Kitahara et
al., 1999). These results suggest that in the initial stages of VC, NO mediated
signalling in floccular unipolar brush cells could be a driving force of the flocculus
mediated inhibitory circuits, resulting in the restoration of balance between the
bilateral vestibular nuclei.
In contrast to the above results in rat, subcutaneous L-NAME perfusion in guinea
pig either had no effect on VC, or accelerated compensation of SN if administered
prior to the labyrinthectomy (Smith et al., 2001). In addition, NOS activity in the
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ipsilesional MVN of guinea pigs was significantly decreased immediately following
UL, with no recovery of levels recorded by 50h post-UL (Anderson et al., 1998),
whereas no change in MVN NOS levels were observed in rat at time-points from 12
hours to 2 weeks post-UL (Kitahara et al., 1997a). Liu et al. (2003) observed a
significant decrease in the endothelial form of NOS (eNOS), but not the inducible
form of NOS (iNOS) in the ipsilesional MVN of rat 2 weeks post-UL but not before.
Thus there may be large species differences between rat and guinea pig in NOS
activity, the subtype of NOS expressed, and in the floccular/NO contribution to VC.
Activation of intracellular signalling pathways in the cerebellum following UL
has been implicated in the process of VC. Goto et al. (1997) demonstrated a
regionally selective asymmetric expression of protein kinase C (PKC) isoforms in
Purkinje cells within 6 hours of a UL, which had returned to normal within 24 hour.
PKC levels increased in floccular and nodular lobes of the vestibulo-cerebellum
contralateral to the lesion, and decreased in nodular lobes ipsilateral to the lesion.
Intracerebroventricular injection of PKC inhibitors in rat significantly retarded the
loss of SN during the first 8 hours post-UL (Balaban et al., 1999), and intrafloccular
microinjection of PKC inhibitors prevented increase in the excitability of MVN
neurones at 4 hours post-UL, which is though to contribute to the recovery of their
resting activity early in compensation (Johnston et al., 2002) (see Section 2.6.6). De
Zeeuw et al. (1998a) reported that both cerebellar long term depression (LTD) and
VOR adaptation were abolished in transgenic mice that express a pseudosubstrate
PKC inhibitor, in Purkinje cells. Thus retardation of VC by PKC inhibitors is
consistent with transient attenuation of LTD in the vestibulo-cerebellum.
2.4.2 Role of the inferior olive in vestibular compensation
The olivo-cerebellar projection has been suggested to be indispensable for VC as
lesions of the inferior olive disrupt VC (Llinas et al., 1975; Azzena et al., 1979).
Llinas et al. (1975) reported that chemical lesioning of the IO in rat, prevented
compensation occurring, or caused decompensation in animals that had received a
labyrinthectomy 6 months previously. Biochemical studies have reported increased
immediate early gene and brain-derived neurotropic factor (BDNF; a member of the
neurotropin family) expression after labyrinthectomy in compartments of the olivo-
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cerebellar system that integrate and transmit vestibular related information. C-fos
mRNA, Fos protein, and BDNF levels, are all increased in the contralateral (3 nucleus
of the inferior olive within 1 hour of a UL (Kaufman et al., 1992; Cirelli et al., 1996;
Sato et al., 1997; Li et al., 2001). The f3 nucleus of the IO projects to the contralateral
uvula-nodulus, which in turn provides a bilateral GABAergic projection to the
vestibular nuclei. BDNF has been shown to modulate synaptic transmission efficacy,
and to induce structural changes in axons and dendrites (McAllister et al., 1999).
Thus after UL, the IO detects the imbalance between bilateral vestibular nuclei, via
projections from the vestibular nuclei themselves and from abnormal visual stimuli
from the dorsal cap. Functional reorganisation, or modifications in synaptic efficacy
in the olivo-cerebellar system may recalibrate the imbalance between vestibular
nuclei, facilitating VC.
Summary
Results from lesion studies are always difficult to interpret as failure to
compensate, suggests the region is necessary for compensation but does not indicate
that it is causal. Also CNS lesions can result in diaschisis, which could be mistaken
for retarded compensation, or decompensation. Thus far the results from lesion
studied do not identify a clear role for the cerebellum or IO in VC. Biochemical
studies however, indicate that the cerebellum and IO may be involved in the
rebalancing of resting discharge between the bilateral VNC neurones after UL.
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2.5 NEUROCHEMICAL CHANGES DURING VESTIBULAR
COMPENSATION
Three main types of method have been used to study the neurochemical
components of VC: 1) behavioural studies, examining the effect of various drugs,
administered systemically or via an implanted cannula, on the time course of
behavioural compensation; 2) electrophysiological studies, recording the effect of
drugs on the neuronal correlates of VC; 3) biochemical and pharmacological studies:
receptor binding studies, phosphorylation studies or biochemical assays performed
on tissue from animals at various stages of compensation.
At present, the majority of studies are behavioural, yet interpretation of such
studies is difficult because of the inability to specify the exact site of drug action.
Different transmitter systems may play a role in different phases of VC, and there
may be many different neurochemical changes that contribute to any specific aspect
of behavioural recovery.
2.5.1 Glutamate
The presence of glutamate as a major neurotransmitter and neuromodulator
within the VNC has attracted the possibility that glutamate receptor subunits,
especially the NMDA receptor, may be involved in vestibular compensation.
Biochemical studies of glutamate in the VNC during vestibular compensation have
utilized HPLC, binding, immunohistochemical and in situ hybridisation techniques.
In a large-scale HPLC study, Li et al. (1996b) found a complex range of amino acid
changes in the bilateral VNC between 2 and 30 days post-UVD in rat. Significant
decreases in glutamate levels were observed in all ipsilesional subnuclei except the
MVN by two days post-UVD, which were maintained through to 30 days as
compared to control animals. Decreased glutamate levels were observed in the dorsal
region of the ipsilesional MVN by 30 days post-UVD. Normal glutamate levels were
found in the ipsilesional VNC at 10 months post-UVD in squirrel monkey (Henley
and Igarashi, 1991). No change was found in the density of glutamate binding sites in
the ipsilesional VNC between 2 weeks and one year post-UVD in rat (Raymond et
al., 1989). More recently, Li et al. (1997) reported large decreases in AMPA and
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NMDA receptor binding in the ipsilesional VNC, relative to the intact side, between
2 and 30 days post-UVD. Immunohistochemical studies revealed small but
significant decreases in the AMPA receptor subunits GluR2/3 immunoreactivity on
the lesioned side of all VNC regions in rat except the dorsal region of the MVN,
relative to the intact side at 7 days post-UVD (Li et al., 1996a). Most of these
asymmetries disappeared between 14 and 30 days post-UVD. Conversely, a more
recent immunohistochemical study in rat, found a bilateral decrease in GluR3
receptor subunit immunoreactivity in the MVN three days after UL returning to
normal by 8 days post-UL (Rabbath et al., 2002). In situ hybridisation (ISH) studies
have generally found no change in the NR1 subunit of NMDA receptors (which is a
key subunit of NMDA receptors) in the ipsilesional VNC of rat between 5 hours and
2 weeks post-UVD (Horii et al., 2002; King et al., 2002; de Waele et al., 1994; but
see Sans et al., 1997). A recent ISH study linked to real time quantitative PCR, found
decreases in the NMDA receptor subunit NR2A, the AMPA receptor subunit GluR2
and the metabotropic glutamate receptor subunit mGluR7, in the ipsilesional VNC at
6 hours post-UL (Horii et al., 2002). These decreases were reversed at 50 hours post-
UL, a timepoint which in rat correlates with the disappearance of most of the static
symptoms of UL. However the down-regulation of these glutamate receptor subunits
may be the result of decreased glutamate levels after denervation, rather than being a
causal factor of compensation.
Electrophysiological studies do not support any changes in glutamate receptors
during VC. Knopfel and Dieringer (1988) reported that the increase in efficacy of the
commissural system in frog, which is associated with vestibular compensation
(Dieringer and Precht, 1979a), does not result from an increased NMDA receptor
component. Similarly, Smith and Darlington (1992) found no difference in the
responses of MVN neurones to NMDA antagonists in slices from normal guinea
pigs, or from guinea pigs labyrinthectomised 3 days to 2 months previously. There
have been no electrophysiological studies to date looking at the effect of non-NMDA
glutamate receptors on compensation, or looking at compensated neurones from 0-3
days post-UL.
Most data implicating glutamate receptors in VC is behavioural. In guinea pig
systemic injections of the NMDA receptor antagonists MK-801 or CCP either
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disrupted the development of VC during the first 24 hours (Darlington and Smith,
1989), or caused decompensation when the injection was delivered at 2-3 days, but
had no effect after 12 days post-UVD (Smith and Darlington, 1988). Similar results
were obtained with systemic injections of MK-801 in frog (Flohr and Luneburg,
1993) and rat (Kitahara et al., 1995b; Kim et al., 1997). Again the decompensating
effects were time dependant and could not be observed at 60 days post-UL in frog
(Flohr and Luneburg, 1993), nor after 2 weeks in rat (Kitahara et al., 1995b).
Substances administered systemically may have effects on regions other than the
VNC, affecting compensation through indirect physiological changes such as altered
blood pressure or drowsiness. Cannula studies, with drugs administered directly into
the VNC, have provided more direct evidence for NMDA receptor modulation of
VC. Injection of the NMDA receptor antagonist, CCP, directly into the ipsilesional
VNC caused decompensation in guinea pigs compensated for 2-3 days (Sansom et
al., 1990). De Waele et al. (1990) recorded similar results with the NMDA receptor
antagonist DL-APV administered to posturally compensated guinea pigs.
Surprisingly, systemic, i.e.v., or intra-VNC injections of MK-801 before UL has the
opposite effect to post-UL injections, in that SN and postural symptoms of UL are
reduced (Aoki et al., 1996; Sansom et al., 1992, 2000). Recently, Gliddon et al.
(2000) investigated the involvement of group 1 metabotropic glutamate receptors
(mGluRs) in VC in guinea pig. Perfusion of the group 1 mGluR antagonist AIDA
into the ipsilesional VNC from 30 minutes before to 30 minutes after UVD,
significantly reduced YHT and the frequency of SN, suggesting that this receptor
subtype may be involved in the expression of postural and ocular motor symptoms
post-UVD.
Taken together, the results from biochemical, electrophysiological and
behavioural studies indicate that there are probably no long-term changes in the
number, affinity or efficacy of glutamate receptor subunits that could be involved in
the maintenance of VC. However results from behavioural experiments suggest that
NMDA and mGluR receptors may play a key role in the induction or development of
VC whereas after a limited time period, which varies between species, they become
redundant. This is consistent with their role other forms of plasticity such as LTP,
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which has recently been demonstrated in the MVN (Grassi et al., 1998; Darlington
and Smith, 2000; Grassi and Pettorossi, 2001; Puyal et al., 2003).
2.5.2 GABA
Changes in the GABAergic system after unilateral vestibular deafferentation
have been less extensively studied than those in the glutamatergic system. The
GABAergic system is involved in vestibulo-ocular and vestibulo-spinal reflexes (see
Section 1.3.1), and could play a role in vestibular compensation after deafferentation.
In normal animals, unilateral microinjection of GABA receptor agonists and
antagonists into the lateral and medial vestibular nuclei resulted in postural
asymmetries (Luccarini et al., 1992) and changes in the gain of the horizontal VOR
(Straube et al., 1991). Behavioural data from humans with labyrinthine dysfunctions,
demonstrated that systemic injection of the GABA antagonist picrotoxin accelerated
compensation of postural symptoms (Ehrenberger et al., 1982) whereas systemic
injections of GABA agonists to compensated frogs can cause decompensation (Flohr
et al., 1985).
Electrophysiological studies have investigated the responses of MVN neurones
from control and labyrinthectomised rats to the GABAa and GABAb agonists,
muscimol and baclofen. Yamanaka et al. (2000) observed a marked down-regulation
of the functional efficacy of both GABAa and GABAb receptors in the rostral region
of the ipsilesional MVN at 4 hours post-UL, marked by a rightward shift and a
decrease in slope of the dose-response relationship for both agonists. The down-
regulation of GABAb receptor efficacy persisted long term, while GABAa receptor
responses had returned to normal by 7-10 days post-UL (Johnston et al., 2001).
Biochemical studies have also noted changes in the GABAergic system
following UVD. A study by Li et al. (1996b), using HPLC techniques, observed
early decreases in GABA concentrations in the ipsilesional VNC post-UL, with
levels recovering in most regions, and significantly increasing in the dorsal MVN
and LVN by 30 days post-UL. Immunohistochemical studies found increased GABA
levels in the ipsilesional MVN, IVN and LVN at 3-7 days post operation, with
decreased levels in the contralesional LVN (Thompson et al., 1986; Tighilet and
Lacour, 2001). One year post-UL, a bilateral increase in GABA levels was found in
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the MVN, with the higher increase observed on the ipsilesional side (Tighilet and
Lacour, 2001). However, an in situ hybridisation study detected no imbalance or
change in GAD mRNA levels between 5 hours and 3 weeks post-UL in rat (de Waele
et al., 1994). Using autoradiography, Calza et al. (1992) observed a decreased
benzodiazepine binding in the ipsilesional MVN at 3-23 hours post-UL, which
returned to normal within 3 days suggesting a transient down-regulation of GABAa
receptors.
The data from electrophysiological and binding studies suggest that there is a
rapid down-regulation in the functional efficacy of GABA receptors in the ipsilateral
MVN following lesion. This down-regulation could help to overcome the excessive
commissural inhibition from the contralesional MVN, contributing to the rebalancing
of resting activity between the bilateral VN.
2.5.3 Acetylcholine
There are several lines of evidence suggesting that acetylcholine (ACh) is a
possible neurotransmitter involved in vestibular compensation, the majority arising
from behavioural studies. Systemic administration of ACh agonists to compensated
frog and squirrel monkey, resulted in decompensation or increasing severity of the
remaining static symptoms (Abeln et al., 1981; Ishikawa and Igarashi, 1985).
Correspondingly, systemic administration of ACh antagonists resulted in over¬
compensation, or a reduction in the severity of static symptoms. Acetylcholinesterase
(AChE) inhibitors also elicit decompensation in fully compensated frog (Bienhold
and Flohr, 1980; Flohr et al., 1985). More recently Fukushima et al. (2001)
investigated the role of cholinergic vestibulo-cerebellum fibres in the compensation
process. They found that selective destruction of vestibulo-floccular and vestibulo-
uvulonodular cholinergic mossy fibres resulted in much more severe vestibulo-ocular
symptoms during the initial stages of compensation.
Biochemical studies have noted changes in levels of ACh and related chemicals
throughout compensation. Torte-Hoba et al. (1996) investigated AChE
immunoreactivity in the VNC of rat, at 6 hours, 3 weeks and 1 year post-UL. They
observed significantly decreased AChE activity in the ipsilesional caudal MVN at 6
hours post-UL, with a weaker decrease in activity persisting at one year. Yamada et
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al. (1988) found no change in levels of ACh, muscarinic ACh receptor binding sites,
or activity of AChE in the LVN up to 7 days post-UL in rat. However, Calza et al.
(1992) observed a slight increase in the density of muscarinic receptors in the
ipsilesional LVN between 3 and 10 days post-UL. More significant was the decrease
in density of muscarinic receptors in the ipsilesional MVN, observed from 3 hours to
90 days post-UL (Calza et al., 1992).
The results from behavioural and biochemical data together do not necessarily
suggest that there is any plasticity in the ACh system which is responsible for
compensation. Systemic injections of drugs which potentiate ACh transmission (ACh
agonists or AChE inhibitors) cause decompensation in already compensated animals,
whereas drugs which decrease ACh transmission (ACh antagonists) improve
compensation (for a review see Smith and Darlington, 1991). The asymmetries in
normal ACh receptor levels could be the result of the UL and the ACh modulating
drugs may be having their effects by acting on these asymmetries.
2.5.4 Monoamines
Vestibular related syndromes in humans are clinically treated with histaminergic
medications, implying a role for histamine in functional recovery of the vestibular
system (Tighilet et al., 2002). Betahistine, a partial agonist at the Hi receptor and an
antagonist at the H3 receptor (Arrang et al., 1985), facilitates compensation of both
postural and locomotor symptoms following UVD in cat (Tighilet et al., 1995). A
subsequent immunohistochemical study showed a significant bilateral decrease in
histamine fibre staining in the vestibular and tuberomammillary nuclei at 1, 3 and 52
weeks post-UVD; treatment of control and compensating cats with betahistine
resulted in a near-total lack of histamine staining in these regions (Tighilet and
Lacour, 1997). Betahistine works by up-regulating histamine turnover and release
from nerve terminals, probably by blocking presynaptic H3 receptors (Tighilet et al.,
2002). These results indicate that the decreased histamine fibre staining after UVD
results from an increased release of histamine into the VNC, which promotes
functional vestibular recovery.
Modifications of the serotonergic, dopaminergic and noradrenergic systems
during VC are less clear. Cransac et al. (1996) studied the concentrations of
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serotonin, dopamine, noradrenaline and their metabolites in the MVNs of albino and
pigmented rats 6 hours after UL. In albino rats there was a bilateral increase in
noradrenaline metabolites and an ipsilateral increase of dopamine, whereas no such
changes were observed in pigmented rats. No change in serotonin levels were found
in either species of rat but an increased utilisation of serotonin was suggested in the
pigmented rat (Cransac et ah, 1996). Behavioural data on the effects of these
monoamines on vestibular compensation are also unclear. Systemic administration of
dopamine antagonists to frog have been show to retard (Smith and Darlington, 1991)
or have no effect on compensation (Bienhold et al., 1981). Systemic injections of
noradrenaline agonists in compensated frogs caused decompensation of roll head tilt,
whereas noradrenaline antagonists caused overcompensation (Flohr and Luneburg,
1985).
2.5.5 Neuropeptides
The adrenocorticotropic hormone neuropeptide fragment, ACTH4.10, enhances
compensation of roll head tilt in frogs (Flohr and Luneburg, 1982). Compensation of
spontaneous nystagmus and vestibulo-spinal reflexes was enhanced in squirrel
monkey by treatment with ACTFLmo (Igarashi et al., 1985). Accordingly, systemic
administration of ACTFLtio, or the ACTH4-9 analogue Org 2766, significantly
accelerated the compensation of spontaneous nystagmus in guinea pig (Gilchrist et
ah, 1990, 1994, 1996b). In vitro electrophysiological studies have compared the
effects of ACTH4-10 on MVN neurones from labyrinthectomised and control guinea
pigs (Darlington et ah 1992, 1993). No difference in the inhibitory effects of ACTH4_
10 on MVN neurones was found between control and labyrinthectomised animals, or
between ipsi- or contralesional neurones from compensated animals. The opioid
receptor antagonist naloxone, has been demonstrated to significantly reduce the
frequency of SN in compensating guinea pig, but has little effect on compensation of
postural symptoms (Dutia et ah, 1996).
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Summary
Many neurotransmitter and neuromodulator systems undergo changes during
VC. These neurochemical changes occur over a range of different time courses,
which may be related to the different stages in the initiation, development and
maintenance of VC. The glutamatergic system has been the most extensively studied
during compensation; yet while behavioural studies indicate that there may be some
short term species specific involvement of glutamate receptors, biochemical studies
have failed to find any consistent changes in receptor affinity, efficacy or number
post lesion. Thus far there is no convincing evidence that changes in any of the above
systems are causal factors in VC.
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2.6 POSSIBLE MECHANISMS OF VESTIBULAR COMPENSATION
The ipsilesional vestibular nucleus complex (VNC) is a vital centre for vestibular
compensation, since lesions of this region are shown to prevent, or cause a loss of,
compensation (Spiegel and Demetriades, 1925, cited in Schaeffer and Meyer, 1974).
Concurrent with this is the generally accepted hypothesis that recovery from static
symptoms during compensation is associated with the return of resting activity in
ipsilesional VNC neurones (Precht and Dieringer, 1985). Since the vestibular nerve
does not undergo any functional regeneration post UVD, the problem for researchers
was how the VNC neurones replace the resting activity lost as a result of
deafferentation. Results from animal experiments have led to several hypotheses for
possible mechanisms which may restore the lost resting activity.
2.6.1 Reactive synaptogenesis
Reactive synaptogenesis is the sprouting of healthy synaptic boutons into the
synaptic contacts left by the degenerating axons of neurones destroyed during
labyrinthectomy. Evidence for axonal sprouting and the formation of new synapses
on second order vestibular neurones has been found in frogs (Dieringer et al., 1984;
Goto et al., 2000, 2001). The only evidence for new synapse formation in mammals
was found by Korte and Friedrich in cats, where at 5 days post UVD a new group of
small boutons with flattened vesicles appeared in the SVN following disappearance
of the normal large boutons (Korte and Friedrich, 1979). Yet the authors themselves
suggest reserve at this finding, proposing that the newly observed boutons may have
been previously present but altered by physiological activity after UL. Other studies
in cats have found inconclusive (Raymond et al., 1991; Dieringer, 1995), or no
evidence (Gacek et al., 1988) of reactive synaptogenesis up to one year post
operation. Even where structural changes are observed it is hard to make the
distinction between it being a causal affect or the effect of the compensation process.
Ultimately, reactive synaptogenesis, which is thought to begin 6 days post operation
(Smith and Curthoys, 1989), is too slow to account for the rapid compensation of
static symptoms which is complete within 2-3 days in most species.
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2.6.2 Denervation supersensitivity
Vestibular nucleus neurones deprived of glutamate as a result of ablation of the
eighth nerve, could develop denervation supersensitivity, up-regulating their
glutamate receptors, thus resulting in a greater effect of any remaining inputs.
Glutamatergic neurones from other areas, synapsing onto the up-regulated receptors
of VN neurones may cause enough excitation to re-establish their resting activity.
Some studies have indicated that an initial up-regulation of NMDA receptors may
occur in the VNC (de Waele et al., 1990; Pettorossi et al., 1992). However, this up-
regulation is not maintained in the long term as injection of NMDA receptor
antagonists after 2 weeks in the guinea pig and 6 weeks in frog has no effect on loss
of compensation (Smith and Darlington, 1992). Other electrophysiological (Knopfel
and Dieringer, 1988; Smith and Darlington, 1992), biochemical (de Waele et al.,
1994; Rabbath et al., 2002) and pharmacological studies (Raymond et al. 1989) in a
range of species, have been unable to provide any evidence of an increase in NMDA
or AMPA receptor efficacy, affinity, or numbers post UL.
2.6.3 Cerebellar shutdown hypothesis
The cerebellar shutdown hypothesis (McCabe and Ryu, 1969), suggests the
cerebellum modulates its output to cause a reduction of activity in the vestibular
nuclei following UL. This would reduce the high spontaneous activity in the
contralesional nuclei, decreasing commissural inhibition and leading to the
rebalancing of activity between the bilateral VNC. This conclusion was drawn from
the observation that in cat, one day following UL, both MVN are electrically silent
(McCabe and Ryu, 1969; McCabe et al., 1972). This bilateral shutdown of activity
was attributed to the cerebellum which had been partially removed in all previous in
vivo recordings. However, it was subsequently demonstrated that between 12 and 20
hours following UL in guinea pig with intact cerebellum, vigorous type I neuronal
activity is present in the contralesional MVN (Smith and Curthoys, 1989). The cat
presents both ocular and postural symptoms immediately following a UL, suggesting
that the contralesional MVN is active and it is the asymmetry in bilateral resting
activity of the VN that is responsible for these symptoms. These results suggest that
the cerebellar shutdown hypothesis may not be correct.
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2.6.4 Substitution ofsensory inputs
Neural recovery after UL could be due to the substitution of other sensory inputs
for the missing labyrinthine inputs. Sensory inputs suggested for this include visual,
neck proprioceptive and somatosensory (Smith and Curthoys, 1989). Visual
deprivation in cat (Courjon et al., 1977), guinea pig (Smith et al., 1986) and rhesus
monkey (Fetter et al., 1988) significantly reduced the rate of compensation of a
number of static and dynamic symptoms. Yet the role of vision may be species and
symptom specific, for example complete visual deprivation retarded the recovery of
SN in cat (Courjon et al., 1977) but had no effect on the recovery of SN in guinea pig
(Smith et al., 1986). A level of compensation is eventually reached in all visually
deprived animals, where SN is absent even in complete darkness (Haddad et al.,
1977).
Spinal afferents have been implicated in VC. Transection of the spinal cord
before UL retards compensation of head deviation (Azzena, 1969) and transection
post-UL causes decompensation (Azzena, 1969; Jensen, 1979). Using
autoradiography, Dieringer et al. (1984), demonstrated an increased spinal afferent
projection to the VNC in frogs, 4 months post-UL. On a shorter timescale (from 3
days post-UL), Vibert et al. (1999a) recorded an increased efficacy of spinal input
into the ipsilesional MVN, and decreased input into the contralesional MVN,
intimating the functional substitution of deficient vestibular inputs with spinal related
reflexes. As with many of the above theories, most of the experimental data for
sensory substitution is collected at a time at which recovery from static symptoms is
almost complete.
2.6.5 Intrinsic mechanism hypothesis
Recently the search for mechanisms of neuronal recovery has moved away from
external and substituting inputs, to focus on intrinsic properties of the neurones
themselves. The intrinsic mechanism hypothesis (Darlington and Smith, 1996), states
that the recovery of resting activity in the ipsilesional vestibular nucleus complex is
largely the result of changes in the intrinsic membrane properties of vestibular
nucleus neurones. In vitro brainstem slice studies have shown that vestibular
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neurones retain the spontaneous firing activity observed in vivo, in the absence of
vestibular nerve or other CNS inputs and even once synaptic transmission has been
blocked (Gallagher et al., 1985, 1992; Darlington et al., 1989; Serafin et ai, 1991a,
b; Johnston et al., 1994; Vibert et al. 1999b; Ris et al., 2001; Him and Dutia, 2001).
MVN neurones demonstrate a persistent Na+ current which may be partly responsible
for the spontaneous firing of these cells in vitro (see Section 1.1.2). However, the
contribution of these intrinsic membrane properties to the in vivo firing of MVN
neurones is unknown.
Darlington and Smith (1996) originally proposed that VNC resting activity is lost
following UL as a result of 'neural shock' or diaschisis (induced by elevated Ca2+
levels in these cells), and recovery is due to the return of function to the intrinsic
membrane properties that normally provide this resting activity. There has been no
experimental evidence to date to support the theory that 'neural shock' renders the
neurones electrophysiologically unresponsive. Indeed, Cameron and Dutia (1997)
revealed that even at 2 hours post-UL in rat, when the in vivo symptoms are near
their maximum intensity, MVN neurones isolated in vitro had discharge rates no
different from normal. This supported the view that silencing of MVN neurones in
vivo was due to disfacilitation, after loss of excitatory eighth nerve input and
subsequent increased commissural inhibition. More significantly, recording from the
rostral region of the ipsilesional MVN in rat horizontal brainstem slices, they
demonstrated that beginning between 2-4 hours post-UL there is a significant
increase in neuronal excitability compared to slices from control animals. This was
measured as an increase in mean spontaneous tonic discharge rate from 14.1 ±0.69
spikes/sec (mean ±S.E.M.) in MVN slices from control rats to 21.56 ±1.7 spikes/sec
in MVN slices from rats labyrinthectomised 4 hours previously. The significant
increase in excitability was maintained until 48 hours post-UL, whereupon it
remained elevated but no longer significant versus control. Cameron and Dutia
proposed that this significant increase in excitability of the ipsilesional MVN
neurones is responsible for the restoration of the resting activity in the initial stages
of VC, as it will act to overcome the disfacilitation and increased commissural
inhibition the neurones are subject to in vivo.
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In the guinea pig, Darlington and colleagues reported a trend towards higher tonic
discharge rates of ipsilesional MVN neurones from brainstem slices of fully
compensated animals, compared to MVN neurones in slices from normal animals
(Darlington et ah, 1992; Smith and Darlington, 1992). Further in vitro experiments in
guinea pig brainstem slices provide evidence for increased neuronal excitability in
MVN neurones after UL. In coronal brainstem slices, Vibert et al. (1999b) noted an
increase in firing rate of ipsilesional MVN neurones at 7 days post-UL, which had
increased to a level significantly higher than control by 30 days post-UL. This rise in
firing rate actually increased further in synaptic uncoupling conditions (low Ca2+l
high Mg2+ solution), resulting in a significant increase in ipsilesional neuronal
excitability by 7 days post-UL. The authors proposed that from one week after the
lesion, VC increasingly relies on changes in the intrinsic membrane properties of
ipsilesional vestibular neurones. Ris et ah (2001) also investigated the intrinsic
pacemaker properties ofMVN neurones in coronal brainstem slices from guinea pig.
A cocktail of antagonists of the main neurotransmitters in the vestibular nuclei
(glutamate, GABA and glycine) was used to block synaptic transmission. Under
these conditions they recorded a significant increase in the number of spontaneously
active MVN neurones encountered and an increased firing rate of these neurones, at
48 hours and one week after labyrinthectomy compared to neurones from unlesioned
animals. This result provided further evidence for an increase in pacemaker activity
of MVN neurones after UL, and provided additional support for the theory that
increased pacemaker activity can lead to the restoration of spontaneous firing activity
in the deafferented vestibular neurones after labyrinthectomy.
Mechanisms underlying increased excitability in ipsilesional vestibular
neurones
Recent intracellular studies by Him and Dutia (2001), revealed that the increase
in resting activity of rostral ipsilesional MVN neurones in rat following UL is due to
changes in the intrinsic properties of type B but not type A neurones. At 24-72 hours
post-UL type B neurones displayed an increase in input resistance, spike amplitude
and spontaneous firing rate, and had more depolarised resting membrane potentials
than control neurones. These changes may be the effect of modulation of the
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expression or function of Na+, K+ or Ca2+ channels, and could increase the
responsiveness of type B neurones to their own intrinsic membrane conductances and
external excitatory inputs. A systematic voltage clamp experiment detailing all the
currents in control MVN slices and investigating any changes in these currents post-
UL is needed to elucidate the precise role of these membrane properties.
Another possible mechanism proposed to underlie the increased excitability in
MVN neurones was an adaptive down-regulation of the functional efficacy of GABA
receptors on these neurones (Cameron and Dutia, 1997). This theory is supported by
the observation of an initial decrease in benzodiazepine binding in the ipsilesional
MVN, 3-24 hours post-UL, which returns to normal within 3 days (Calza et ah,
1992). Electrophysiological studies demonstrated that within 4 hours of UL in rat,
the neurones in the rostral region of the ipsilesional MVN showed a marked down-
regulation in their responsiveness to the GABAa and GABAb receptor agonists
muscimol and baclofen in vitro (Yamanaka et al., 2000). Changes in GABAb
receptor efficacy persisted for at least one week post-UL, whereas GABA A receptor
efficacy had returned to control levels by this time (Johnston et al., 2001). A
decreased responsiveness to glycine, at 3 days post-UL in guinea pig, has also been
recorded (Vibert et ah, 2000a). Decreased responsiveness of ipsilesional MVN
neurones to inhibitory amino acids may be functionally compensatory as neuronal
responses to commissural and cerebellar inhibitory inputs will be blunted; this could
counteract the disfacilitation and increased commissural inhibition that silences these
cells immediately after UL.
There now appears not to be a causal link between the down-regulation of GABA
receptor efficacy and the increased excitability in MVN neurones following UL, as
there was no correlation between the in vitro discharge rates and the cells responses
to GABA agonists (Yamanaka et al., 2000). In agreement, an ipsilesional
flocculectomy performed at the same time as UL was shown to prevent the increased
excitability in MVN neurones, but did not prevent the down-regulation of the
functional efficacy of GABA receptors (Johnston et al., 2002), indicating the
existence of two independent cellular mechanisms mediating the two post-lesional
changes. The development of the increase in neuronal excitability in the rostral
ipsilesional MVN post-UL appears to be dependant on an intact ipsilesional flocculus
Vestibular Compensation 69
(Johnston et al., 2002). In addition, intra-floccular microinjection of the PKC
inhibitor BIS-1 and the mGluRl antagonist AIDA prevented the increase in
excitability (Johnston et al., 2002). The authors suggest that the increased excitability
in MVN neurones post-UL may be the result of LTD in the ipsilesional flocculus.
Glucocorticoid receptors (GR) have been implicated in the development of the
increased excitability in MVN neurones post-UL (Cameron and Dutia, 1999;
Johnston et al., 2002). In rats that were kept urethane anaesthetised for 4-6 hours
after UL, thereby not experiencing the stress that normally accompanies UL, the
increase in excitability of the ipsilesional MVN neurones did not occur (Cameron
and Dutia, 1999). Significantly, administration of the synthetic GR agonist,
dexamethasone, to urethane anaesthetised rats at the same time as the UL restores
these changes. These results suggest that the acute stress response, that accompanies
the severe behavioural syndrome following UL, plays an important role in
facilitating the cellular changes that mediate the increased excitability in ipsilesional
MVN neurones in rat. Johnston et al. (2002) indicated that the locus for this GR
dependant plasticity was the ipsilesional flocculus, as intra-floccular microinjection
of the GR antagonist RU38486 abolished the increased excitability.
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Summary
The vestibular system displays remarkable plasticity in its ability to adapt to the
permanent loss of one vestibular afferent input. The behavioural recovery that
follows a peripheral vestibular lesion is the result of multiple different processes,
throughout which, separate symptoms compensate at different rates and to various
extents. There are inter-species variabilities in the importance of specific CNS
structures in VC and the effect of various compounds on the rate of recovery. Data
also indicates that different mechanisms of adaptation may be activated at different
time points between species. A neural factor common to all species in the process of
VC is the recovery of resting activity in the ipsilesional VNC which starts to develop
very quickly following lesion. Static compensation is associated with, and may be
partly caused by, the return of this resting activity. Mechanisms for the rebalancing
of resting activity between the bilateral VN can be generally divided into pre- and
postsynaptic categories. Presynaptic theories suggest changes in the synaptic input to
the ipsilateral VNC, such as altered efficacy of non-vestibular sensory inputs and
increased transmitter release, whereas postsynaptic theories favour changes in the
ipsilateral VNC neurones themselves such as up-regulation of excitatory postsynaptic
receptors. There is evidence for many complex biochemical changes occurring in the
VNC and cerebellum following UL, and it is probable that both pre- and postsynaptic
alterations occur to bring about compensation. Yet how these various factors are
linked, and which of them have a causal relationship with the physiological changes
underlying compensation, remains to be determined.
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Chapter 3
STRESS AND NEURAL PLASTICITY IN THE
VESTIBULAR SYSTEM
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3.1 INTRODUCTION
An increasing number of studies suggest that stress hormones and their
metabolites have an important role in the process of vestibular compensation (for
review see, Seemungal et al., 2001). During stress, glucocorticoid steroids are
secreted from the adrenal cortex; they have potent effects on metabolism and gene
expression in a wide variety of tissues. Anxiety and stress in patients with vertigo
significantly delays the recovery from vestibular symptoms (Yardley et al., 1994).
Conversely, treatment of patients with the glucocorticoid steroid methylprednisolone,
improves compensation of symptoms of vestibular neuritis (which rapidly damages
the unilateral peripheral vestibular organs) (Ariyasu et al., 1990; Kitahara et al.,
2003). Thus steroid hormones, and particularly glucocorticoid based therapies may
be useful in the treatment of vestibular disorders.
Yamanaka et al. (1995a) showed that administration of the synthetic
glucocorticoid agonist dexamethasone, prior to surgery facilitated the behavioural
recovery following UL in rabbit; in contrast, administration of the glucocorticoid
antagonist, RU38486, delayed compensation. Glucocorticoids may have a direct
action on MVN neurones, as iontophoretic administration of dexamethasone to the
VNC produced a dose dependent increase in the firing rate of type 1 MVN neurones,
which could be blocked by RU38486 (Yamanaka et al., 1995a). However in a recent
study, systemic administration of dexamethasone was found to have no effect on the
rate of compensation of spontaneous nystagmus in the guinea pig (Alice et al., 1998).
More intriguingly the development of the increase in excitability of MVN
neurones, observed from 4 hours post-UL in rat, is dependant on activation of
glucocorticoid receptors. Thus, the development of increased excitability in rostral
ipsilesional MVN neurons was prevented by systemic administration of the
glucocorticoid receptor (GR) antagonist RU38486, and did not develop in animals
that remain anaesthetised after UL. However, in anaesthetised animals that were
treated with the synthetic GR agonist dexamethasone simultaneously with UL, the
increase in excitability did occur (Cameron & Dutia, 1999). These data indicate that
the acute stress that normally accompanies the severe behavioural symptoms
immediately after UL may have an important role in the process of vestibular
compensation in rat. This chapter investigates the role of the stress system in
neuronal plasticity in lesioned rostral MVN neurones following UL.
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3.2 LITERATURE REVIEW
3.2.1 The stress response
An essential requirement for the survival of any organism is its ability to
maintain internal homeostasis in response to a variety of stressful conditions.
Mammals have developed a complex neuroendocrine stress axis, the hypothalamo-
pituitary-adrenocortical (HPA) axis (see Figure 3.1), which coordinates metabolic
and behavioural responses to both physical and psychological stressors. The end
product of this axis is the release of adrenal steroids from the adrenal cortex. The
adrenal steroids are known collectively as corticosteroids and consist of
mineralocorticoids and glucocorticoids. They exert effects on metabolism and gene
expression in virtually every organ and tissue in the body. Corticosteroids exert their
effects through two types of intracellular receptors: mineralocorticoid receptors
(MRs) and glucocorticoid receptors (GRs). Regulation of corticosteroid actions is
achieved at the levels of steroid synthesis and metabolism. The HPA axis regulates
steroid synthesis, while corticosteroids are metabolised in many tissues by enzymes,
including 1 l(3-hydroxysteroid dehydrogenase (Ilf3-HSD), which specifically
regulates the levels of active glucocorticoids within the body's tissues.
3.2.2 Corticosteroid synthesis
Corticosteroids are synthesised from cholesterol in the adrenal cortex. The
adrenal cortex is subdivided into three morphologically distinct zones: the zona
glomerulosa is responsible for the production of the major mineralocorticoid,
aldosterone; the zona fasiculata and zona reticularis are responsible for the
production of the glucocorticoids, Cortisol (in humans) and corticosterone (in
rodents). Glucocorticoid synthesis and release is controlled almost entirely by the
binding of adrenocorticotropic hormone (ACTH) to specific receptors on the outer
cell membrane of the adrenal cortex. ACTH is in turn released from corticotrophes in
the anterior pituitary gland and its secretion is regulated by corticotrophin releasing
factor (CRF), arginine vasopressin (AVP) and other agents released from the
hypophyseal portal circulation in response to a variety of stimuli (Fig. 3.1. For a
review, see Jones and Gillham, 1988). Glucocorticoids provide negative feedback
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Figure 3.1 Schematic representation of the hypothalamic-pituitary-adrenal
axis. CRF, corticotrophin releasing factor; AVP, arginine vasopressin; I.H.,
inferior hypophysial; S.H., superior hypophysial. (Adapted from Turnbull and
Rivier, 1999)
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onto the CRF and AVP neurones in the hypothalamic paraventricular nucleus (PVN),
and also onto the corticotrophes in the anterior pituitary, thus completing a negative
feedback route which regulates their plasma concentration (Orth, 1992).
In addition to the homeostatic negative feedback loop controlling glucocorticoid
secretion, there are other factors known to affect glucocorticoid release.
Glucocorticoid and ACTH secretion exhibit a circadian rhythm in mammals (Kant et
al., 1986). This is modified by sleep and light patterns such that pulse amplitude
ACTH secretion reaches a peak a few hours before waking and declines throughout
the day to reach a nadir in the evening. Plasma glucocorticoid levels rise and fall in
response to ACTH secretion thus reaching maximal levels in the early morning. The
mechanism of this circadian rhythm is probably a combination of an endogenous
pacemaker in the suprachiasmatic nucleus of the hypothalamus and environmental
stimuli (Jones and Gillham, 1988).
Both physical and psychological stress such as exercise, trauma, surgery, fear
and depression activate the HPA axis by increasing hypothalamic secretion of CRF
and AVP, stimulating ACTH and glucocorticoid secretion.
3.2.3 Glucocorticoid circulation and receptors
Glucocorticoid hormones are released immediately following synthesis, with
only small amounts stored in the gland (Dickerman et al., 1984). Circulating
glucocorticoids are mostly bound to the plasma proteins, corticosteroid-binding
globulin (CBG) or transcortin. Only a small amount (3-4%) travels as free hormone
(Dunn et al., 1981). Glucocorticoids have widespread and varied actions in the body
and CNS. Within the body they modulate fuel homeostasis and salt balance, have
profound immunosuppressive effects, effect bone metabolism and connective tissue
function. In the central nervous system (CNS) they have multiple effects including
modulation of sleep patterns, mood, cognition and reception of sensory inputs (De
Kloet et al., 1998).
Glucocorticoids act by binding to the intracellular MRs and GRs. These ligand-
activated receptors function as nuclear transcription factors and modulate cell
function by activating or repressing target genes or gene networks. These classical
actions are usually slow in onset and long in duration. More recently, rapidly evoked
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changes in electrical properties of neurones have been demonstrated by both steroids
and neurosteroids, indicating the presence of a membrane receptor for the steroids
(Joels, 1997).
Many of the known steroid receptors have been characterised by binding studies
and cloning. Steroid receptor proteins have molecular masses of around 65 to 100
kDa (O'Malley, 1990). Each receptor protein binds a single steroid molecule, but the
receptors usually dimerise when bound to DNA (Perlmann et al., 1990; Baniahmad
and Tsai, 1993). The most highly conserved domain is a cystine-rich DNA binding
domain containing a zinc finger structure (Freedman et al., 1988; Freedman and
Fuisi, 1993). Two zinc fingers confer specificity for the steroid response element and
are required for, and stabilise the receptor-DNA interaction (Freedman and Luisi,
1993; Glass, 1994). Glucocorticoids are thought to enter cells by passive diffusion,
and bind to the C-terminal ligand binding domain of their receptors. This leads to the
dissociation of one of its associated heat shock proteins (hsp) hsp90, thus
"activating" the receptor and enabling it to bind to DNA (Sanchez et al., 1985; Denis
et al., 1988). The activated receptor-hormone complex translocates to the nucleus
where it binds as homodimers to specific regulatory DNA sequences called
glucocorticoid response elements (GREs) (Glass, 1994). GREs are frequently located
near the promoter region of target genes, and receptor binding results in activation or
suppression of transcription (Baniahmad and Tsai, 1993). Intriguingly, both GR and
MR bind to the same DNA response elements (the DNA binding domain being
highly conserved between MR and GR, with 94% homology), indicating that the
specificity of genomic actions lies in DNA sequences outside the GRE, or in
interactions with other transcription acting proteins (Pfahl, 1993).
The two receptors differ in their affinity for ligands. In rat, corticosterone binds
with a high affinity (Kd~0.5nM) to the MR, and with an approximately 10-fold lower
affinity to the GR (Joels, 1997). The daily variations in glucocorticoid levels, due to
circadian fluctuations and acute stress, will alter the relative occupation of MR and
GR. Under basal conditions there will be a predominant activation of MR, but upon
increasing glucocorticoid levels, at the diurnal peak or in response to stress, GR will
become additionally activated (Reul and de Kloet, 1985).
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3.2.4 MR and GR distribution in the brain
Both MR and GR receptor types are expressed in the brain. GR are expressed
fairly ubiquitously by most neurones and glia, with high levels found in the
hippocampus, neocortex, thalamus, cerebellum and stress related nuclei of the
hypothalamus and brainstem (Morimoto et al., 1996; Kawata et al., 1998). MR show
a more restricted distribution, with high expression confined mainly to the limbic
regions, and lower expression observed in the brainstem, sensory and motor nuclei
and spinal cord (McEwen et al., 1986; Reul and de Kloet, 1986; Ahima and Harlan,
1990).
3.2.5 Glucocorticoid actions in the brain
Glucocorticoids work at various levels to alter cellular excitability. They can
alter ionic conductances, affect the efficacy of transmitter systems, and alter general
cell properties such as metabolism and cell morphology. Glucocorticoids can alter
the electrical properties of neurons by targeting voltage gated ion channels,
signalling cascades activated by neurotransmitters (including ligand-gated ion
channels and G-protein coupled receptors), and the pumps and transporters
responsible for maintenance of ionic gradients across the cell membrane. Many
studies of steroidal action have been carried out on the hippocampal brain slice, since
hippocampal CA1 pyramidal neurons express a high density of both MR and GR.
With use of selective ligands for MR and GR and artificial manipulations of
corticosteroid levels in ADX rats, discrimination between the physiological effects
mediated by either receptor subtype is possible.
Of the voltage-gated ion conductances investigated, Ca2+ currents are the most
potently regulated by corticosteroids. Predominant MR activation as seen under rest
at the circadian nadir, is associated with a small amplitude of voltage-gated Ca2+
conductances (Karst et al., 1994). Additional activation of GR increases the
amplitude of Ca2+ conductances (Kerr et al., 1992; Karst et al., 1994; Werkman et
al., 1997). Absence of any glucocorticoid receptor activation, as observed in ADX
rats, also results in large Ca2+ conductances; thus a U-shaped dose-dependency
relation exists for glucocorticoid effects on Ca2+ current amplitude (Werkman et al.,
1997). Glucocorticoid altered current amplitudes appeared in slices after a few hours
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and effected mainly high voltage activated Ca2+ currents (Karst et al 1994). This time
delay between manipulation of corticosterone levels and effect, and the fact that
these changes rely on protein synthesis imply a genomic mechanism for action
(Joels, 1997). Properties of Ca2+ currents, such as voltage dependence and their
steady state inactivation, appeared to remain unaltered by corticosteroid treatment,
leading to the suggestion that corticosterone acts to increase the number of Ca2+
channels rather than producing a change in Ca2+ channel structure (Werkman et al.,
1997). However Nair et al. (1998) recently characterised the mRNA expression of
voltage and ligand gated Ca2+ channels in individual dissociated CA1 neurones in
response to long term corticosterone, observing that this treatment altered the
expression of mRNA to those subunits favouring enhanced Ca2+ influx (e.g.
increased expression of NR2B over NR2A). Thus electrophysiological and molecular
evidence supports the concept that voltage and ligand gated Ca2+ channel subunits
are modulated to increase Ca2+ influx after GR activation.
Of all K+ conductances tested, only the inwardly rectifying K+ conductance,
which is active at very negative membrane potentials, was sensitive to corticosteroid
receptor activation. Increasing occupation of GR in addition to MR was shown to up-
regulate the amplitude of the inwardly rectifying K+ current (Iq) (Karst et al., 1993),
which generally serves to counteract temporary disturbances of the resting membrane
potential.
Ligand-gated ion channels appear far less regulated by corticosterone than
voltage-gated channels. In general, modulatory actions of corticosterone on synaptic
transmission mediated by glutamate- or GABA receptors were seen with very high
concentrations of the hormone (Joels, 2000). The mechanisms by which
corticosteroids modulate amino acid transmission are unclear. When effective,
corticosteroid effects are relatively fast in onset (< 20 min delay), but are reversible
within 10-20 minutes. Activation of MR receptors appears to stabilise (Joels and de
Kloet, 1993) or even enhance glutamate and GABA mediated synaptic transmission
(Rey et al., 1989), whereas GR activation decreases this. Untreated ADX rats also
elicit a decrease in synaptic transmission, indicating again a U-shaped dose-
dependency curve for glucocorticoid effects on amino acid transmission (Joels,
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1997). Hence MR and moderate GR activation results in stabilised or enhanced
synaptic transmission.
It has become clear in recent years that some metabolites of peripherally released
steroids and brain derived neurosteroids can rapidly alter the excitability of neurones
by binding to membrane receptors on ion channels. One of the most documented
examples of a non-genomic action of steroids is the modulation of GABAa receptors
by neurosteroids. The neurosteroid dehydroepiandrosterone (DHEA), and its
sulphate derivatives, are secreted from the adrenal cortex during stress and can act as
non-competitive modulators of the GABAa receptor (Demirgoren et al., 1991). 5a
derivatives of progesterone such as allopregnanolone and dihydroprogesterone bind
to GABAa receptors at sites different from benzodiazepine and barbiturates and are
allosteric agonists for GABAa, inducing chloride currents (Lambert et al., 1995). In
different neuronal populations distinct neurosteroids may act as positive or negative
modulators of GABAa. For example, allopregnanolone has been shown to act in
vitro to potentiate GABAa mediated responses, while pregnenolone sulphate
negatively modulates the same receptors (Compagnone and Mellon, 2000). In vivo,
allopregnanolone rapidly potentiated the extracellularly recorded inhibitory
responses of cerebellar Purkinje neurones to GABA (Smith et al., 1987).
Iontophoretic application of the neurosteroid dehydroepiandrosterone sulphate
(DHEAS), onto MVN neurones in vivo, had no effect on the spontaneous and
rotation induced firings of type 1 neurones (Yamamoto et al., 1998). However,
DHEAS dose dependently blocked the decrease in firing which occurred when
GABAa and GABAb agonists were applied to the neurones (Yamamoto et al., 1998).
These effects occurred within a few seconds of administration suggesting that the
neurosteroid can block both GABAa and GABAb mediated signalling via a non-
genomic, perhaps membrane action.
Following UL in rat, there are changes in the responsiveness of ipsilesional
MVN neurones to GABA: A marked down-regulation of the functional efficacy of
both GABAa and GABAb receptors is observed in the rostral region of the
ipsilesional MVN, in brainstem slices taken from animals that have compensated for
4 hours following UL (Yamanaka et al., 2000). This down-regulation may be
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functionally compensatory as it will help the lesioned neurones overcome the
excessive commissural inhibition they are subject to in vivo, following UL.
Glucocorticoid receptors have been implicated in the up-regulation of excitability
that occurs in ipsilesional MVN neurones from 4 hours following UL in rat
(Cameron and Dutia, 1999; Johnston et al., 2002). This chapter investigates the
possibility that glucocorticoids play a role in the GABA receptor plasticity at this
time.
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3.3 AIMS AND EXPERIMENTAL RATIONALE
The following experiments were designed to investigate the role of the stress
axis in the down-regulation of GABA receptor efficacy in lesioned rostral MVN
neurones at 4h post-UL.
1. To investigate the effect of endogenous stress hormones on the down-
regulation of GABA receptor efficacy in vitro, 14 animals received a left UL under
urethane anaesthesia (UL) and were kept in a temperature regulated cage for 4 hours
following surgery. These animals did not wake up at any time after UL and therefore
experienced none of the stress normally associated with the vestibular
deafferentation syndrome.
2. To determine whether the down-regulation of GABA receptor efficacy in
MVN neurones was affected by the anaesthetic used, 14 animals received a sham
operation under urethane anaesthesia (Sham), and were kept in a temperature
regulated cage for 4 hours after surgery.
3. To mimic the endogenous activation of the stress axis that would normally
occur in alert labyrinthectomised animals, the synthetic glucocorticoid receptor
agonist, dexamethasone (DEX), was administered (5mg/kg i.p.), 15 min before the
lesion to urethane anaesthetised labyrinthectomised animals (UL+DEX) (n=15).
4. To control for any direct effects of dexamethasone on the down-regulation of
GABA receptor efficacy in MVN neurones, 14 sham operated urethane anaesthetised
animals received the same protocol of dexamethasone administration as above
(Sham+DEX).
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3.4 METHODS
Animals
Male Sprague-Dawley rats 80-120g (Bantin & Kingman, UK) were used
throughout these experiments. Animals were housed in litter groups under control
conditions: ambient temperature 21-23 °C, humidity 50-60%, 12 hour light-dark
cycle, food and water ad libitium. Animals were kept in the Medical Faculty Animal
Area (MFAA) for at least 4 days before the start of experimental procedures, to
accustom them to handling and minimise the effects of non-specific stress. Animal
care and experimental procedures were conducted in accordance with UK Animals
(Scientific Procedures) Act 1986.
Anaesthesia
For all experiments in this chapter, rats were given a single intraperitoneal (i.p.)
injection of urethane (ethyl carbamate, 25% weight/volume solution; Sigma, UK) at
a dose of 1.25g/kg, 15 min before the start of surgery. This produced the required
level of anaesthesia for the duration of the experiments.
Surgery
Animals were anaesthetised with urethane anaesthesia. A sufficient level of
surgical anaesthesia was determined by lack of reflex to a paw pinch. Surgery was
carried out under aseptic conditions. For experiments using DEX, a single i.p.
injection 5mg/kg was administered after anaesthesia, 15 min before the start of
surgery. Animals were shaved at the back of the head between the two ears, and the
area was cleaned with disinfectant iodine solution (Betadide, UK). Under a
microscope (Wild ms-c, Heerburg, Switzerland) a 3 cm incision was made with a
sterile scalpel above the left ear, and the surrounding connective tissue removed
using sharp surgical scissors. The area was clamped using surgical clips. The middle
ear was opened and the ossicles removed with fine forceps. Muscles attached to the
caudal side of the lamboidal ridge were cleared and the temporal bone exposed. The
bony duct of the horizontal semicircular canal was visualised, then exposed by
drilling with a 0.7mm diameter dental drill (Precision P.C.B drill RS Components,
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UK). The area was kept clear with a needle attached to a suction pump (Eschmann
VP25, International Market Supply). The canal was opened above the point of exit of
the seventh cranial nerve, and the drilling continued following the open canal duct
anteriorally through the ampula into the vestibule. The contents of the vestibular
cavity were rinsed with 100% ethanol (Sigma, UK). The wound was sutured and the
animals returned to their home cages. Sham operated animals underwent the same
procedure, but the canal was not opened and the inner ear was undamaged.
Preparation and maintenance of slice containing MVN in vitro
After 4 hours the animal was decapitated using a small animal guillotine. Scalp
and neck muscles were removed, and fine curved scissors were used to make a
midline incision in the scull extending from the occipital to the frontal bone, and an
incision across the midline. The occipital, parietal and frontal bones were removed
using fine bone rongeurs. The whole exposed brain was cleared of meninges and a
fine scalpel used to cut the cranial nerves and tip the brain into a beaker of ice cold
(4°C) artificial cerebrospinal fluid (aCSF; see solutions) bubbled with 95% O2 and
5% CO2. The brain was kept in the ice cold aCSF for one minute before being placed
on a cold dissecting stage. The cortex extending rostrally from the inferior colliculus
was removed from cerebellum and brainstem block. The brainstem containing the
overlying cerebellum was placed on its rostral surface and the brainstem gently
removed from the cerebellum by parting the two with a blunt scalpel blade and
cutting through the cerebellar peduncles. This remaining brainstem block containing
the MVNs sitting prominently either side of the IVth ventricle on the dorsal surface
of the medulla, was cleared of adherent pia. The block was then cemented with the
floor of the forth ventricle uppermost to the advancing stage of a Vibroslice
(Campden Instruments Ltd, UK). The stage was secured into the chamber of the
Vibroslice and submerged in ice cold aCSF pre-bubbled with 95% O2 and 5% C02.
The block of tissue containing the MVN was cut in the horizontal plane
approximately horizontal to the floor of the fourth ventricle, thus containing the
entire rostro-caudal length of the MVN. The first slice containing the top 100-200pM
of the nuclei was discarded. The next slice was cut to a thickness of 350pM and was
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the thickness used for all experiments. The slice contained both MVNs, sat either
side of the fourth ventricle. This was trimmed down the midline, to give the ipsi- and
contralateral nuclei. The ipsilateral (left) MVN was transferred to an interface-type
chamber which was continuously perfused with aCSF bubbled with 95% O2 and 5%
CO2 (pH 7.4, flow rate 1.8 ml/min) and maintained at a temperature of 33°C ± 0.2°C.
A continuous stream of 95% O2 and 5% CO2 gas saturated with water vapour was
passed over the slice to oxygenate the slice and keep it moist. Slices were incubated
for at least an hour in the chamber before recording commenced.
Drugs and Solutions
1. Artificial cerebrospinal fluid (aCSF)
The aCSF used for the preparation and maintenance of the slices was made up
fresh on the day of the experiment according to the following recipe (Llinas and
Sugimori, 1980)(in mM): Sodium chloride (NaCl) 124; Potassium chloride (KC1) 5;
Potassium dihydrogen ortophosphate (KH2P04) 1.2; Calcium chloride 2-hydrate
(CaCl2) 2.4; Magnesium sulphate heptahydrate (MgS04) 1.3; Sodium bicarbonate
(NaHCOa) 26; D-(+)glucose 10. The aCSF was bubbled with a gas mixture of 95%
O2 and 5% C02 to oxygenate it and maintain its pH at 7.4.
2. Muscimol and Baclofen
The GABAa agonist muscimol (5-aminomethyl-3-hydroxyisoazole) and the
GABAb agonist baclofen (4-amino-3[4-chlorophenyl]butanoic acid) were obtained
from Sigma, UK. Small aliquots of stock solution were made in distilled water and
frozen until required. Aliquots of the stock solutions were thawed and diluted to their
final concentrations in oxygenated aCSF immediately before use. Drug solutions
were applied to the slice by switching the perfusion inlet tube to the appropriate
reservoir.
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3. DEX
Dexamethasone 21-phosphate was obtained from Sigma, UK. Aliquots of
lmg/ml solution were made in distilled water and frozen until required.
Dexamethasone was administered i.p. at a dose of 5mg/kg, 15 min prior to the start
of surgery.
Data collection and analysis
A conventional electrophysiological set-up was used for data collection, storage
and analysis: glass microelectrodes filled with 2M NaCl coupled to an Axoclamp 2B
amplifier (Axon instruments, USA), were used to systemically explore the MVN for
tonically firing cells. The voltage output from the amplifier, which was amplified 10
times and filtered at 3 kHz, was passed to a two-channel storage oscilloscope (HM
205-3, Hameg, Germany) and monitored continuously. The voltage output was fed to
a CED 1402 plus analogue-to-digital interface (Cambridge Electronic Design,
Cambridge, UK) connected to a microcomputer (DCS 386, UK), which was used to
display the instantaneous discharge frequency, autocorrelation and interspike interval
histogram in real time, in order to ensure stable recording conditions. All data
analysis was completed off-line, except when measuring extracellular firing rates
which was done on-line. Several tonically active cells were often recorded in the
course of a single track and the location of each track was noted with reference to the
boundaries of the MVN. For the purpose of the analysis the MVN was divided by
eye into three regions: rostral third, middle third and caudal third.
In the experiments in this chapter, recordings of the mean tonic discharge rate of
cells sampled in the rostral third of the MVN were made, and the location of each
cell recorded. The response of these cells to a 60-second test pulse of agonist were
measured, as the maximal decrease in discharge rate expressed as a percentage of the
resting discharge rate of each cell. The mean inhibitory effects of each concentration
of the two agonists were calculated for all the cells tested, and sigmoidal functions of
the form y=Bottom + (Top-Bottom) / (l+10A((logEC50-X)*HillSlope)), were fitted
to the dose-response relationship using GraphPad Prism 3.03 software (GraphPad
Software Inc, San Diego, USA). Although values were assigned to 100% inhibition
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for all responses where the tonic activity of the cells were completely inhibited by
GABA agonists, the parameters of the curve fitting algorithm were not constrained to
within this range. The dose response relationships were compared using two-way
ANOVA with Student-Newman-Keuls post hoc testing using SigmaStat 3.0 (SPSS
Inc, Chicago, USA). Significance was assumed when p<0.05. Results are given as
mean ±S.E.M. throughout.
Stress and neural plasticity in the MVNfollowing UL 87
3.5 RESULTS
Extracellular recordings were made from tonically active neurones, in the rostral
region of the MVN, in brainstem slices from rat. The rostral region of the MVN has
been shown to receive a particularly dense innervation of primary afferents from the
ipsilateral semicircular canal (Stein and Carpenter, 1967; Gacek, 1969; Brodal, 1974;
Sato et al., 1989). Previous studies (Yamanaka et al., 2000; Johnston et al., 2001)
have shown that in slices prepared from 4h UL animals, MVN cells in the rostral
region of the ipsilesional nucleus show a marked down-regulation of their response
to both the GABAa agonist muscimol, and the GABAb agonist baclofen, seen as a
rightward shift and a decrease in slope of the dose response relationships for the two
agonists. The effect of the glucocorticoid agonist dexamethasone on the
responsiveness of MVN neurones to GABA was investigated by bath application of
muscimol and baclofen to MVN slices prepared from urethane anaesthetised animals
that had received a sham labyrinthectomy or a left labyrinthectomy 4h previously
either with or without administration of dexamethasone (DEX).
1. Effect of glucocorticoid agonist dexamethasone on the mean discharge rate
of ipsilesional rostral MVN neurones in vitro
As shown in figure 3.2, the mean discharge rates of MVN cells from DEX
treated, sham operated animals (Sham+DEX) was not different from Sham operated
animals (Sham) (Sham+DEX: 14.9 ±0.96 spikes/sec, n=41 cells, versus Sham: 15.0
±1.13 spikes/sec, n=38 cells); all animals remained anaesthetised for 4h following
surgery. These data indicate that DEX treatment alone does not result in changes in
the mean in vitro discharge rate of MVN neurones. The firing rate of neurones
recorded from UL animals which remained anaesthetised for 4h following surgery
(UL: 15.5 ±1.23 spikes/sec, n=48 cells) were not different from the Sham or
Sham+DEX groups. This indicates that the lesion alone is not sufficient to induce the
increase in excitability of MVN neurones. However, neurones recorded from DEX
treated anaesthetised UL animals (UL+DEX) were found to be firing at a
significantly higher mean discharge rate than all other groups (21.0 ±1.46 spikes/sec,
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n=34 cells; p<0.002, one-way ANOVA). These data confirm the previous findings of
Cameron and Dutia (1999) who recorded firing rates of neurones in the rostral
ipsilesional MVN of: 15.22 ±1.44 spikes/sec in sham operated animals anaesthetised
with avertin so they awoke after the surgery, increasing to 21.61±1.8 spikes/sec in
avertin anaesthetised UL animals. Upon urethane anaesthesia, the firing rate in UL
animals fell to 16.79 ±1.49 spikes/sec, but addition of DEX to urethane anaesthetised
UL animals restored the firing rate to 22.31 ±1.8 spikes/sec. These data suggest that
while the lesion alone is not sufficient to induce the increase in excitability of MVN
neurones, administration of DEX to UL anaesthetised animals restores the large
compensatory increase in excitability seen in alert animals.
2. Effect of glucocorticoid agonist dexamethasone on the responsiveness of
MVN neurones to muscimol and baclofen following UL
As illustrated in figure 3.3, bath application of the GABAa agonist muscimol,
and the GABAb agonist baclofen to spontaneously active MVN neurones, caused
reversible, dose-related inhibition of all the MVN neurones tested. Table 3.1 shows
the parameters of the sigmoidal curves fitted to the dose-response relationship
(maximal inhibition, half-maximal agonist concentration (EC50) and slope) for all the
data in these experiments.
The effects of muscimol and baclofen on rostral MVN neurones in slices from
anaesthetised animals having undergone a sham operation (Sham), sham operation
with administration of DEX (Sham+DEX), or a left labyrinthectomy (UL), did not
differ as illustrated by their respective dose response curves in figures 3.4 and 3.5.
These data indicate that neither the lesion alone, or DEX treatment alone is sufficient
to induce the down-regulation of GABA receptor efficacy seen in alert animals.
In slices prepared from anaesthetised animals that had been unilaterally
labyrinthectomised 4h previously and administered the glucocorticoid receptor
agonist DEX (5mg/kg i.p., 15 min before the lesion) (UL+DEX), cells in the rostral
region of the ipsilesional nucleus showed a marked decrease in their responsiveness
to both muscimol and baclofen. This was seen as a significant rightward shift in the
dose response curve relationships for both agonists compared to all other groups
(Fig. 3.4 and 3.5, p<0.001, two-way ANOVA). There was over a three-fold increase
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in the EC50 value of the fitted dose response curves for muscimol, and a two and a
half-fold increase in the EC50 value of the fitted dose response curves for baclofen
when compared with any other experimental group, and these were accompanied by
a decrease in slope in both cases (see Table 3.1). These data indicate that in
urethane-anaesthetised labyrinthectomised animals, administration of DEX restores
the down-regulation of GABA receptor efficacy as seen in alert animals.
The relationship between the in vitro resting discharge rates of the ipsilesional
rostral MVN neurones and their inhibitory responses to the representative doses of
3pM baclofen and 10|iM muscimol are illustrated in figure 3.6. In slices from
UL+DEX animals, more cells were found with resting firing rates above 20
spikes/sec, reflecting the increase in the mean resting discharge rate of these cells
after UL (Figures 3.6A and 3.6B, crosses). In parallel with this the inhibitory effects
of the two agonists were uniformly reduced. There was no correlation of the
inhibitory response and the resting discharge of the neurones within any individual
experimental group. However, a significant negative correlation was found for
responses to 3pM baclofen, when data from experimental groups which showed no
significant difference in firing rates and % inhibition versus Sham control were
pooled (Sham, Sham+DEX, UL; p<0.005, spearman rank correlation). When all data
sets responding to 3p,M baclofen were pooled (Sham, Sham+DEX, UL, UL+DEX),
this significance increased to p<0.0001. No significant correlation was found with
pooled data in response to IOjxM muscimol.
Summary
These data show that the compensatory down-regulation of GABA receptor
efficacy seen at 4h post-UL, in neurones in the rostral third of the ipsilesional MVN
in alert UL animals, was abolished when animals were kept anaesthetised and did not
experience the stress that normally follows UL. Significantly, in urethane-
anaesthetised labyrinthectomised animals, administration of the synthetic GR agonist
dexamethasone, restores the down-regulation of GABA receptor efficacy. Therefore,
these experiments suggest that the increase in mean firing rate and down-regulation
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of GABA receptors in rat rostral ipsilesional MVN neurones at 4h post-UL,











Sham 104.0 ±8.63 11.5 ±3.9 1.70 ±0.58 92.4 ±4.1 2.7 ±1.2 1.15 ±0.25
Sham+DEX 104.6 ±5.57 14.2 ±1.9 1.36 ±0.30 107.7 ±6.5 2.45 ±1.3 1.03 ±0.29
UL 105.3 ±3.35 10.1 ±1.4 1.35 ±0.15 100.5 ± 8.5 3.13 ±1.3 1.21 ±0.44
UL+DEX 111.7 ±3.67 27.86 ±1.2 1.20 ±0.07 112.6 ±27.4 9.2 ±1.6 0.74 ±0.47
Table 3.1 Parameters of the dose-response relationships fitted to the mean
inhibitory responses of MVN cells to muscimol and baclofen, in each of the
experimental conditions.
Summary of maximum inhibition, EC50 and slope ± S.E.M. from fitted dose
response curves of MVN neurones from urethane anaesthetised: sham operated
animals (Sham), sham operated animals administered DEX (Sham+DEX; 5mg/kg
i.p. 15 min before surgery), left labyrinthectomised animals (UL), and left
labyrinthectomised animals administered DEX (UL+DEX; 5mg/kg i.p. 15 min
before surgery).



























Sham Sham+DEX UL UL+DEX
4h post-sham 4h post-lesion
Figure 3.2 Effect of glucocorticoid agonist dexamethasone on the mean
discharge rate of ipsilesional rostral MVN neurones in vitro
Histograms showing the mean ± S.E.M. in vitro tonic discharge rates of ipsilateral
rostral MVN neurones in slices prepared from urethane anaesthetised animals that
had received a sham operation or a left UL 4h previously, either with or without
administration of dexamethasone (DEX: 5mg/kg, i.p.) 15 min prior to surgery.
Statistics: **P<0.002, versus MVN neurones from Sham, Sham+DEX and UL
animals. One-way ANOVA.
Figure3.3ResponsoftonicallyactivMVNneuronesGABAand ba on sts. A.ResponseofMVNneuronelocatedithr strali df3,10an0 MtGABAago i t, muscimol. B.ResponseofMVNneuronlocatedithr stralthirdf1,3anIOjxMGABABgoni t, baclofen.
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3.6 DISCUSSION
The compensatory down-regulation of GABA receptor efficacy observed in
rostral neurones of the lesioned MVN following UL was abolished in animals which
were not allowed to recover from anaesthesia. Administration of the glucocorticoid
agonist dexamethasone, to mimic activation of the stress axis in non-recovery UL
animals restored the down-regulation of GABA receptor efficacy. Administration of
dexamethasone to sham operated animals had no effect on GABA receptor efficacy.
These experiments suggest that acute activation of the stress axis post-UL, the
subsequent release of endogenous glucocorticoids and the activation of
glucocorticoid receptors are necessary to induce the compensatory down-regulation
of GABA receptor efficacy in rostral neurones of the lesioned MVN during the early
stages of vestibular compensation (VC).
3.6.1 Mechanisms of changes in GABA receptor efficacy in the MVN following
UL
In the rostral ipsilesional MVN, in slices taken from alert animals
labyrinthectomised 4h previously, there is a marked down-regulation in the
functional efficacy of both GABAa and GABAb receptors, seen as a significant
rightward shift and decrease in slope for their dose-response relationships to
muscimol and baclofen (Yamanaka et al., 2000; Johnston et al., 2001). These results
demonstrated an adaptive down-regulation of the affinity or efficacy of postsynaptic
GABA receptors on the MVN neurones. This down-regulation is functionally
compensatory, in that it will reduce the sensitivity of the ipsilesional MVN neurones
to the excessive commissural inhibitory synaptic drive that silences them in vivo.
Consequently their intrinsic pacemaker-like conductances (Serafin et al., 1991a;
Johnston et al., 1994) and remaining excitatory synaptic inputs in vivo, will be more
effective in causing membrane depolarisation and the restoration of firing activity
after UL. Thus the ipsilesional down-regulation of GABA receptor efficacy may help
rebalance the excitability of the bilateral vestibular nuclei, promoting VC.
The mechanisms that generate this down-regulation of GABA receptor efficacy
are unknown; however most neurotransmitter receptors are subject to regulation
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following activation by their agonists. The initial regulatory effect of agonist
exposure is a rapid (seconds to minutes) desensitisation of the receptor, producing a
loss of immediate responsiveness. Although there is an increased GABAergic input
onto the ipsilesional MVN neurones post-UL, it is unlikely that the changes in
GABA receptor efficacy are due to desensitisation, as all dose response
measurements were made after a lh incubation period in normal aCSF thus removing
any excess GABA from the slices. If agonist exposure persists (minutes to hours),
receptors are then removed from the cell surface into an internal membrane pool, in a
process referred to as internalisation or sequestration. The internalised receptors can
either be recycled to the surface or degraded. Chronic exposure to agonists (hours to
days) can results in degradation of receptors and is often termed down-regulation.
Direct evidence for a down-regulation of GABAa receptors post-UL was provided
■7
by Calza et al. (1992), who observed a decrease in benzodiazepine (H-
flunitrazepam; 3H-FNZ) binding in the ipsilesional MVN at 3-23h post-UL which
returned to normal within 3 days. Simple internalization cannot account for the
decreased H-FNZ binding, as FNZ is membrane permeant, and labels both
intracellular and extracellular GABAa receptors (Czajkowski and Farb, 1986).
Whether the reduction in ligand binding in these neurones is correlated with a loss of
receptor function remains to be determined.
The effects of chronic exposure of neurones to GABA have been widely
investigated in neuronal cell cultures. Incubation of neuronal cultures derived from
embryonic chick brain with ImM GABA for 48h caused a reversible decrease of
GABAa receptor numbers (Maloteaux et al., 1987; Tehrani and Barnes, 1988; Roca
et al., 1990), and decreased the levels of mRNA encoding the al, (32S, and yl
GABAa receptor subunit isoforms with no change in mRNA turnover (Montpied et
al., 1991; Lyons et al., 2000). The observed down-regulation of mRNA subunits
preceded the receptor down-regulation; furthermore, GABA exposure inhibits
GABAa receptor al and (31 subunit promoter activity (Lyons et al., 2000). These
data are consistent with a transcriptional mechanism of GABAa receptor down-
regulation. Shorter term regulation of GABAa receptors by GABA has been recorded
by Hirouchi et al. (1992), who observed a decrease in GABAa receptor al subunit
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mRNA levels in mouse cortical neuron cultures following a 4h exposure to 10pM
muscimol. A down-regulation of GABA receptor efficacy was recorded in rat MVN
neurones after incubation of the brainstem slice in 10pM muscimol for 4h (Him,
1999; Masters thesis, Edinburgh University). These results suggest that exposure to
increased GABA alone is sufficient to induce a down-regulation of at least GABAa
receptors. However this is not the case for the down-regulation of GABA receptor
efficacy in rostral neurones of the lesioned MVN post-UL, as the present results
demonstrate that labyrinthectomy alone in anaesthetised animals did not result in this
down-regulation. Immediately following labyrinthectomy, in anaesthetised and in
alert animals in vivo, there is a silencing of the ipsilesional MVN neurones. This is
due not only to the loss of tonic excitatory drive from the deafferented primary
vestibular afferents, but also due to an enhanced commissural inhibition from the
contralateral MVN neurones, which become hyperactive due to the decrease in
commissural inhibitory drive from the lesioned side (Smith and Curthoys, 1988b).
Hence, in anaesthetised animals there is an increased GABAergic input onto the
ipsilesional MVN neurones in vivo, but this alone is not sufficient to stimulate the
down-regulation of GABA receptor efficacy, as this was only observed in UL
anaesthetised animals administered the glucocorticoid agonist DEX at the time of
surgery (see Figures 3.4, 3.5). These data indicate that the down-regulation is
dependant both on the vestibular lesion and on the activation of glucocorticoid
receptors, during the acute stress response that follows UL.
3.6.2 Involvement of the stress system in vestibular compensation
The results presented here are in agreement with those of Yamanaka et al.
(1995a) and Cameron and Dutia (1999), implicating a role for the stress system in
vestibular compensation. Cameron and Dutia (1999) demonstrated that the increase
in excitability of ipsilesional MVN neurones post-UL in rat, thought to facilitate the
rebalancing of excitability between vestibular nuclei, and therefore VC, did not occur
in animals which remained anaesthetised after UL so that they did not experience the
stress normally associated with UL (see Fig. 3.2, compare with statistics of Cameron
and Dutia (1999), outlined in Section 3.5.1). Administration of DEX to these animals
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restored the increase in excitability; conversely, systemic administration of the GR
antagonist RU38486 to alert animals prevented the increase. Yamanaka el al. (1995a)
observed that systemic (i.v.) administration of DEX accelerated recovery of
spontaneous nystagmus after UL in rabbit in a dose dependant manner, while
RU38486 retarded it. However, Alice et al. (1998) observed that none of the three
doses of DEX (5, 10, or 40mg/kg i.p.) administered to guinea pigs between 0 and 36
hours following UL (the injection schedule designed to mimic that of Yamanaka et
al., 1995a) had any effect on the rate of recovery of SN. The discrepancies between
the two studies may be due to the fact that in guinea pig there are significant
differences in various components of the pituitary-adrenal axis compared with other
species (for reviews, see Funder, 1994; Keightley and Fuller, 1996). Guinea pigs
have very high circulating levels of Cortisol, and a low-affinity, low-capacity
corticosteroid-binding globulin so that free Cortisol levels are relatively high
compared to other species. Guinea pigs also have very low affinity GRs, with
approximately one-twentieth the affinity for DEX as those in the rodent (Kraft et al.,
1979). Thus, administration of DEX to guinea pigs may have little effect on the rate
of VC as it is likely that the majority of GRs are already occupied in this species.
Jerram et al. (1995) reported that systemic administration of the GR agonist
methylprednisolone (30 mg/kg s.c.), before and 4h post-UL reduced the frequency of
SN in guinea pigs. This result seems to contrast with that of Alice et al. (1998), yet
although the frequency of SN was reduced by methylprednisolone, the rate at which
it compensated was not, and no beneficial effects on postural compensation were
observed. Methylprednisolone has a higher affinity for GRs than dexamethasone
(Kawata, 1995) and the effects on SN observed by Jerram and colleagues could be
due to the increased GR activation. Interestingly, the effects of methylprednisolone
on SN followed an inverted U-shaped dose-response function; 30mg/kg decreased
the rate of SN, but 15 or 60mg/kg had no effect on its rate (Jerram et al., 1995). This
inverted U-shaped dose-response relation, is a classic feature of glucocorticoid
modulation of a range of cellular processes such as modulation of ion channel
excitability (Joels, 1997; Section 3.2.5) and in the hippocampus, primed burst
potentiation (Diamond et al., 1992). Recently, Yamamoto et al. (2000) demonstrated
that additional restraint stress applied to UL rats, delayed the recovery of SN as
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compared to unstressed UL rats. Hence, glucocorticoids may be acting on the process
of VC in an inverted U-shaped dose dependant manner, such that no, or low GR
activation, or very high levels of GR activation are detrimental, but an optimum level
of GR activation is required for the efficient development of VC. This theory could
be tested on a behavioural and cellular level both in vivo and in vitro, by
administration of varying concentrations of corticosterone pellets to
adrenalectomised rats, thus artificially controlling circulating levels of
corticosterone. After UL in these animals, in vivo recordings could be made
measuring the time taken for the silenced ipsilesional MVN neurones to recover their
spontaneous activity; in vitro recordings made, measuring the time course of the
development of the increased excitability and down-regulation of GABA receptor
efficacy in ipsilesional MVN neurones and these could be coupled with behavioural
measurements.
3.6,3 Mechanisms of steroid modulation of GABA receptor efficacy following
UL
Two types of action have been demonstrated to be mediated by steroid
hormones. Classical genomic actions, via steroid binding to intracellular receptors
are usually slow in onset and prolonged in duration, whereas rapidly evoked changes
in electrical properties of cells have been observed and a membrane receptor for
steroids has been implicated for these actions (see Section 3.2.5).
Genomic modulation ofGABA function
The GABAa receptor is a pentamer, assembled from a diversity of subunits (a,
(3, y, 5, s, n and p), that gates a chloride conductance (Hevers and Luddens, 1998;
Mehta and Ticku, 1999). Heterologous expression of GABAa receptor subunits has
revealed that a combination of at least one a, one (3 and one y subunit is required to
form a channel with properties observed in vivo (DeLorey and Olsen, 1992). The
receptor complex contains multiple, allosterically interacting binding sites, usually
including sites for GABA, barbiturates, benzodiazepines (BZD), chloride channel
antagonists, and endogenous steroids (Majewska et al., 1986). Native and
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recombinant GABAa receptors composed of different subunit combinations, differ in
pharmacological properties such as channel kinetics and allosteric modulation
(Vicini, 1999).
Much research into the effects of corticosterone application and stress paradigms
on GABAa receptor function has been undertaken in the hippocampus, and has
frequently yielded contradictory findings (for review, see Stone et al., 2001). This
may be due to a functional heterogeneity among hippocampal GABAa receptors
resulting in different modulatory actions of glucocorticoids in different regions, as
demonstrated by Orchinik et al. (2001). Even so, whilst restraint stress (Mosaddeghi
et al., 1993) and corticosterone applications (Stone et al., 2001) have been shown to
decrease BZD binding in the hippocampus, and swim stress selectively alters the
GABAa complex preference for BZD antagonists over agonists (Park et al., 1993),
other studies have shown hippocampal BZD binding to increase (Wilson and
Biscardi, 1994), remain unchanged (Motohashi et al., 1993) or have bidirectional
responses to stress (Medina et al., 1983).
The GABAb receptor is a G-protein coupled receptor, which modulates synaptic
transmission through intracellular effector systems (Kaupmann et al., 1997; Bettler et
al., 1998; Bowery et al., 2002). Both presynaptic and postsynaptic GABAb receptors
exist. Presynaptic autoreceptors inhibit the release of GABA, whereas heteroceptors
inhibit the release of glutamate, noradrenaline, dopamine, serotonin, substance P,
cholecystokinin or somatostatin by suppressing neuronal Ca2+ conductances (for
review, see Bowery, 2002). Postsynaptic GABAb receptors are coupled to K+
channels by a G-protein, receptor activation leading to increased K+ conductance and
hyperpolarisation of cells. GABAb receptors can be modulated not only at the level
of the membrane receptor itself, but also by modulation of G-protein coupled
systems downstream of the receptor, such as protein kinase systems (Carman and
Benovic, 1998). Hence, there are many regulatory mechanisms involved in the
desensitisation and down-regulation of GABAb receptors which could be targeted by
glucocorticoids.
The results presented in this thesis indicate that in the MVN following UL, DEX
is acting in concert with the lesion to decrease the GABA receptor efficacy. It is
unclear whether this is mediated by a genomic or membrane action of the steroid.
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The GABAa receptor subunit y2, is responsible for BZD binding (Gunther et al.,
1995), and decreases the sensitivity of GABAa receptors to GABA (Zhu et al.,
1996). Changes in BZD binding in the hippocampus in response to corticosterone
applications were accompanied by changes in the level of y2 subunit mRNA
(Orchinik et al., 1995, 2001; Stone et al., 2001). These data indicated a
transcriptional regulation of GABAa receptor function in response to corticosterone.
It would be interesting to determine whether the decreased BZD binding in
ipsilesional MVN neurones from 3h post-UL in rat (Calza et al., 1992), and the
down-regulation of GABAa receptor efficacy from 4h post-UL observed in this
thesis, are accompanied by similar reductions in GABAa receptor subunit mRNAs.
Rapid modulation ofGABA function
Many actions of glucocorticoids on GABA receptor function have been recorded,
which are rapid in onset and relatively short in duration (Vidal et al., 1986; Joels and
de Kloet, 1993). While specific binding sites exist on the GABAa receptor complex
for neurosteroids, the data in this chapter indicate that the down-regulation is
dependant on glucocorticoid receptor activation, and a specific binding site for
glucocorticoids on this complex has not been identified. Recent evidence in different
species, suggests that rapid glucocorticoid actions are mediated by distinct membrane
receptors and activation of non-genomic signalling mechanisms (for review, see
Losel et al., 2003). Glucocorticoids have been shown to bind specifically to cellular
membrane sites (Suyemitsu and Terayama, 1975; Harrison et al., 1979; Orchinik et
al., 1991) and to induce rapid influences on electrolyte movement across cellular
membranes (Hua and Chen, 1989; ffrench-Mullen, 1995). Although the molecular
identity of the membrane-associated receptors for corticosteroids is still unresolved, a
high-affinity binding site for corticosterone, which appears to meet the criteria for a
functional membrane-associated corticosteroid receptor, has been partially purified
and characterised in neuronal membranes from amphibian brain (Evans et al., 2000).
This receptor has characteristics of a G-protein coupled receptor in that
[JH]corticosterone specific binding is enhanced by Mg2+ and inhibited by guanyl
nucleotides (Orchinik et al., 1992). Other studies indicate that a membrane
Stress and neural plasticity in the MVNfollowing UL 105
glucocorticoid receptor (mGR) similar to that found in amphibian brain may exist in
mammalian brain (Harrison et al., 1979; Sze and Towle, 1993).
The time point post-UL, at which the GR mediated down-regulation of GABA
receptor efficacy first occurs, is not known. Experiments to determine if GABA
receptor efficacy is down-regulated prior to the 4 hour timepoint in these
experiments would give an initial indication of whether they were membrane or
genomic mediated actions. At a 4 hour timepoint, it is more likely that the down-
regulation in efficacy is due to phosphorylation of ion channels and receptors than to
degradation of receptors or changes in GABA receptor subunits. This view is
supported by experiments showing the early importance of protein kinases in
vestibular compensation (Balaban et al., 1999; Johnston et al., 2002), and the
observation that systemic injections of a protein synthesis inhibitor (cycloheximide)
had no effect upon the early stages of resting activity recovery in the ipsilateral VNC
of guinea pigs (Ris et al., 1998). Compensation following UL in rats, is accompanied
by transient, regionally selective changes in the distribution of protein kinase C
(PKC) immunopositive Purkinje cells in the vestibulo-cerebellum, which parallel the
time course of the disappearance of spontaneous nystagmus (Goto et al., 1997;
Balaban and Romero, 1998). Sansom et al. (1997), observed that MVN neurones
following UL show changes in the phosphorylation of several likely PKC substrates.
Inhibition of PKC significantly decreased the rate of recovery of SN in guinea pigs
for up to 8 hours post-UL (Balaban et al., 1999; Sansom et al., 2000), and PKC
inhibitors injected directly into the ipsilateral flocculus prevented the increase in
excitability of rostral ipsilesional MVN neurones seen at 4 hours post-UL (Johnston
et al., 2002). These data indicate that PKC activation is an important requirement for
vestibular compensation at an acute stage post-UL.
Administration of dexamethasone up-regulates PKC activity and the expression
of y and s isozymes of PKC in the rat brain (Dwivedi and Pandey, 1999). It is
possible that PKC activation is the result of glucocorticoid binding to membrane
receptors. There is growing evidence that rapid actions of glucocorticoids can be
mediated by coupling of a membrane receptor to intracellular signalling pathways
(for review, see Chen and Qiu, 2001). Glucocorticoids have been shown to inhibit
Ca2+ currents via a G-protein coupled activation of PKC in guinea pig hippocampal
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CA1 neurones (ffrench-Mullen, 1995) and in PC12 cell lines (Chen and Qiu, 2001).
In rat paraventricular nucleus neurones, a rapid suppression of glutamatergic inputs
was generated by corticosterone and dexamethasone, an effect which could be
blocked by G-protein and PKC inhibitors (Di et al., 2003). The G-protein coupled
effects of glucocorticoids, resulted from binding of a membrane receptor, as
glucocorticoids conjoined to bovine serum albumin, rendering it membrane
impermeable, were still effective in inhibiting Ca2+ currents (Chen and Qiu, 2001)
and glutamatergic inputs (Di et al., 2003). Other signalling pathways such as the G-
protein-PKA pathway have been implicated in rapid membrane actions of
glucocorticoids (Borski et al., 1991; Chen and Qiu, 1999).
Thus, glucocorticoids may be affecting GABA receptor efficacy via modulation
of intracellular kinase pathways, resulting in changed phosphorylation states of the
receptors. Phosphorylation of GABAa receptor subunits via a PKC-dependant
pathway results in a decrease in receptor activity (Brandon et al., 2000; 2002), a
reaction direction which ties in with the current observed down-regulation of GABA
receptor efficacy. Desensitisation of G-protein coupled receptors such as GABAb
receptors, are primarily mediated by kinases such as PKA and PKC (for review, see
Carman and Benovic, 1998). PKC has been observed to suppress GABAb mediated
responses in slices of cerebellar cortex (Taniyama et al., 1992), and GABAb
mediated inhibition of glutamate release (Perkinton and Sihra, 1998).
3.6.4 Time course of GABA receptor down-regulation
GABAa and GABAb receptors are differentially regulated following UL. While
the functional efficacy of GABAb receptors remain significantly down-regulated at
7-10 days post-UL, GABAa receptor efficacy has returned to normal by this time
(Johnston et al., 2001). The transient down-regulation of GABAa receptors may be
related to a transient activation of the stress axis in the few days post-UL. The time
for which corticosterone levels remain elevated post-UL remains to be determined.
The time course for the requirement of GR activation for the development of cellular
plasticity could be determined in a converse set of experiments to those presented in
this chapter: alert UL animals could be injected with the GR antagonist, RU 38486,
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at regular intervals post-UL, and its effects on cellular and behavioural recovery
recorded.
It is interesting to note the correlation observed between the resting discharge rate
and response to 3|iM baclofen in rostral MVN neurones when data from
experimental groups is pooled (see Figure 3.6B). This indicates that the factors that
regulate and maintain the down-regulation of GABAb receptor efficacy may be
related to the factors that regulate the excitability in rostral MVN neurones. Thus the
sustained down-regulation of GABAb receptor efficacy may be related to the
sustained increase in excitability of rostral MVN neurones. However, ipsilateral
flocculectomy was shown to prevent the increase in excitability of ipsilateral rostral
MVN neurones post-UL, while the down-regulation of GABAb receptor efficacy
remained, although the extent of this down-regulation was much less than for that of
GABAa (Johnston et al., 2002).
Summary
The present results demonstrate that the down-regulation of GABA receptor
efficacy in rostral ipsilesional MVN neurones observed from 4h post-UL is
dependent on the activation of glucocorticoid receptors. This down-regulation of
GABA receptor efficacy is likely to be functionally compensatory as it will
counteract the disfacilitation and excessive commissural inhibition to which these
cells are subject in vivo, helping restore the balance in neuronal activity between the
bilateral VN. Therefore, the acute stress that normally follows vestibular lesions
appears to be important in the initiation of vestibular compensation.
The exact actions of glucocorticoids in inducing the down-regulation of GABA
receptor efficacy are unknown. They may be acting at a genomic level to regulate
GABA receptor subunit expression, or could be acting through membrane receptors
and second messenger systems to alter the phosphorylation state of the receptors.
Future experiments into the mechanisms of glucocorticoid action in vestibular
compensation could provide parallels for glucocorticoid mediated plasticity in other
brain regions.
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Chapter 4
11 (3-HYDROXYSTEROID DEHYDROGENASE IN THE
VESTIBULAR SYSTEM
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4.1 INTRODUCTION
The previous chapter implicated glucocorticoid receptor activation in the
development of plasticity in MVN neurones following UL. Until recently it was
believed that glucocorticoid actions in the CNS were determined solely by the
concentration of hormone in circulation (modulated by hormone binding to plasma
proteins), and by the presence and relative density of the MR and GR receptor types
in a particular tissue. However, it has become apparent that pre-receptor metabolism
of glucocorticoids by the 1 lP-hydroxysteroid dehydrogenase (11P-HSD) enzymes
also potently regulate steroid access to receptors within certain tissues. Given the role
of glucocorticoid receptor activation in the up-regulation of neuronal excitability and
down-regulation of GABA receptor efficacy in lesioned rostral MVN neurones
following UL, it is of interest whether glucocorticoids are modulated on a cellular
level by 11P-HSD enzymes in the MVN and vestibulo-cerebellum.
11P-HSD catalyses the interconversion of active 11-hydroxycorticosteroids
(Cortisol in humans and most mammals, corticosterone in rats and mice) to their inert
11-keto forms (cortisone, 11-dehydrocorticosterone), which have little or no intrinsic
affinity for MR or GR (Fig. 4.1). To date, two isozymes of 11P-HSD have been
characterised which are the products of two distinct genes and differ considerably in










Figure 4.1 Biochemical reaction of the metabolism of glucocorticoids by the 11P-
hydroxysteroid dehydrogenase enzymes, 11P-HSD1 and 11P-HSD2.
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11P-HSD type 2
llp-HSD type 2 (11(3-HSD2) is an NAD-dependant enzyme with a high affinity
for glucocorticoids. The 11[3-HSD2 gene is highly expressed in classical aldosterone
selective target tissues (kidney, colon, pancreas, sweat glands) and the placenta. In
the brain it is expressed only in discrete regions primarily associated with the central
actions of aldosterone in salt appetite and blood pressure regulation (Robson et al.,
1998). 11P-HSD2 functions exclusively as an lip-dehydrogenase, inactivating
glucocorticoids (Fig. 4.1; Seckl, 1997). Mineralocorticoid receptors bind
corticosteroids and aldosterone with equal affinity in vitro (Arriza et al., 1988). The
presence of 11P-HSD2 in these tissues allows selective access of aldosterone to these
non-selective MRs in vivo (Sheppard and Funder, 1987). In the congenital absence of
11P-HSD2, glucocorticoids illicitly occupy mineralocorticoid receptors causing
sodium retention, hypokalemia and hypertension (Ulick et al., 1979; Stewart et al.,
1988).
11 fi-HSD type 1
11P-HSD type 1 (11(3-HSD1) is a reversible NADP(H)-dependant enzyme with a
low affinity for glucocorticoids. 11P-HSD1 is widely expressed, most actively in
liver, testis and lung with lower levels of activity in brain, heart and vasculature. In
the brain, high levels of mRNA expression, bioactivity and immunoreactivity are
found in hippocampus, cerebellum and cortex, with lower levels demonstrated in the
brainstem (Moisan et al., 1990a, b; Lakshmi et al., 1991; Sakai and Lakshmi, 1992).
11P-HSD1 is a 34kDa glycosylated protein first purified from rat liver in the 1980s
(Lakshmi and Monder, 1985, 1988). In these original studies, 11P-HSD1 in the liver
was shown to be bi-directional, although the reductase activity was unstable in vitro
(Lakshmi and Monder, 1988). The function of 11P-HSD1 is considerably less clear-
cut than that of 11P-HSD2. High levels of 11P-HSD1 activity are often found in sites
where there is negligible MR, but where glucocorticoids play a key role in
metabolism through activation of low affinity GR. Thus 11P-HSD1 may play a role
in modulating glucocorticoid access to their receptors. The high llp-HSDl activity,
mRNA expression and immunoreactivity in the cerebellum, which contains no
11/3-HSD1 in the vestibular system 111
measurable MR, supports the role for 11(3-HSD1 in the regulation of glucocorticoid
access to GR (Moisan et al., 1990b). 11P-HSD1 in the hippocampus is co-localised
with MR and GR, thereby possibly modulating access to both types of receptor.
The key to understanding the functions of 11|3-HSD1 in the brain came from
studies of its reaction direction. Although 11(3-HSD1 shows bi-directional activity in
homogenates in vitro, it appears to act predominantly as a reductase in intact cells
and in vivo. In intact mammalian COS-7 cells transfected with 11P-HSD1 cDNA,
intact primary cultures of hepatocytes and in adipose tissue cell lines, 11P-HSD1 acts
almost exclusively as a reductase, regenerating active glucocorticoids (Low et al.,
1994a; Stewart et al., 1994; Napolitano et al., 1998). In primary cultures of
hippocampal cells (mainly neurones) 11P-HSD1 is the sole isozyme expressed and
again acts predominantly as a reductase (Rajan et al., 1996). Hippocampal neurones
are sensitive to excess glucocorticoid, which produces atrophy of the dendrites,
neuronal and cognitive dysfunction and neuronal loss (McEwen, 2000). The
reductase activity of 11P-HSD1 has the potential to potentiate the neurotoxic effects
of glucocorticoids. Ajilore and Sapolsky (1999) characterised the reaction direction
of 11P-HSD in vivo in the hippocampus, using glucocorticoid neuroendangerment as
an indirect assay of 11P-HSD1 function. 11-dehydrocorticosterone (11-DHC),
exacerbated kainic acid toxicity in adrenalectomised (ADX) rats, indicating the
activation of 11-DHC to corticosterone in vivo. This neuroendangering action of 11-
DHC was prevented by inhibition of 11P-HSD1 with the non-selective 11P-HSD
inhibitor, carbenoxolone (Ajilore and Sapolsky, 1999). To further study the function
of 11P-HSD1 in vivo, mice homozygous for targeted disruption of the 11P-HSD1
gene were recently generated (Kotelevtsev et al., 1997). Aged wild type (WT) mice
developed elevated corticosterone levels that correlated with learning impairments in
the watermaze (Yau et al., 2001). Despite elevated corticosteroid levels throughout
life, the glucocorticoid associated learning deficit was ameliorated in 11(3-HSD1
knockout mice (Yau et al., 2001). The 11(3-HSD1 knockout mice also showed lower
intra-hippocampal corticosterone levels than WT mice, presumably due to lack of
11-DHC activation.
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11(3-HSD1 can be regulated by a range of hormones in a tissue and species
specific manner (Idrus et al., 1996; Ricketts et al., 1998). Factors influencing 11(3-
HSD1 activity include glucocorticoids, thyroid hormones, sex steroids, growth
hormone, insulin and cytokines (for review, see Stewart and Krozowski, 1999).
Many studies to date have pointed towards a positive regulation of 11P-HSD1 by
glucocorticoids. The synthetic glucocorticoid, dexamethasone (DEX), induces 11(3-
HSD1 activity in rat cultured hippocampal neurones (Rajan et al., 1996). In vivo,
treatment of ADX rats with DEX for 10 days significantly increased hippocampal
11(3-HSD1 activity and mRNA expression compared with sham or ADX controls
(Low et al., 1994b). Similar effects of DEX on 11P-HSD1 activity are observed in
other brain regions including the cortex, cerebellum and hypothalamus of the rat
(Seckl, 1997). Elevating corticosteroid levels artificially in rat, by long term (21
days) treatment with corticosterone in the drinking water, caused a significant
increase in 11P-HSD1 activity in the pituitary, hippocampus and amygdala (Jellinck
et al., 1997). However, the effects of exogenous stressors, despite raising plasma
corticosterone to the same level as those observed after administration, had mixed
effects on 11P-HSD1 activity (Jellinck et al., 1997). Chronic arthritic stress (14 days)
significantly increased hippocampal 11P-HSD1 activity but not mRNA expression in
rat (Low et al., 1994b); chronic restraint stress (21 days) failed to change llp-HSDl
activity in various regions of the rat brain including hippocampus (Jellinck et al.,
1997); and chronic psychosocial stress (28 days) attenuated hippocampal llp-HSDl
activity in the tree shrew (Jamieson et al., 1997). Induction of 11P-HSD1 in the brain
during acute stress would help amplify intracellular glucocorticoid actions, whereas
chronic attenuation of the enzyme activity may represent a homeostatic mechanism
to ameliorate the otherwise excessive metabolic effects of glucocorticoid excess.
The acute stress that accompanies the severe behavioural symptoms of UL
activates the HPA axis (Fig. 3.1) as demonstrated by the induction of Fos protein in
the paraventricular nucleus of the hypothalamus (Cameron and Dutia, 1999) and
raised salivary Cortisol levels in guinea pig (Gliddon et al., 2003). The resulting
activation of glucocorticoid receptors appears to be essential for the expression a
number of plastic changes in the MVN following UL in rat (see Chapter 3). If IIP-
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HSD1 is expressed in the MVN and vestibulocerebellar regions, these
glucocorticoid actions could be finely controlled at a cellular level by glucocorticoid
metabolism. In addition, changes in lip-HSDl activity may contribute to this early
stage of post-lesional plasticity, by potentiating or otherwise regulating the exposure
of the MVN and cerebellum to glucocorticoids, during the time when the adaptations
in MVN cell properties are taking place.
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4.2 AIMS AND EXPERIMENTAL RATIONALE
The enzyme ll(3-hydroxysteroid dehydrogenase type 1 (11(3-HSD1) regenerates
active glucocorticoids from inert forms in certain tissues, modulating glucocorticoid
effects in these tissue. The following experiments were designed to investigate 11(3-
HSD1 activity in central vestibular and vestibulo-cerebellar tissues from rat.
1. To investigate the presence of 11(3-HSD1 in the MVN and vestibulo-
cerebellum, its activity was assayed in the MVN, flocculus/paraflocculus (F/PF)
complex and nodulus/uvula (NU) of normal animals (n=4).
2. To investigate whether changes in 11(3-HSD1 activity contribute to the early
post-lesional changes in vestibular plasticity, by regulating the exposure of the MVN
and cerebellum to glucocorticoids, during the time when adaptations in MVN cell
properties are taking place, activity was assayed in ipsilateral and contralateral MVN
and F/PF, and in the NU from normal animals (n=8), sham operated animals (n=16)
and animals that had undergone vestibular compensation for 4 hours after UL (n=16).
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4.3 METHODS
Except for the following, all methods in this chapter are identical to those
described in Chapter 3.
Anaesthesia
For all surgery in this section rats were given a single intraperitoneal (i.p.)
injection of avertin (tribromoethanol; see drugs and solutions) 15 min before the start
of surgery. This solution was injected at a dose of lml/lOOg body weight and
provided surgical anaesthesia for 30-40 min. This produced the required level of
anaesthesia for the duration of the surgery; a sufficient level of anaesthesia was
determined by lack of the limb withdrawal reflex to a paw pinch.
Surgery
Animals began to show recovery from anaesthesia within 50-60 minutes of
induction, typically 20-30 min after completion of the labyrinthectomy. All animals
showed the severe characteristic symptoms of unilateral vestibular loss including
spontaneous nystagmus, circular walking, barrel rolling and head deviation towards
the side of the lesion. Sham operated animals underwent the same procedure, but the
canal was not opened and the inner ear was undamaged. These animals did not
exhibit any of the behavioural symptoms associated with unilateral vestibular loss.
The animals were allowed to recover in their home cages for 4 hours, before they
were re-anaesthetised with halothane (see drugs and solutions) by inhalation and
decapitated for collection of brain tissue.
Tissue preparation
After decapitation, the skull was removed using fine bone rongeurs, with care
taken on removal of the occipital bone to release the flocculus/paraflocculus (F/PF)
complexes. After immersion of the released brain in ice cold aCSF for one minute,
the F/PF complex was dissected from either side of the cerebellum, identifying the
left (ipsilateral) and right (contralateral) nuclei. The cerebellar hemispheres were
removed and the caudal most folia containing the nodulus and uvula (NU) were
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dissected. 800|uM thick horizontal slices of the dorsal brainstem containing the MVN
were cut on a vibroslice, the left and right MVN were isolated by cutting along the
midline and trimming. Immediately after dissection all tissue was frozen on dry ice
and stored at -72°C until use.
11P-HSD1 assay
Tissue was homogenised on ice in C buffer (8% glycerol, 150mM NaCl, ImM
EDTA, 50mM Tris) in Dounce tissue homogenisers. Routinely four MVN and four
F/PF were homogenised in 200pl C buffer, whilst four NU were homogenized in
800|itl C buffer. Total protein concentration was estimated colorimetrically (BioRad
protein assay kit, UK), and tissue samples were diluted to a final assay concentration
of 0.2mg/ml with C buffer. Duplicate aliquots of homogenate containing 0.2mg/ml
protein were incubated at 37°C with 400pM NADP and lOnM [3H]-corticosterone
([3H]-B) in a total volume of 250pl To terminate the assay, 1ml of ethyl acetate was
added to each sample and mixed to separate the steroids from the homogenate. The
upper ethyl acetate layer was removed into HPFC tubes and dried down under air at
55°C. Steroids were resuspensed in 40pl ethanol containing 0.5mg/ml each of
unlabelled corticosterone and 11-dehydrocorticosterone. Silica gel coated aluminium
thin layer chromatography (TLC) plates (Merck Ftd, UK) were divided into lanes of
1.8cm width to allow application of ten samples onto each plate. Steroid samples
were pipetted onto the plates 4pl at a time, allowing drying between applications
until all 40pl of each sample had been plated. Corticosterone and 11-
dehydrocorticosterone were separated by running the TFC plates in sealed tanks
containing a mixture of chloroform:95% ethanol (92:8) for 45 minutes. Conversion
of corticosterone (B) to 11-dehydrocorticosterone (A) was quantified by scanning
densitometry using Aida image software (Raytest, Straubenhardt, Germany). Enzyme
activity could be calculated as the percentage conversion of B to A using the
equation A/(A+B)*100, because virtually no other products were formed under the
conditions of incubation.
An initial assay used tissue pooled from 4 normal animals to assess the differing
levels of 11(3-HSD1 between brain regions (n=4). All tissue samples in this assay
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were incubated in parallel for 90 minutes. From preliminary assays, the incubation
time for each tissue type was adjusted such that the percentage conversion was
within the range 10-50% for the given time. 11(3-HSD1 was then assayed in
ipsilateral and contralateral MVNs (incubation 330 min) and F/PF (incubation 45
min), and in the NU (incubation 60 min) of normal animals (n=8), sham operated
animals (n=16) and animals that had undergone vestibular compensation for 4 hours
after UL (n=16). For each assay, tissue was pooled from 4 animals and samples run
in duplicate; four assays for each tissue type were processed in parallel, and the mean
±S.E.M. of these assays calculated. Differences in activity between control and
surgery groups were tested for statistical significance using one-way ANOVA;
difference between ipsi- and contralateral tissue were analysed by Students paired t-
test. Results were considered significant at p<0.05.
Drugs and Solutions
1. Avertin
Avertin was made up fresh on the day of surgery, using the following recipe, and
could be stored for up to 3 days at 4°C: 0.312 g tribromoethanol (Sigma, UK) was
added to 1.25 ml ethanol (Sigma, UK) and mixed until the tribromoethanol dissolved
completely. To this solution 0.187 ml tetra amyl alcohol was added followed by
14.25 ml sterile saline (0.9%). This solution was injected intraperitoneally (i.p.) at a
dose of lml/lOOg body weight and provided surgical anaesthesia for 30-40 min.
2. Halothane
Prior to decapitation, animals were anaesthetised with halothane (Flurothane,
May and Baker Ltd., UK) by inhalation. The anaesthetic was administered by placing
the animals in a small Perspex box containing a piece of halothane soaked cotton
wool. A sufficient level of anaesthesia was determined by lack of reflex response to a
paw pinch.
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4.4 RESULTS
The activity of 1 lP-hydroxysteroid dehydrogenase type 1 (11(3-HSD1) was
assayed in the MVN, flocculus/paraflocculus complex and nodulus/uvula of normal
animals (n=4). Activity was then assayed in ipsilateral and contralateral brain regions
from normal animals (n=8), sham operated animals (n=16) and animals that had
undergone vestibular compensation for 4 hours after UL (n=16) to assess any
possible changes in activity following labyrinthectomy.
1. lip-HSDl activity in vestibular related brain tissues
Figure 4.2 shows the results of an assay of 11(3-HSD1 activity in MVN,
flocculus/paraflocculus and nodulus/uvula tissue pooled from four normal rats. The
samples were incubated in parallel for a standard time of 90 min, and each sample
was assayed in duplicate. The values shown in Fig. 4.2 are thus the mean of two
parallel, repeated assays for each tissue, carried out under identical conditions. High
levels of 11|3-HSD1 activity were observed in the flocculus/paraflocculus and the
nodulus/uvula, while 11(3-HSD1 activity in the MVN was five fold lower
(Flocculus/paraflocculus: 65.6 ±0.25 % conversion to 11-dehydrocorticosterone;
Nodulus/uvula: 46.7 ±2.2 % conversion to 11-dehydrocorticosterone; MVN: 10.3
±0.3 % conversion to 11-dehydrocorticosterone). This finding is in line with previous
reports showing high levels of 11P-HSD1 immunoreactivity, mRNA levels and
bioactivity in cerebellum, and lower levels in the brainstem (Moisan et al., 1990b;
Lakshmi et al., 1991). In addition, this result shows that high levels of 11(3-HSD1
activity are found in the flocculus/paraflocculus and nodulus/uvula, which are
cerebellar areas intimately involved with the control of vestibular reflexes and eye
movements.
2. lip-HSDl activity in control and labyrinthectomised tissues
Figure 4.3 and table 4.1 show 11(3-HSD1 activity in the MVN,
flocculus/paraflocculus and nodulus/uvula in tissue samples taken from normal
animals, sham-operated animals, and animals that had undergone vestibular
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compensation for 4h after UL. In this assay the incubation time for each tissue type
was adjusted taking into account the levels of activity demonstrated in the initial
assay (Fig. 4.2), to maximise conversion of corticosterone without the reaction
reaching saturation. Thus flocculus/paraflocculus samples were incubated for 40 min,
nodulus/uvula samples for 60 min, and MVN samples for 330 min. There were no
significant differences in the levels of 11P-HSD1 activity either between normal and
post-UL tissues, or between the ipsilesional and contralesional MVN or
flocculus/paraflocculus after UL (Table 4.1).
MVN Flocculus/paraflocculus Nodulus/uvula
Ipsi Contra Ipsi Contra
UL 20.5 ±3.3 16.9 ±2.2 27.6 ±1.8 27.6 ±1.8 29.8 ±1.8
Sham 20.2 ±1.6 35.2 ±4.6 33.4 ±2.9
Normal 15.6 ±0.9 32.2 ±1.8 36.6 ±1.9
Table 4.1. 11P-HSD1 activity assessed in the MVN, flocculus/paraflocculus and
nodulus/uvula in normal animals, sham operated animals and animals which had
undergone a left labyrinthectomy 4h previously (UL). Ipsi: ipsilesional side of the
brain (left nuclei); contra: contralesional side of the brain (right nuclei). All values
expressed as mean ± S.E.M., % conversion of corticosterone to 11-
dehydrocorticosterone.












Figure 4.3 lip-hydroxysteriod dehydrogenase type 1 activity following UL
11P-HSD1 activity (expressed as % conversion of corticosterone to 11-
dehydrocorticosterone) in ipsilesional and contralseional MVN (A), ipsilesional
and contralseional flocculus/paraflocculus (B) and in nodulus/uvlua (C); from
normal rats, sham operated rats and animals that underwent vestibular
compensation for 4 hours post-UL
No statistical differences were found between any groups tested.
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4.5 DISCUSSION
The enzyme, 1 lp-hydroxysteroid dehydrogenase type 1 (llfJ-HSDl) regenerates
active glucocorticoids from inert forms. The early deafferentation-induced changes
in the properties of ipsilesional MVN cells observed at 4h post-UL in rat (the
increase in mean firing rate and down-regulation of GABA receptor efficacy), are
dependant on GR activation (Chapter 3; Cameron and Dutia, 1999). This study
investigated the presence of 11J3-HSD1 in the MVN and vestibulocerebellar tissues
to determine if glucocorticoid actions could be finely controlled at a cellular level by
glucocorticoid metabolism. It was hypothesised that changes in 11J3-HSD1 activity
may contribute to this early stage of post-lesional plasticity, by potentiating or
otherwise regulating the exposure of the MVN and cerebellum to glucocorticoids,
during the time when the adaptations in MVN cell properties are taking place.
This experiment is the first to specifically investigate 113-HSD1 activity in
central vestibulo-oculomotor centres of the brainstem and cerebellum. The results
demonstrate the presence of 11(3-HSD1 activity in the MVN, flocculus/paraflocculus
and uvula/nodulus, and suggest that this modulatory enzyme is likely to be involved
in regulating the exposure of these centres to circulating glucocorticoids. This could
be of clinical significance since many treatments for vestibular disorders in man
utilise steroid hormones (Seemungal et al., 2001). The high levels of 11(3-HSD1
activity in flocculus/paraflocculus and uvula/nodulus are of particular interest. These
areas are likely to be rendered highly responsive to glucocorticoids, through the local
amplification of active steroid concentrations by 11(3-HSD1 activity. Indeed it was
recently shown that the flocculus is an important site of glucocorticoid action in the
initial stages of vestibular compensation after UL, where glucocorticoids may
facilitate synaptic plasticity in the cerebellar cortex (Johnston et al., 2002). The
functional significance of the lower level of 11(3-HSD1 activity in the MVN remains
to be established, although the requirement of GR activation for GABA receptor
down-regulation indicates a role for glucocorticoids specifically in the MVN (see
Chapter 3).
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11P-HSD1 activity is modulated by a range of hormones in peripheral tissues,
and by glucocorticoids in peripheral and brain tissues (see Section 4.1 for detailed
discussion). Adrenalectomy in rats significantly reduced 11J3-HSD1 mRNA
expression in the hippocampus and 11(3-HSD1 activity in the hippocampus,
cerebellum and cortex after ten days, but not after one. This decrease was reversed,
to levels above those found in sham operated rats, by administration of the
glucocorticoid agonist dexamethasone (Low et al., 1994b). Chronic (15 days)
arthritic stress has also been shown to increase hippocampal 11(3-HSD1 activity. By
contrast, chronic psychosocial stress (28 days) in the tree shrew, was found to
attenuate hippocampal 11P-HSD1 activity (Jamieson et al., 1997). Thus the effects
of glucocorticoids on regulation of 11P-HSD1 follow a complex time course, could
be species specific and may vary according to the stressor used (Jamieson et al.,
1999). Induction of 11(3-HSD1 in the brain during acute stress would help amplify
intracellular glucocorticoid actions, whereas chronic attenuation of the enzyme
activity may represent a homeostatic mechanism to ameliorate the otherwise
excessive metabolic effects of glucocorticoid excess. The present results show that
the levels of 11(3-HSD1 activity in the vestibulo-cerebellum and MVN are stable
over the 4h period after UL. They therefore disprove the hypothesis that changes in
enzyme modulatory activity may occur in parallel with the deafferentation-induced
changes in the properties of the ipsilesional MVN neurons over this time. The
present study does not however address the possibility that changes in 11(3-HSD1
activity may occur at later times after UL, or in other vestibular nuclei such as the
lateral vestibular nucleus or its related cerebellar areas, during vestibular
compensation.
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Chapter 5
MECHANISMS UNDERLYING ADAPTATIONS IN THE
FIRING PROPERTIES OF MVN NEURONES IN VITRO
DURING VESTIBULAR COMPENSATION
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5.1 INTRODUCTION
The development of vestibular compensation for the static symptoms following
UL has been correlated with a restoration of the spontaneous resting discharge in the
ipsilesional VNC (for a discussion, see Chapter 2). Various theories have been
proposed to explain how these neurones replace the resting activity lost as a result of
deafferentation. One hypothesis suggests that rapid modifications in the intrinsic
pacemaker properties of brainstem neurones may underlie this recovery (Darlington
and Smith, 1996; see Section 2.6.5). In guinea pig, a significant increase in the
excitability of ipsilesional MVN neurones in coronal brainstem slices in vitro is
observed after 30 days of compensation (Vibert et al., 1999b). However, blockage of
synaptic transmission with low Ca2+/ high Mg2+ solution within these slices resulted
in a significant increase in excitability from 7 days post-UL, which increased further
by 30 days post-UL (Vibert et al., 1999b). Ris et al. (2001) observed an increase in
excitability of ipsilesional MVN neurones in coronal brainstem slices in vitro, from
48 hours post-UL in guinea pig, when the slices were perfused with a cocktail
containing antagonists of the major neurotransmitters in the MVN (CNQX, D-APV,
strychnine and bicuculline). They used this method of blocking synaptic transmission
because the low Ca2+/ high Mg2+ solution used by Vibert et al. (1999b) is known to
affect the intrinsic firing properties of neurones (Dutia et al., 1992; Ris and Godaux,
2001). These data suggest that in the guinea pig, the later stages of VC rely
increasingly on modifications of the intrinsic properties of the deafferented VN
neurones.
An increase in excitability of ipsilesional MVN neurones in vitro is observed
from within 4 hours post-UL in rat, specifically in the rostral region of the MVN. It
is unknown whether these changes in neuronal excitability in rat are maintained by
modification of the pacemaker properties of these neurones, or by alterations in the
synaptic inputs onto these neurones. In this chapter the relative importance of
intrinsic membrane properties versus synaptic inputs, to the spontaneous firing
characteristics of ipsilateral MVN neurones are investigated at varying times
following UL in rat.
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5.2 AIMS AND EXPERIMENTAL RATIONALE
The following experiments were designed to investigate the mechanisms
underlying changes in neuronal activity in horizontal brainstem slices containing the
ipsilateral MVN during the process of vestibular compensation in rat.
1. To confirm the increase in firing rate observed previously in rostral but not
caudal MVN neurones after UL, the firing rates in vitro of neurones from either the
rostral or caudal third of ipsilateral MVN slices were recorded. Slices were taken
from labyrinthine intact (control) animals, or animals labyrinthectomised 4 hours, 48
hours or 1 week previously.
2. To investigate the contribution of synaptic inputs to the firing rate of control
MVN neurones in vitro, synaptic transmission was blocked by adding to the
perfusing aCSF a cocktail of the specific antagonists of the main neurotransmitters in
the vestibular nuclei (glutamate, GABA and glycine). The classic method of blocking
synaptic transmission by perfusion of the brainstem slice with low Ca2+/high Mg2+
solution was not used as this procedure can cause changes in the pacemaker
properties of these neurones (Dutia et al., 1992; Ris and Godaux, 2001).
3. To compare the contribution of intrinsic pacemaker properties to the firing
rates of MVN neurones after labyrinthectomy, neurones were recorded in normal
aCSF and in aCSF containing the cocktail of neurotransmitter antagonists.
Recordings were taken from rostral and caudal regions of the MVN in slices from
animals labyrinthectomised 4 hours, 48 hours and 1 week previously.
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5.3 METHODS
Experimental data were obtained from 1234 MVN neurones from 42 male
Sprague Dawley rats. Except for the following, the methods employed in this chapter
of the thesis are identical to those described in the methods section of Chapter 3.
Anaesthesia
1. Avertin (tribromoethanol)
For all experiments the surgery was carried out under avertin anaesthesia (Dyer et
al., 1981). The anaesthetic was made up fresh at the beginning of each week
according to the following recipe: 0.312 g tribromoethanol was added to 1.25 ml
ethanol and mixed until tribromoethanol dissolved completely. To this solution 0.187
ml 2-methylbutan-2-ol and subsequently 14.25 ml sterile saline (0.9%) was added;
the anaesthetic was stored at 4°C. The solution was injected i.p. at a dose of
lml/lOOg body weight and provided surgical anaesthesia for 30-40 min. All
Chemicals were purchased from Sigma, UK.
2. Halothane
Prior to decapitation, animals were anaesthetised with halothane (Flurothane,
May and Baker, Ltd., UK) by inhalation. The anaesthetic was administered by
placing the animal in a small perspex box containing a piece of halothane-soaked
cotton wool. A sufficient level of anaesthesia was determined by lack of reflex
response to a paw pinch.
Surgery and behavioural measurements
All surgery in this chapter was carried out under avertin anaesthesia. Each
animal was observed following recovery from anaesthesia, which was complete
within 50-60 min after induction. Unilaterally labyrinthectomised animals showed
characteristic symptoms including tonic eye deviation, spontaneous ocular
nystagmus, circular walking, head deviation towards the side of the lesion, extensor
weakness in the ipsilesional limbs and barrel rolling.
Mechanisms underlying adaptations in MVN neurones in vitro following UL 128
Solutions
1. Cocktail aCSF
The following drugs were added to the normal perfusing aCSF to block the main
neurotransmitters in the MVN:
(a) -(-) Bicuculline methobromide (20pM), to block GABAa receptor
mediated transmission (Ris et al., 2001)
(b) (2S)-(+)-5,5-Dimethyl-2~morpholineacetic acid (SCH 50911; 20|uM),
to block GABAb receptor mediated transmission (Xiong and
Stringer, 2001)
(c) Strychnine hydrochloride (lOpM), to block glycine receptor
mediated transmission (Ris et al., 2001)
(d) D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV; 50pM) to block
NMDA receptor mediated transmission (Ris et al., 2001)
(e) 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX; 20pM)
to block AMPA/kainate receptor mediated transmission (Ris et al.,
2001)
All drugs were purchased from Sigma, UK, except SCH 50911 which was
purchased from Tocris Cookson Ltd, UK. Stock solutions of the drugs were made in
distilled water and kept frozen until use. Aliquots of the stock solutions were thawed
and diluted to their final concentrations in oxygenated aCSF. The slice was perfused
for at least 15 min with the cocktail aCSF before any recordings were taken.
Data collection and analysis
In these experiments both rostral and caudal thirds of the MVN were explored
and the mean tonic discharge rate of sampled neurones recorded. Statistical
comparisons of the mean discharge rates of either rostral or caudal MVN neurones in
different groups were carried out using one- or two-way ANOVA with Student-
Newman Keuls post hoc testing. Significance was assumed when p<0.05. Values are
given as mean ±S.E.M. throughout.
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5.4 RESULTS
Extracellular recordings from tonically active MVN neurones were made in
brainstem slices prepared from normal animals or animals which had received a left
UL 4h, 48h or lwk previously. Each MVN was divided by eye into three
approximately equal parts, namely rostral, middle and caudal parts. Recordings were
made in the rostral and caudal parts of the MVN, and the location of each neurone
was recorded. All MVN neurones included in this study (n=1234) showed a regular
sustained discharge for 120s, then their firing rates were recorded for 60s. The firing
rates of the cells were recoded in normal aCSF and in aCSF supplemented with a
cocktail of antagonists of the major neurotransmitters in the vestibular nuclei
(CNQX, D-APV, SCH 50911, strychnine and bicuculline).
Changes in spontaneous activity of MVN neurons at different stages of
vestibular compensation
As shown in figure 5.1 and table 5.1 the mean discharge rate of cells in the
rostral third of the MVN in slices perfused with normal aCSF and prepared from
animals labyrinthectomised 4h (18.2 ± 0.95 spikes/sec, n=76 neurones), 48h (18.4
±0.93 spikes/sec, n=82 neurones) or lwk (20.7 ±0.93 spikes/sec, n=90 neurones)
previously, were significantly higher than in slices prepared from control animals
(15.2 ±0.9 spikes/sec, n=84 neurones, p<0.0005, one-way ANOVA, Fig. 5.1). This
confirms the results of previous experiments, where a significant increase in the
excitability of lesioned rostral MVN neurones is seen after UL. As shown in figure
5.2 and table 5.1, cells in the caudal third of the MVN showed no significant change
in their mean discharge rate at any time after UL. The increase in excitability of
lesioned rostral MVN neurones has been shown using intracellular recording
techniques to be due to changes in type B rather than type A neurones (Him and
Dutia; 2001). Thus it is likely that the increase in firing rate of rostral MVN
neurones, recorded extracellularly here reflects an increase in type B neuronal
activity, which will be masked to some extent by the recording of unchanged type A
neuronal activity.
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Effect of synaptic blockers on spontaneous activity of MVN neurons
All neurons, recorded in normal aCSF or in aCSF containing synaptic blockers
displayed a regular discharge like that shown in figure 5.3C. These active neurons
were found throughout the whole MVN. The discharge of neurons recorded in slices
perfused with a cocktail of synaptic blockers (cocktail aCSF) was as regular as that
of the neurons recorded in slices perfused with normal aCSF. Figure 5.3 presents
histograms of the coefficient of variance (calculated as the standard deviation of the
interspike interval divided by the mean of the interspike interval ±S.E.M) of
neurones in rostral and caudal regions of the MVN from control animals recorded in
normal aCSF (Fig. 5.3A) and in cocktail aCSF (Fig. 5.3B). The mean coefficient of
variance (±S.E.M) was not different between populations: it was 0.095 ±0.014
(median =0.067) in control neurons in normal aCSF and 0.101 ±0.007 (median
=0.080) in control neurons in cocktail aCSF (p=0.25, Mann-Whitney test).
The number of neurons recorded per 350pM track through the MVN slice
provides an indicator of the relative number of spontaneously active neurons within a
given slice. In both the rostral and caudal regions there is no significant difference in
the number of spontaneously active neurons recorded in control slices perfused with
either normal aCSF (rostral, 1.9 ±0.14; caudal 1.9 ± 0.2) or cocktail aCSF (rostral,
2.1 ±0.17; caudal, 2.0 ±0.13; Fig. 5.4, 5.5).
The mean firing rate of the neurones submitted to the cocktail of antagonists was
not different from those recorded in normal aCSF in either the rostral or caudal
region of the MVN (Table 5.1, Fig. 5.1, 5.2). The effect of the cocktail of antagonists
was further documented by monitoring the firing rate of control neurones while the
perfusion medium was shifted from normal aCSF to cocktail aCSF. The firing rate
did not change in most neurones as illustrated in figure 5.1A, a few showed a
transient increase in activity, followed by a decrease towards control levels, as
illustrated in figure 5.7B.
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Effect of synaptic blockers on spontaneous activity of MVN neurons at different
stages of vestibular compensation
The number of neurones detected per track through the slice, remained static
throughout vestibular compensation, when assessed under normal aCSF or under the
antagonist cocktail (Fig. 5.4, 5.5). The discharge rates of neurones in all experimental
conditions remained regular and there was no significant difference in the mean
coefficient of variance between any experimental group (Fig. 5.6).
Neurones recorded in the rostral region of the MVN in slices prepared from
animals labyrinthectomised 4h previously, and perfused with the antagonist cocktail,
show an increase in their excitability equivalent to that observed in normal aCSF at
this timepoint (neurones recorded in cocktail aCSF: control, 14.8 ±0.90 spikes/s; 4h
UL, 18.5 ±1.2 spikes/s, p<0.05, 2-way ANOVA. Table 5.1, Fig. 5.1). However,
rostral MVN neurones recorded in slices prepared from animals labyrinthectomised
48h or 1 week previously, perfused with cocktail aCSF, showed firing rates
equivalent to those recorded from control animals (Table 5.1, Fig. 5.1). This
contrasts with increase in excitability observed in these neurones when the slices are
perfused with normal aCSF (Fig 5.1). Thus the increase in excitability in rostral
MVN neurones observed in slices from animals labyrinthectomised 48h or 1 week
previously is lost upon addition of the cocktail of antagonists (p<0.05, 2-way
ANOVA). This effect was documented by monitoring the firing rate of neurones
from 48h or 1 week UL animals, while the perfusion medium was shifted from
normal aCSF to cocktail aCSF. The firing rate did not change in some neurones, a
few showed a transient increase in activity, followed by a decrease to a level below
that of the initial rate, as illustrated in figure 5.8A, and many showed a decrease in
activity upon addition of the cocktail (Fig 5.8B).
Neurones recorded in the caudal third of the MVN show no change in their mean
discharge rate at any time during vestibular compensation, and no change upon
addition of the cocktail of antagonists to the perfusing aCSF (Table. 1, Fig. 5.2).
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Control Normal 15.2 ±0.90 84 16.4 ±0.81 81
Cocktail 14.8 ±0.90 75 17.7 ±1.2 76
4h post-UL Normal 18.2 ±0.95 76 17.4 ±1.1 70
Cocktail 18.5 ± 1.2 70 18.6 ±1.2 70
48h post-UL Normal 18.4 ±0.93 82 16.5 ±1.2 70
Cocktail 15.7 ±0.90 80 19.1 ±1.3 70
lwk post-UL Normal 20.7 ±0.93 90 16.5 ±0.90 72
Cocktail 16.4 ±0.90 90 16.6 ±0.97 78
Table 5.1
The mean resting discharge rate of MVN neurons in vitro recorded from slices
prepared from either labyrinthine intact animals (control) or animals which had
previously received a left labyrinthectomy at the time stated, n is the number of
neurones included in each sample. Values in bold indicate a significant difference
when compared to the corresponding control region (p<0.05, two-way ANOVA).
Figure5.1MeanfiringatesofostralVNne ron si o mandc ckt iCSFd ff r tt m followingUL Histogramsshowingtheme ninvitroonicdischa gera s±S.E.M.fMVNeu onestraldip il te nucleusislipreparedatthimtat dfollowingunilat rallabyrinth ctomy Openbarsrepresentd tacordedfromslicesp rfuwithno alCSF Filledbarsrepresentd tacord dfromslicesp rfuwithCSFcon i ingcktailfneurot ansmitterntagonis s Statistics:*p<0.05versuscontrolslices,inmalCSF §p<0.05versuscontrolslice ,incktaiaCSF t p<0.05slicesinormalaCSFve sucocktail>2-wayANOVA
RostralMVN




















Figure5.3Histogramsfthecoeffici ntvari nceintersp ki e valfn u on sfrcontrol animalsinor alCSFndc t iningckt ilfsy apticblockers Comparisonoftheregularitiesne onaldischargMVNr sfr munlesionedan m ls,r co dno al aCSFndinco tainingcktailfntagoniststhemaineurotransmitterstMVN(cock ilaC ). Histogramsfthecoefficientvari ncerecord din: A.NormalaCSF B.aCSFcontainingcktailfneurotransmitterntagon sts




































Figure 5.6 Histograms of the mean coefficient of variance for MVN
neurones recorded at varying time points following UL in normal perfusing
medium and in medium containing a cocktail of neurotransmitter
antagonists.
Mean ±S.E.M. coefficients of variance obtained from MVN neurones from
animals at the time stated following UL.
A. Neurones recorded in the rostral region of the MVN
B. Neurones recorded in the caudal region of the MVN
Open bars represent data recorded in normal aCSF
Filled bars represent data recorded in aCSF containing a cocktail of
neurotransmitter antagonists
No statistical differences were found between any groups tested
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5.5 DISCUSSION
Perfusion of brainstem slices prepared from normal rats with a cocktail of
neurotransmitters antagonists (CNQX, D-APV, SCH 50911, strychnine and
bicuculline), had no effect on the number of spontaneously active neurones detected
in either rostral or caudal regions of the MVN. The mean firing rate and the
coefficient of variance of these neurones was also unchanged by addition of the
cocktail of antagonists. These results suggest that in normal animals the firing
activity of MVN neurones in vitro, in slices removed from their normal afferent
inputs, is maintained primarily by the intrinsic pacemaker properties of these
neurones.
At 4h post-UL, an increase in the mean firing rate ofMVN neurones is observed
solely in the rostral region of the ipsilateral MVN. Addition of the cocktail of
antagonists to the slice had no effect on the firing rate firing of these neurones, i.e.
the firing rate remained increased compared to control values. The number of
neurones in the rostral MVN and the regularity of their firing were not different from
control levels at 4h post-UL, either in normal aCSF or in aCSF containing the
antagonists. These results suggest that the increase in excitability of rostral MVN
neurones at 4h post-UL is maintained primarily by modifications in the intrinsic
pacemaker properties of these neurones. Neurones in the caudal region of the MVN
displayed no significant difference in any of the tested parameters, at any time post-
UL.
At 48h and 1 week post-UL, an increase in the mean firing rate of spontaneously
active rostral ipsilesional MVN neurones is observed in slices perfused with normal
aCSF. When assessed under the action of the cocktail of antagonists, the mean firing
rate of the spontaneously active neurones decreased to a level not significantly
different from control. The number of neurones in the rostral MVN and the regularity
of their firing were not different from control levels at either time post-UL, either in
normal aCSF or in aCSF containing the antagonists. These experiments suggest that
by 48h post-UL, the increase in excitability of rostral MVN neurones is maintained
by alterations in the neurotransmitter inputs onto these neurones.
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5.5.1 Basis of spontaneous activity in the MVN
Vestibular nucleus (VN) neurones display spontaneous activity both in vivo and
in vitro. In vivo much of this activity was presumed to be a result of the excitatory
input from the vestibular afferents. Yet experiments in bilaterally labyrinthectomised
guinea pigs revealed only a 50% decrease in firing rate of VN neurones compared to
control (Ris and Godaux, 1998). Thus, in vivo, a substantial amount of the activity in
the vestibular nuclei is maintained either by excitatory inputs from sources other than
the primary vestibular afferents, or by an intrinsic capacity of the neurones to
generate action potentials (pacemaker properties). In vitro, MVN neurones maintain
a considerable amount of resting activity in brainstem slices without their normal
afferent inputs. In order to determine whether this spontaneous activity is due to
intrinsic as opposed to synaptic influences, various 'synaptic uncoupling' media have
been used within brainstem slices. The established method of blocking synaptic
activity in slices is by perfusion with low Ca2+/ high Mg2+ medium. This suppresses
all synaptic inputs, because calcium entry into the presynaptic terminal is a
prerequisite of transmitter release. Spontaneous discharge persists in some MVN
neurons submitted to this treatment (for review, see Ris and Godaux, 2001),
suggesting that a pacemaker-like mechanism is involved in the generation of tonic
activity in these neurones. The measure used to assess the level of spontaneous
activity in MVN neurones is the mean firing rate, and blockage of synaptic
transmission with low Ca2+/ high Mg2+ medium has been used to assess the extent of
involvement of pacemaker properties in generating this activity (Vibert et al.,
1999b). The weakness of this technique is that some of the pacemaker properties of
MVN neurones are maintained by Ca2+ currents (see Section 1.2.2), hence blockage
of Ca2+ may alter the neuronal firing properties. Prolonged exposure (more than 20
min) to a low Ca2+/ high Mg2+ solution alters the discharge patterns of many
vestibular neurones causing them to fire in regular bursts (Dutia et al., 1992; Vibert
et al., 1999b; Ris and Godaux, 2001); thus the use of mean firing rate to assess the
level of spontaneous activity in MVN neurones is questionable in these conditions.
The present method uses a cocktail of neurotransmitter antagonists (modified
from the methods of Ris et al., 2001) to block synaptic transmission. The advantage
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of this technique is that it blocks synaptic transmission without affecting the intrinsic
membrane properties of the neurones. The continued regularity of firing in the
cocktail aCSF justifies the use of mean discharge rate to quantify the activity of these
neurones. The weakness of this technique is that there are many neurotransmitters
and neuromodulators within the vestibular nuclei (see Section 1.3 for a detailed
review) which may affect the spontaneous firing rate of the neurones, which are not
blocked by the cocktail.
In the present study, in normal animals the firing activity of MVN neurones in
slices removed from their normal afferent inputs, remains unchanged by the addition
of the cocktail of antagonists to the perfusing medium (Table 5.1), indicating that the
major neurotransmitters within the MVN do not maintain the spontaneous discharge
of these neurones in vitro.
5.5.2 Mechanisms regulating spontaneous activity in the MVN during vestibular
compensation
Recent intracellular experiments have revealed that the increase in excitability of
rat MVN neurones post-UL is due to an increase in excitability of type B but not type
A neurones (Him and Dutia, 2001). Type B neurones can be distinguished from type
A by their narrower action potentials, and a two-component AHP: a first, fast and
small component followed by a delayed and slower one (see Figure 1.4; Section
1.2.2 for a detailed discussion). The fast and small AHP is mediated by a tetra-ethyl
ammonium (TEA)-sensitive potassium current (Ik) and a transient A-type current
(presumably IA blocked by 4-aminopyridine). In contrast, the delayed slow AHP is
insensitive to TEA but abolished by Ca2+ free medium and bath-application of
apamin; it is therefore mainly mediated by an apamin-sensitive Ca2+-activated
potassium current (iK(Ca), via SK channels) (Johnston et al., 1994). These SK
mediated K+ currents control the regularity of the firing rate of these cells (De Waele
et al., 1993). Type B neurones have narrow action potentials, generated in part by a
tetrodotoxin (TTX)-sensitive sodium current (the voltage-gated INa)- Long-lasting
subthreshold plateau potentials, which are TTX-sensitive and therefore ascribed to a
persistent sodium current (Inep), have also been detected in more than half of type B
neurones in guinea pig (Serafin et al., 1991a, b). This persistent inward current will
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drive the membrane potential towards depolarisation between successive spikes. In
addition, 30% of rat type B neurones possess low threshold Ca2+ channels which will
further contribute to membrane depolarisation (Johnston et al., 1994). The
combination of these currents in MVN neurones allows for, and controls, the
spontaneous pacemaker activity: Na+ and Ca2+ currents driving the neurones towards
depolarisation, K+ currents opposing this and stabilising the pacemaker activity. The
increase in intrinsic pacemaker activity detected here at 4h post-UL could result from
changes in a variety of channels: there could be a down-regulation in the number or
efficacy of K+ channels, or and up-regulation of channels carrying inward current
(e.g. INa, iNaP and low voltage gated Ca2+ channels).
Recently Patk et al. (2003), investigated changes in the expression of voltage
gated Na+ channels and the Ca2+-activated potassium channels (SK channels) after
UL in rat. They found no change in mRNA levels for the investigated subunits in the
vestibular nuclei, between 1 and 30 days post-UL. Unfortunately they did not
examine an earlier timepoint than 1 day, as the present data suggest that in rat, the
increase in excitability is only maintained by changes in the intrinsic pacemaker
properties ofMVN neurones for a transient period following UL. The data from Patk
et al. (2003) initially appears to corroborate the present data, indicating no changes in
ion channels involved in controlling pacemaker properties of the neurones from 48h
post-UL. However, the in situ hybridization technique is only sensitive to about a
30% change in subunit expression which would not detect subtle transcriptional
changes. In addition, changes in pacemaker conductances may be maintained by
translational rather than transcriptional regulation. Membrane ionic conductances
other than those mediated by voltage gated Na+ channels and the Ca2+-activated
potassium channels may be modulated post-UL. Indeed within 24h post-UL in rat, an
increase in the proportion of type B neurones which display low threshold rebound
potentials (LTS-like potentials), mediated by low threshold Ca2+ channels (perhaps
by T-type Ca2+ channels), was observed in the ipsilesional MVN (Him and Dutia,
2001). Thus there may be an up-regulation of low threshold Ca2+ channels in a
population ofMVN neurones post-UL. At 24-72h post-UL the mean input resistance
and spike amplitudes of type B neurones were significantly greater than control (Him
and Dutia, 2001), perhaps mediated by changes in the channels controlling
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pacemaker conductances, or perhaps due to a decreased chloride conductance
through GABA receptors which are down-regulated at this time (see Chapter 3).
The increase in firing rate of MVN neurones in rat, detected here from 48h post-
UL, cannot be due to, as was previously suggested (Darlington and Smith, 1996), an
increase in the pacemaker properties of these neurones, because the increase is
blocked by the cocktail of neurotransmitter antagonists (Table 5.1, Fig. 5.1). These
results suggest that there is either an increase in the amount of excitatory synaptic
input onto these neurones, or that the neurones have become more receptive to the
remaining excitatory inputs. It is less possible that the increased excitability is due to
a decrease in the inhibitory inputs onto these neurones, because the cocktail of
antagonists did not affect the firing rate of neurones in control slices, indicating that
the synaptic inputs remaining in the slice are not sufficient in control conditions to
alter the firing rate of the neurones, therefore a decrease in the inhibitory inputs
would have even less chance of influencing cellular excitability. However, this
theory could be tested by repeating the experiment using either excitatory or
inhibitory antagonists, and continued further by breaking down the cocktail into
individual receptor antagonist components. This would allow identification of the
specific receptors mediating the increase in excitability.
The resting membrane potentials of all type B MVN neurones from 24h to 10
days post-UL were significantly more depolarised than those of control type B
neurones (Him and Dutia, 2001). This increased depolarisation may be a factor
involved in the increase in the firing rate of MVN neurones, observed in the present
experiments at 48h and 1 week post-UL. Increased membrane depolarisation would
render these neurones more responsive to excitatory synaptic inputs from remaining
nerve terminals within the slice, thus synaptic input that previously was not enough
to generate spikes, could now be sufficient to generate additional action potentials in
these neurones. The same effect could be achieved if there was an up-regulation of
excitatory postsynaptic receptors on the neurones, with remaining synaptic inputs
initiating a larger depolarising effect through the up-regulated channels. Previous
studies revealed asymmetric changes in a number of glutamatergic receptor subunits
from within 6 hours post-UL (Li et al., 1997; Horii et al., 2001; Rabbath et al., 2002;
see Section 2.5.1 for detailed discussion). However, these demonstrate either no
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change, or a decrease in glutamate subunit expression in the ipsilesional VNC, which
is in the opposite direction to that which would restore the excitability in MVN
neurones. Ipsilesional decreases in mRNA for the glutamatergic receptor subunits
NR2A, GluR2 and mGluR7 at 6h post-UL, had returned to normal levels by 50h
post-UL (Horii et al., 2001), thus may be a consequence of a transient ipsilesional
reduction in glutamate levels after the lesion (see below). Other electrophysiological
(Knopfel and Dieringer, 1988; Smith and Darlington, 1992), biochemical (de Waele
et al., 1994; Rabbath et al., 2002) and pharmacological studies (Raymond et al.
1989) in a range of species, have been unable to provide any evidence of an increase
in NMDA or AMPA receptor efficacy, affinity, or numbers following UL.
An alternative explanation for the increase in excitability detected here from 48h
post-UL, could be an increase in excitatory synaptic input onto MVN neurones. A
recent in vivo microdialysis study in rat provided evidence for an increase in
excitatory synaptic input onto MVN neurones within 12h post-UL. Inoue et al.
(2003) revealed that the concentration of glutamate in the ipsilesional MVN
decreased significantly to a nadir at 4h post-UL, presumably due to the
deafferentation of the primary glutamatergic inputs, and recovered to a level higher
than basal at 12, 24 and 48h post-UL, though this difference was not significant. The
error signal promoting the increase in intrinsic excitability at 4h post-UL may
involve the decreased glutamate levels in the ipsilesional MVN; increasing glutamate
levels may supersede the increase in intrinsic excitability as the mechanism
enhancing the in vitro excitability of these neurones. The restoration of glutamate
levels to control values (indeed slightly higher than control) by 12h post-UL provides
evidence that there is an enhancement of glutamatergic input into the MVN,
presumably from remaining sensory inputs. Microdissection of the VNC linked to
HPLC revealed decreased glutamate levels in all ipsilesional VNC nuclei except the
MVN between 2 and 30 days post-UVD (Li et al., 1996b). This decrease in
glutamate levels was ascribed to degeneration of the vestibular nerve terminals (Li et
al., 1996b). If this is the cause of the decreased glutamate levels, a similar decrease
should be observed in the MVN which is rich in primary vestibular terminals (see
Section 1.1.1). The lack of decreased glutamate levels in the MVN may be indicative
of an increased glutamatergic input from other sensory systems. An increased
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efficacy of spinal input onto the ipsilesional MVN neurones, and decreased input
onto the contralesional MVN was recorded from 3 days post-UL in an isolated whole
brain preparation of the guinea pig (Vibert et al., 1999a), indicating a functional
substitution of deficient vestibular inputs with spinal related reflexes. The above
experiments and the data recorded in this chapter, provide evidence for the theory
that the increase in excitability observed in ipsilesional MVN neurones from 48
hours post-UL in rat is maintained by an increased excitatory synaptic input onto
these neurones.
5.5.3 Comparison with other studies
The question of whether spontaneous activity in the MVN in vitro, on the side of
a previous UL, is due to intrinsic as opposed to synaptic influences has been
investigated in two previous studies, both in guinea pig (Vibert et al., 1999b; Ris et
al., 2001). An important factor to consider when comparing this study with previous
studies blocking synaptic input, is that in normal perfusing medium there are species
differences regarding changes in mean firing rate of MVN neurones in vitro after
UL. Initial experiments in guinea pig reported that the mean resting discharge rate of
ipsilesional MVN neurones in brainstem slices from 6 to 8 week compensated
animals increased, although this increase was not significantly higher than control
(Darlington et al., 1989). However, the number of neurones recorded in this
experiment (15 neurones from 7 slices) was too low for definite conclusions to be
drawn. Later studies by the same group did find statistically significant increases in
the firing rates of ipsilesional MVN neurones from animals compensated for between
3 days and 8 weeks compared to control (Darlington et al., 1992; Smith and
Darlington, 1992). However, the data from all stages of compensation was pooled;
therefore it was not possible to determine when the increase in excitability first
occurred, or to examine changing excitability levels over time. The earliest time at
which the excitability ofMVN neurones has been assessed in vitro post-UL in guinea
pig is at 1 day (24 hours). Vibert and colleagues, using brainstem slices from guinea
pigs, found no significant increase in the firing rate of ipsilesional MVN neurones
between 1 and 7 days post-UL compared to control, but an imbalance in firing rate
between the ipsi- and contralesional sides of UL animals was observed from 7 days
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and a significant increase in firing rate was recorded at 30 days post-UL (Vibert et
al, 1999b; 2000a). An increase in the firing rate of ipsilesional MVN neurones in
vitro is observed at 4 hours post-UL in rat, which persists for at least 7-10 days
(Cameron and Dutia, 1997; 1999; Yamanaka et al., 2000; Him and Dutia, 2001;
Johnston et al., 2001; present data). However, this increase was only observed in the
rostral third of the MVN in horizontal brainstem slices. Recordings of MVN
neuronal activity in guinea pigs in vitro, have been made from coronal brainstem
slices, which do not necessarily contain the rostral region of the MVN; indeed Vibert
et al. (1999b) took several coronal slices per brainstem therefore probably recorded
from the entire rostro-caudal length of the MVN. Thus it is unknown whether the
increase in excitability of ipsilesional MVN neurones at 30 days post-UL in guinea
pig is occurring across the entire MVN, or in specific regions as occurs in rat. No
recordings of the excitability of MVN neurones in brainstem slices from rat, have
been made after 10 days of compensation, hence no comparisons can be made with
data from the guinea pig at 30 days post-UL.
To investigate the contribution of intrinsic pacemaker properties in deafferented
vestibular neurones during VC, Vibert and colleagues perfused guinea pig brainstem
slices with low Ca2+/ high Mg2+ solution to block all synaptic inputs. They observed
large increases in the resting activity of ipsilesional MVN neurones from animals
labyrinthectomised 7 days previously compared to MVN neurones from labyrinthine-
intact animals (Vibert et al., 1999b). Under the synaptic uncoupling conditions, the
increase in ipsilesional MVN excitability had increased further by 30 days post-UL.
The authors concluded that from 7 days after the lesion, VC relies increasingly on
changes in the intrinsic properties of the deafferented vestibular neurones. Despite
the side effects of low Ca2+/ high Mg2+ solution (see Section 5.5.1), the firing rates of
neurones recorded on the contralateral side of the slice, therefore submitted to the
same solution, were significantly lower than the firing rates of ipsilesional neurones,
validating the result. In a more recent study, Ris et al. (2001) used a cocktail of the
main neurotransmitters in the MVN (CNQX, D-APV, strychnine and bicuculline) to
reduce synaptic transmission without affecting the intrinsic properties of the
neurones. In contrast to the synaptic uncoupling studies, they recorded a significant
increase in the firing rate of ipsilesional MVN neurones from 48 hours post-UL
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compared to MVN neurones from labyrinthine-intact animals in slices perfused with
the cocktail of antagonists. Unfortunately they did not record the firing rate of
deafferented MVN neurones in normal perfusing medium, so it is unclear if this
increase in excitability under neurotransmitter blockage is translated to an increased
excitability in normal medium. The most striking effect of perfusion of MVN
neurones from unlesioned animals with the cocktail of antagonists was a dramatic
reduction in the number of neurones recorded per slice compared to neurones
recorded in normal aCSF (mean number of neurones ±SD of 9.5 ±3.5 in cocktail
aCSF compared to 30.7 ±11.1 in normal aCSF) (Ris et al., 2001). This is in marked
contrast to the present data in rat where no change in the number of spontaneously
active neurones per track is found either in normal or cocktail aCSF in the rostral or
caudal region of the MVN at any time after UL (Fig. 5.4, 5.5). The decrease in the
number of neurones detected per slice in guinea pig, was paralleled by a significant
reduction in the mean discharge rate of the remaining MVN neurones (Ris et al.,
2001). Neither the present data (Fig. 5.1, 5.2, Table 5.1), nor that of Vibert et al.
(1999b), detected any difference in the mean firing rate of MVN neurones when
recording in normal medium compared to medium blocking synaptic transmission.
The discrepancies between these experiments may lie in the specific
neurotransmitters blocked. Vibert et al. (1999b) blocked all excitatory and inhibitory
synaptic inputs, Ris et al. (2001) blocked GABAa, glycine, NMDA and
AMPA/kainile receptor mediated transmission, whereas the current methods also
included an antagonist for GABAb receptors. It appears that in normal conditions in
vitro, the excitatory and inhibitory synaptic influences are not of sufficient amplitude
to alter the excitability of vestibular neurones. However, if all excitatory inputs are
removed, the remaining inhibitory inputs may hyperpolarise neurones to an extent
that can affect the number of action potentials generated. Thus the decrease in mean
firing rate of control ipsilesional MVN neurones, elicited by the cocktail of Ris et al.
may be the result of GABAergic inhibition through GABAb receptors,
hyperpolarising neurones in the absence of excitatory depolarisations to an extent
that decreases the number of action potentials generated by the intrinsic pacemaker
properties. The increase in firing rate observed at 48h post-UL, in the cocktail
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conditions (Ris et al., 2001), but not in conditions of synaptic uncoupling (Vibert et
al., 1999b), may be related to a down-regulation of GABAb receptor efficacy as
observed in rat post-UL (see Chapter 3).
The increase in excitability of ipsilesional rat MVN neurones from 4h post-UL
may not have been observed in guinea pigs because the rostral region where these
changes occur has never been specifically investigated. While the data from these
experiments indicate that there is an increase in the pacemaker properties of these
neurons at 4h post-UL, it is important to note that the cocktail does not block all
excitatory neurotransmission in the MVN, and the increased excitability may be
maintained by an increase in excitatory synaptic inputs other than those mediated via
NMDA, AMPA and kainate receptors (see Sections 1.3, 2.5 for discussion of
neurotransmitters present in the VNC).
The data from studies in rat and guinea pig appear to present opposing cellular
changes post-UL. In guinea pig an increase in firing rate of ipsilesional MVN
neurones is recorded between 48h and 30 days post-UL in conditions of synaptic
blockade (Vibert et al., 1999b; Ris et al., 2001). The current data show that synaptic
blockade in rat at these times actually causes a decrease in the firing rate of rostral
MVN neurones. This decrease lowers the firing rate to the level obtained in control
neurones perfused with either normal or cocktail aCSF. There are no increases in
firing rate of the caudal MVN neurones at any time after UL in rat which would
correlate with those observed in guinea pig. However, it may be that the initial
increase in intrinsic excitability in the rat MVN is a transient change related to the
compensation of horizontal spontaneous nystagmus, and an overall increase in
intrinsic excitability equivalent to that seen in guinea pig would be recorded at later
timepoints that those utilized in these experiments.
VC is a complex, heterogeneous process and it would be unsurprising if different
species utilised diverging mechanisms of recovery at different times. For example,
activation of glucocorticoid receptors enables the initial stages of VC in rat, whilst
they play no role in compensation in guinea pig, presumably due to the large
difference in the stress systems between species (see Chapter 3). In rat, recovery of
the resting discharge of deafferented MVN neurones initially appears to be promoted
by modifications of the pacemaker properties of the neurones; this is superseded by
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adaptations in the intact sensory and vestibular-related inputs onto these neurones.
The opposite mode of compensation has been proposed for guinea pig: initial
substituting sensory inputs being increasingly replaced by changes in the pacemaker
properties of the deafferented neurones (Vibert et al., 1999b).
Summary
The present results demonstrate that the significant increase in excitability of
lesioned rostral MVN neurones at 4 hours post-UL is maintained primarily by
changes in the intrinsic pacemaker properties of these neurones. This increase may
be maintained by changes in the subunit expression or phosphorylation state of ion
channels involved in generating pacemaker activity. By 48 hours post-UL the
significant increase in excitability of lesioned rostral MVN neurones appears to be
maintained by an increased excitatory synaptic input onto these neurones. Thus
different mechanisms are utilised in the initiation and maintenance of processes
involved in VC.
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Chapter 6
PROTEOMIC INVESTIGATION OF THE VESTIBULAR
SYSTEM DURING VESTIBULAR COMPENSATION
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6.1 INTRODUCTION
Proteomics is generally defined as the systematic identification of every protein
expressed from the genome in a cell or tissue, as well as the prominent properties of
each protein e.g. post-translational modifications, comparative abundance etc. The
entire protein complement in a given cell or tissue is defined as the 'proteome'.
Proteomics is a powerful and evolving experimental process that largely investigates
changes in protein expression, resulting from various disorders or the effect of
external factors such as brain trauma or surgical lesions. In neuroscience, proteomic
techniques have been applied to a host of applications, including determination of the
proteome of individual brain areas in health and disease (Rohlff, 2000; Butterfield et
ai, 2003; Rohlff and Hollis, 2003). Its goals include the detection of novel drug
targets, diagnostic markers and the investigation of biological events (for review see
Banks et al., 2000). Determination of protein rather than RNA levels has major
advantages as it is the proteins that carry out functions in a cell, and there is often a
low correspondence between changes at the transcription level and changes at the
proteomic level (Ideker et al., 2001).
Proteomics consists mainly of two steps: 1) separation of proteins usually by
two-dimensional gel electrophoresis and 2) protein analysis and identification,
mainly by mass spectrometry. A critical initial process is the extraction and
solubilisation of proteins from cells or tissues. Once extracted the proteins are
denatured into their polypeptide subunits and separated in two dimensions. In the
first dimension, proteins are separated on the basis of differences in their net charge,
by isoelectric focusing (IEF): on the application of a current, the charged polypeptide
subunits migrate in a polyacrylamide gel strip that contains an immobilised pH
gradient until they reach the pH at which their overall charge is neutral (isoelectric
point or pi). This produces a gel strip containing discrete protein bands along its
length. In the second dimension, the polypeptides in the gel strip are solubilised and
denatured in the presence of a negatively charged detergent, sodium dodecyl sulphate
(SDS); the proteins lose their three-dimensional structure and assume a net negative
charge. The gel strip is applied to a standard polyacrylamide gel and the polypeptides
migrate in an electric current towards the anode, thus are separated according to their
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size (molecular weight). After separation and staining, the spots (each of which
corresponds to a protein of unknown identity) are excised from the gel, digested
using trypsin and the peptide fragments are characterised my mass spectroscopy.
Proteins are then identified by comparing the masses of the peptide fragments with
predictions from either DNA or protein databases (see Figure 6.1).
The application of proteomic techniques to investigate changes in protein
expression and post-translational modifications during the process of vestibular
compensation (VC), is potentially a very powerful method of examining the
molecular mechanisms underlying plasticity. At present the molecular mechanisms
of vestibular compensation are largely unknown, but probably involve changes in
protein expression and/or phosphorylation. The adaptations in receptor efficacy in
MVN neurons (see Section 2.5; Chapter 3), may occur through changes in receptor
expression or subunit composition, and/or in the phosphorylation state of the receptor
subunits. If the increase in excitability of MVN neurons from 48h post-UL relies on
an increase in synaptic inputs (see Chapter 5) we may expect adaptations in a variety
of proteins such as cytoskeletal and intermediary metabolic proteins, which are easily
identified in proteomic maps of the brain (Lubec et al., 2003). Several recent studies
indicate that activation of kinase pathways may play an important role in VC (see
Section 3.6) and several currently unidentified guinea-pig brainstem proteins
undergo phosphorylation early in VC (Sansom et al., 1997). In addition, although the
protein synthesis inhibitor cyclohexamide does not prevent the early recovery of
resting activity in the guinea-pig (Ris et al., 1998), 2-D gel electrophoresis has
revealed increased expression of several currently unidentified proteins 1 week post-
UL in this species (Ris et al., 1999). Numerous studies have documented changing
expression of proteins involved in gene expression regulation, such as the
cAMP/calcium response element binding protein (Kim et al., 2000) and immediate
early gene proteins (Kaufman et al., 1992; Kitahara et al., 1995a; Cirelli et al., 1996)
in MVN neurones over hours and days after UL in the rat. In the present study, to
investigate changes in protein expression and phosphorylation post-UL, proteomic
techniques were applied to brain tissue from regions of the central vestibular system
and vestibulo-cerebellum in rat.
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The methodologies of proteomics are continually developing, and the techniques
of protein solubilisation, separation and visualisation require optimisation for any
specific tissue. Over the last three years in the present study, a wide variety of
solubilisation, separation and visualisation techniques were applied to MVN,
floccular and cerebellar tissue. Initial experiments were performed using Coomassie
blue staining to visualise proteins; this ensured that the extraction and solubilisation
techniques used were effective. Coomassie blue stain has a protein detection limit of
>100 ng (Herbert et al., 2001) and therefore is not sensitive enough to visualise low
abundance proteins. Subsequent experiments were performed using silver staining
techniques, which can detect protein spots of between l-10ng on gels. This increased
the detection sensitivity to 10 times that of Coomassie and allowed the visualisation
of around 800 proteins on 2-D gels of MVN tissue (see Figure 6.2). However, silver
staining is not a quantitative staining technique; larger spots do not absorb an
equivalent amount of dye to match their size compared to smaller spots, hence it is
not suitable for quantitative comparisons of densities between spots, even between
two gels stained at the same time. Its other disadvantage is that it is not an end point
stain: termination of the silver reaction requires several, usually precisely timed
manual interventions which affects reproducibility between different runs of gels.
SYPRO Ruby (Bio-Rad Life Sciences, Hertfordshire, UK), is a fluorescence based
stain with a minimum protein detection limit of around lOng. It is a linear,
quantitative, end point staining technique that enables the comparison of protein
expression between different experiments; therefore this stain was adopted for the
following experiments. Continuing from the preparatory experiments, this chapter
describes the optimal proteomic method developed to date. Changes in protein
expression between the ipsilesional and contralesional MVN one week after
labyrinthectomy were investigated, and 69 proteins expressed in the MVN were
identified. The experiments in this chapter were performed in collaboration with Dr
Janet Paterson (Biomedical Sciences, Edinburgh University) and Dr Duncan Short
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Figure 6.2 Example of a silver stained 2D gel of MVN tissue
Tissue was solubilised in a one step separation process: 6 MVNs from 3 normal rats
were homogenised in 200pl of lysis buffer (50mM Tris-HCl pH 7.2, 2mM EDTA,
1% v/v Triton X-100, 100(ig/ml trypsin inhibitor, 60pg/ml aprotinin) and
centrifuged at 13,000g for 15 min. Supernatants were subject to 2D gel
electrophoresis, using pH 3-10 strips in the first dimension, performed as
documented in methods section (Section 6.3). Separated proteins were detected
using sensitive silver staining (Amersham Biosciences, Buckinghamshire, U.K.)
according to manufacturers instructions.
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6.2 AIMS AND EXPERIMENTAL RATIONALE
Determination of the proteome of the MVN would provide a major opportunity
to identify differences in protein expression between tissues from normal and
previously labyrinthectomised animals. This could elucidate mechanisms involved in
the compensation process and has the potential to identify new therapeutic targets for
the treatment of vestibular disorders. The following experiments were designed to
systematically analyse the proteome of the MVN and assess changes in protein
expression in the MVN during vestibular compensation (VC).
1. To assess post-lesional changes in protein expression in the MVN during the
process of VC, differential two-dimensional gel analysis techniques were applied to
ipsilesional and contralesional MVN tissue collected from animals that had been
allowed to compensate for one week after UL (n=18).
2. To determine the identity of proteins whose expression may change during the
process of VC, these were subjected to mass spectrometry and searches of protein
sequence databases.
3. To construct a reference database that catalogues proteins expressed in the
MVN, mass spectroscopy and protein database searches were applied to MVN
proteins which did not show significant changes after UL in the initial analysis.
Proteomic investigation of the vestibular system during VC 159
6.3 METHODS
Except for the following, the methods employed in this chapter of the thesis are
identical to those described in the methods section of Chapter 3. Three groups of six
male Sprague Dawley rats, weighing 100-120g, were subjected to unilateral
labyrinthectomy under avertin anaesthesia as described in detail earlier. The animals
were allowed to recover in their home cages for one week post-UL, when they were
anaesthetised with halothane and decapitated.
Tissue preparation
The brain was removed into ice-cold artificial cerebrospinal fluid (aCSF) and the
brainstem isolated. Horizontal slices of the dorsal brainstem (650pM thick, taken
approximately parallel to the floor of the IVth ventricle) were cut in ice-cold aCSF,
and the left and right MVN were dissected. Care was taken to unambiguously
identify the ipsilesional (left) and contralesional (right) sides, and to trim the MVN
so as to take consistently similar samples of tissue from each animal. The MVNs
were frozen on dry ice and stored at -72°C until required.
Homogenisation and protein solubilisation
For each of the three tissue batches, six ipsilesional and six contralesional MVNs
were separately lysed in Dounce glass tissue homogenisers, with 300pl ice-cold
sucrose buffer (see solutions). The lysate was centrifuged at 356,160g for lOmin at
2°C, and the supernatant (cytoplasmic fraction) retained. The pellet was then
homogenised in 300pl ice-cold detergent solution, which contained n-octyl
glucoside, a strong non-ionic detergent which solubilises hydrophobic membrane
proteins and minimises protein aggregation through hydrophobic interactions (see
solutions). The lysate was centrifuged as before, and the second supernatant
(membrane fraction) retained. Soluble protein content of the supernatants was
determined using the Pierce BCA protein assay kit (Perbio Science, Cheshire, U.K.).
Protein extracts were frozen on dry ice and stored at -72°C until required.
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2-dimensional gel electrophoresis, visualisation and digitisation
For each experiment, three 2-dimensional gels were run for each batch of
cytoplasmic and membrane fractions of the ipsilesional and contralesional MVN to
assess and control for intra-assay variability. Isoelectric focussing (EEF) was
performed using an Amersham Biosciences system (Amersham Biosciences,
Buckinghamshire, U.K.), according to the manufacturer's instructions: protein
extract was mixed with IPG strip rehydration buffer (see solutions) to obtain a
concentration of lOOpg protein per 250pl. In each case, 250(il of protein/buffer
mixture was transferred to a 13cm IPG strip holder, with a pH 3-10 IPG immobiline
drystrip to offer a wide overview of protein expression. Strips were rehydrated at
20°C for 14 hours on an Amersham IPGphor flat-bed unit, followed by IEF at 20°C
starting at 500V for 1 hour, 1000V for 1 hour then increasing voltage to 8000V for a
total of 17500 volt-hours. Following IEF, strips were incubated for 15min in
dithiothreitol (DTT) equilibration solution, then for 15min in iodoacetamide
equilibration solution (see solutions).
Second dimension SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was
carried out at 19.5°C using self-poured 16.5x19cm linear 10% acrylamide gels (see
solutions), run at 20 mA per gel. Electrophoresis was terminated when the dye front
reached approximately 1mm from the gel base. Molecular masses were estimated by
running standard protein markers (Protein MW standards, Amersham Biosciences
Buckinghamshire, U.K.), covering the range 6.5-205 kDa. Gels were incubated with
agitation in fixing solution (10% v/v ethanol, 7% v/v acetic acid) for 30min, then
incubated with agitation in Bio-Rad SYPRO Ruby protein gel stain (Bio-Rad Life
Sciences, Hertfordshire, UK) for at least 3h. Following staining, gels were
transferred to fixing solution for lh, then washed in dHiO. The gels were placed on a
black, non-fluorescent glass plate, kept moist with dHiO and imaged at 302nm using
an Alpha Innotech Fluorchem 8900 Imaging System (Alpha Innotech Ltd., Cannock,
UK). The acquisition time varied from 6-20sec and was chosen to have the overall
strongest signal, while the intensity of the most abundant spot remained within the
linear range of the camera and the background level was minimal. The images were
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captured using the Fluorchem 8000 software package (Alpha Innotech Ltd.,
Cannock, UK).
Image analysis
Image analysis was performed using the Imagemaster 2-D Elite 3.10 image
analysis software (Amersham Biosciences, Buckinghamshire, UK). In each
experiment, 3 ipsilesional and 3 contralesional gels were produced, for both the
cytoplasmic and membrane fractions of the MVN tissue. Within a given experiment,
10-15 large protein spots, expressed in all gels were tagged, and the images were
morphed so the corresponding proteins overlaid each other in all gels. This corrected
for differences in protein migration between gels. Gel images were systematically
compared, in 10mm sections displayed in a montage window, and changes in the
presence or density of expressed proteins that were consistent between the 3
ipsilesional and 3 contralesional gels were recorded. This experiment was repeated
twice more, to determine any consistent changes between the 9 ipsilesional and 9
contralesional gels in the either cytoplasmic or membrane fraction. Systematically
reproducible changes were sought for further analysis and quantification.
Sample preparation for mass spectrometry
Spots of interest were excised from the gel, and placed in Eppendorf centrifuge
tubes. Gel pieces were incubated in 300pl of 200mM NH4HCO3 (ABC)/50%
acetonitrile (ACN) at 30°C for 30min. This was repeated twice to remove SDS. Gel
pieces were then incubated in 300pl 20mM DTT, 200mM ABC/50% ACN at 30°C
for lh to reduce the protein, then washed three times in 300pl 200mM ABC/50%
ACN. Cysteines were alkylated in fresh lOOpl 50mM iodoacetamide (IAA) and
200mM ABC/50% ACN at room temperature in the dark for 20min. Gel pieces were
then washed three times in 500pl 20mM ABC/50% ACN. Gel pieces were spun at
13,000g for 2min then covered with ACN until they turned white (indicates
dehydration). ACN was decanted and gel pieces allowed to dry. For tryptic digestion,
gel pieces were swollen in 10pl of 12.5pg/ml trypsin in 50mM ABC at 4°C. Gel
Proteomic investigation of the vestibular system during VC 162
pieces were placed in 96 well microplates, the tops sealed with Nescofilm and
incubated at 32°C for 16-24h.
Protein identification by mass spectrometry
One microlitre of supernatant from the microplate wells was mixed with lpl of
lOmg/ml cc-cyano-4-hydroxycinnamic acid in 50% ACN/0.1% trifluoroacetic acid
and the mixed solution was spotted onto a 96-spot MALDI (Matrix assisted laser
desorption/ionisation) plate. Samples were analysed on a Voyager DE-STR MALDI-
TOF mass spectrometer (Applied Biosciences, California, USA). The resulting
peptide mass fingerprints were used to search the SWISSPROT protein database
(http://us.expasy.org/sprot/), with MASCOT (http://www.matrixscience.com/): a
search tool which compares the experimentally determined tryptic peptide masses
with theoretical peptide masses calculated for proteins contained in the SWISSPROT
database. A minimum level of 4 peptide matches and approximately 30% sequence




HEPES lOmM, pH 7
EDTA ImM
Sigma P8340 protease inhibitor cocktail 1% v/v
2. Detergent buffer
n-octyl glucoside 2% v/v
Aminohexanoic acid 0.5M
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3. IPG strip rehydration solution
Urea 7M
Thiourea 2M
Triton X-100 0.5% v/v
Bromophenol blue 0.1%w/v
DTT 65mM
IPG buffer 0.5% v/v






Bromophenol blue 0.1% w/v






Bromophenol blue 0.1% w/v
6. Resolving gel solution (10% acrylamide)
Tris-HCl 375 mM
40% Acrylamide/Bis solution 25% v/v
SDS 0.1% w/v
Ammonium persulphate 0.05% w/v
TEMED 0.03% v/v
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6.4 RESULTS
Two-dimensional gel electrophoresis (2-DGE) maps were constructed for rat
MVN proteins. Differential 2-DGE was used to analyse changes in protein
expression between the ipsilesional and contralesional MVNs of rats that had
compensated for 1 week post-UL. A total of 36 gels were analysed in this
experiment. Ipsilesional and contralesional MVN tissue (separately pooled from the
same 6 rats) was subject to a two-step extraction procedure separating homogenates
into a cytoplasmic (isotonically-extracted) and a membrane (detergent treated)
fraction. The first dimension of the 2-DGE, involved isoelectric focusing, separating
proteins according to their charge using pH 3-10 range EPG strips to obtain a wide
overview of the proteins present in the MVN. In the second dimension the proteins
were separated according to their molecular weight by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). The gels were visualised by SYPRO Ruby staining
which can detect from around lOng of protein in a spot. Approximately 800 protein
spots were resolved in such a gel by computer-aided image analysis.
Representative 2-D gel images of the cytoplasmic and membrane associated
fractions from the rat MVN tissue are illustrated in figures 6.4 and 6.5 respectively.
Each batch of MVN tissue was separated 3 times by 2-DGE, either the cytoplasmic
or membrane fraction, prepared from either the ipsilesional or contralesional MVN.
Upon observation of a significant difference between ipsilesional and contralesional
gels, these images can be morphed and the density of the spots between gels can be
averaged for purposes of quantification. Figure 6.3 illustrates non-morphed gels
produced from three separate batches of the cytoplasmic fraction of ipsilesional
MVNs, each pooled from 6 rats.
Within the first two repeats of the experiment, consistent changes in the
expression of four ipsilesional MVN proteins after VC were observed (Fig. 6.4, 6.5,
A-D, runs 1-2). However, the third repeat of the experiments did not reveal the same
consistent change in protein expression (Fig. 6.4, 6.5, A-D, run 3). More repeats of
the experiment are needed to determine the validity of the initial observations, but
time constraints mean these cannot be completed within the scope of this thesis.
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Spots A, B and D (Fig. 6.4 and 6.5) were identified using MALDI-TOF analysis
of their peptide mass fingerprints after trypsin digestion. Spot A was identified as
glutamate dehydrogenase (accession number: pi0860, MW: 61.4 kDa, pi 8.1. Spot
number 3 in Figure 6.6 and Table 6.1). The protein indicated by the arrow in Figure
6.4B (spot B) as well as the larger spot to its immediate right were identified as
fructose biphosphate aldolase C (accession number: p09117, MW 39.3 kDa, pi: 6.7.
Spot number 2 in Figure 6.6 and Table 6.1). Spot D was identified as
phosphoglycerate kinase (accession number: pl6617; MW 44.5 kDa; pi 7.5. Spot
number 27 in Figure 6.7 and Table 6.2). No changes in protein expression between
the ipsilesional and contralesional MVN at 1 week post-UL in rat were revealed
during analysis of the region of the MVN proteome corresponding to region
encompassing the 3 protein changes detected in guinea pig (pi: 5.8-6.10, MW: 58-63
kDa. Ris et al., 1999)
A further 66 MVN proteins which in the initial analysis do not show significant
changes after UL were also identified on the basis of their peptide mass fingerprints.
Identified proteins spots from the cytoplasmic MVN fraction are numbered in Figure
6.6 and the corresponding protein identification data are summarised in Table 6.1.
Identified proteins spots from the membrane MVN fraction are numbered in Figure
6.7 and the corresponding protein identification data are summarised in Table 6.2.
The confidence of the identification is determined by the number of matching
peptides and the coverage of the proteins sequence by the matching peptides: a
minimum of 4 peptide matches and approximately 30% sequence coverage is
necessary for unambiguous protein identification. Where more than one significant
protein hit per digested gel spot was returned from the database search, both proteins
were recorded providing their pi and MW matched that of the region of the gel from
which the protein spot was excised (see spot numbers 6 and 18: Fig. 6.7, table 6.2).
Functions of the identified MVN proteins are outlined in table 6.3. The data for
protein spot number 4 (Pyruvate kinase, Ml isozyme), from the cytoplasmic MVN
fraction, is selected as an example: Figure 6.8 contains the MALDI-TOF peptide
mass fingerprint spectrum of the trypsin digested protein, the predicted tryptic
peptides identified from a SWISSPROT database search and an illustration of the
sequence coverage of the peptides over the identified protein.
Figure 6.3 Examples of two-dimensional gels produced from 3 separate
batches of MVN tissue.
2-D gel images produced from the cytoplasmic fraction of ipsilesional MVN
tissue, collected from rats at 1 week post-UL. Each gel image is produced
from a separate homogenate of MVN tissue pooled from 6 rats, and run in
different experiments. Protein (lOOpg), was separated by 2-D gel
electrophoresis using pH 3-10 strips in the first dimension, and the proteins
were visualised using SYPRO Ruby staining.
MW (kDa)
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Ipsi-MVN Contra -MVN
*
Figure 6.5 Representative 2-D gel of the membrane associated rat MVN proteome
The membrane protein fraction from rat MVN tissue (pooled from 6 animals) was subject
to 2-D gel electrophoresis and proteins visualised with SYPRO Ruby, as documented in
the methods section. The left column shows ipsilesional MVN protein, the right shows
contralesional MVN protein from the same animals. The gels were morphed using 2-D
Imagemaster software and changes in protein expression were detected using the
'montage' display facility.
Rectangle D indicates a region containing a protein, identified as phosphoglycerate
kinase, whose expression appeared to significantly change in the first two repeats of the
experiment (top two panels).
Figure 6.6 2-D gel image of the cytoplasmic fraction of the rat MVN proteome
Protein (lOOpg) was separated by 2-D gel electrophoresis and proteins were
visualised by SYPRO Ruby stain. The protein spots identified in this study by
MALDI-TOF MS are numbered; numbers refer to Table 6.1.
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Spot
number




1 Fructose bisphosphate aldolase A rat p05065 39.3 8.3
2 Fructose bisphosphate aldolase C rat p09117 39.3 6.7
3 Glutamate dehydrogenase (MP) rat pl0860 61.4 8.1
4 Pyruvate kinase, Ml isozyme rat pll980 57.8 6.6
5 Phosphatidylethanolamine binding protein rat p31044 20.8 5.5
6 Alpha enolase rat p04764 47.2 5.8
7 Creatine kinase B-chain rat p07335 42.7 5.3
8 Glyceraldehyde 3-phosphate dehydrogenase rat p04797 35.8 8.4
9 L-lactate dehydrogenase B chain rat p42123 36.6 5.7
10 Malate dehydrogenase mouse p14152 36.4 6.2
11 Serum albumin precurser rat p02770 68.7 6.1
12 Cofilin (non-muscle isoforms) rat p45592 18.5 8.2
13 Triosephosphate isomerase (TIM) rat p48500 26.9 6.4
14 Aspartate aminotransferase rat pl3221 46.3 6.3
15 Glutamine synthetase rat p09606 42.3 6.6
16 Phosphoglycerate kinase rat p16617 45.6 7.5
17 Actin all 41.6 5.4
18 Tubulin a-6 human q9bqe3 49.9 5
19 Ubiquitin carboxyl-terminal hydrolase isozyme LI rat q00981 24.7 5.1
20 Peroxiredoxin 6 (antioxidant) rat 035244 24.8 5.6
21 Peroxiredoxin 1 rat q63716 22.1 8.3
22 Aconitate hydratase (MP) bovine p20004 85.4 8.1
23 Transketolase (TK) rat p50137 67.6 7.2
24 14-3-3 protein gamma human p35214 28.3 4.8
25 Carbonic anhydrase rat p27139 29.1 6.9
26 D3 Dopamine receptor rat pi9020 49.5 9.4
27 Heat shock cognate 71kDa protein human pi 1142 70.9 5.4
28 Rab GDP dissociation inhibitor alpha rat p50398 50.5 5
29 Carbonic anhydrase II rat p27139 29.1 6.9
30 Nucleoside diphosphate kinase B rat pl9804 17.3 6.9
31 Elongation factor 2 (EF2) rat p05197 95.3 6.4
32 L-lactate dehydrogenase A chain rat p04642 36.5 8.4
33 ATP synthase B chain (MP) rat p19511 28.9 9.4
34 Annexin V rat pl4668 35.7 4.9
35 Enoyl-CoA hydratase (MP) rat p14604 31.5 8.4
36 Synaptosomal-associated protein 29 (SNAP 29) rat q9z2p6 29.1 5.3
37 Aconitate hydratase (MP) human q99798 85.4 7.4
38 Superoxide dismutse rat p07632 15.9 5.9
39 Na/K transporting ATPase alpha-2 chain precursor rat p06686 112 5.4
Table 6.1 Identified proteins from the cytoplasmic fraction of rat MVN
proteome
Proteins from the rat MVN cytoplasmic proteome, identified by tryptic mapping and
a SWISSPROT database search. MP; mitochondrial precursor. Ref. Figure 6.6.
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Figure 6.7 2-D gel image of the membrane fraction of the rat MVN proteome
Protein (lOOpg) was separated by 2-D gel electrophoresis and proteins were
visualised by SYPRO Ruby stain. The protein spots identified in this study by
MALDI-TOF MS are numbered; numbers refer to Table 6.2.
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Spot
number




1 Glyceraldehyde 3-phosphate dehydrogenase rat p04797 35.8 8.4
2 Malate dehydrogenase (MP) rat p04636 35.7 8.9
3 Actin all 41.6 5.4
4 Creatine kinase, b-chain rat p07335 42.7 5.3
5 ATP synthase beta-chain (MP) rat pl0719 56.3 5.2
6 L-lactate dehydrogenase rat p42123 36.6 5.7
Guanine nuceotide-binding protein bovine pi1017 35.6 6.1
7 L-lactate dehydrogenase rat p42123 36.6 5.7
8 Mitogen-activated protein kinase 8 rat q63562 52.8 5.7
9 Beta-adrenergic receptor kinase 1 rat p26817 79.9 6.6
10 Heat shock related protein rat p 14659 69.5 5.4
11 Vacuolar ATP synthase cat sub A p,b,h,m q29048, p 68.3 5.4
12 Tubulin alpha 1 chain all p05216, m 50 5
13 Alpha-enolase rat p04764 47.2 5.8
14 ATP synthase beta-chain (MP) rat pl5999 58.8 9.2
15 Heat shock related protein rat pl4659 69.5 5.4
16 Fructose bisphosphate aldolase A rat p05065 39.4 8.3
17 Voltage-dependent anion-selective channel rat q9z210 32.6 8.3
protein 1
18 Vesicle-fusing ATPase h,m p46459,h 82.7 6.4
Dynamin 2 rat p39052 98 7
19 Succinate dehydrogenase (MP) h,b,p p31040,h 72.7 7.1
20 Transketolase rat p50137 67.6 7.2
21 Pyruvate kinase M1/M2 isozyme rat pi 1980/11981 57.8 6.6/7.2
22 Glutamate dehydrogenase rat pl0860 61.4 8.1
23 4-aminobutyrate aminotransferase (MP) rat p50554 56.5 9
24 Solute carrier family 12 member rat q63632 120 6.2
25 Glutamine synthetase rat p09606 42.3 6.6
26 Protein kinase C rat p09217 67.7 5.5
27 Phosphoglycerate kinase rat pl6617 45.6 7.5
Table 6.2 Identified proteins from the membrane fraction of rat MVN
proteome
Proteins from the rat MVN membrane proteome, identified by tryptic mapping and a
SWISSPROT database search. Gel spots can contain overlapping proteins, which
when picked, digested into peptide fragments and used to search the protein
databases can return multiple protein hits. When this is found to occur, all proteins
whose theoretical pi and MW match the pi and MW range of the gel region from
which it was picked are recorded (c.f. numbers 6 and 18). MP: mitochondrial
precursor; h: human; m: mouse; b: bovine; p: pig. Ref. Figure 6.7.
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Intermediary metabolism enzymes
Fructose bisphosphate aldolase A
Fructose bisphosphate aldolase C
Glutamate dehydrogenase (MP)





L-lactate dehydrogenase A chain







ATP synthase B chain (MP)
Transketolase (TK)
Carbonic anhydrase II
Rab GDP dissociation inhibitor alpha
















Beta-adrenergic receptor kinase 1
Protein kinase C








Transcription, splicing and elongation proteins
Elongation factor 2
Heat shock proteins and chaperones
Heat shock cognate 71kDa protein
Heat shock related protein
Ubiquitination and proteasome related proteins






Na/K transporting ATPase alpha-2 chain precursor
Mitogen-activated protein kinase 8
Vesicle-fusing ATPase
Solute carrier family 12 member
Table 6.3 continued. Functions of identified MVN proteins
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Mass (m/z)
Name: Pyruvate kinase, Ml isozyme (Pyruvate kinase muscle isozyme)
Accession number: PI 1980; Species: rat
MW: 57818 Da; pi: 6.6
m/z submitted MH+ matched Database sequence
754.4967 754.4688 (K) KPRPTR (A)
787.4360 787.4215 (R) QAHLYR (G)
840.5240 840.5307 (R) APIIAVTR (N)
884.4904 884.4776 (R) MQHL1AR (E)
953.5058 953.4805 (K) IENHEGVR (R)
990.5634 990.5624 (R) LLFEELAR (A)
1019.5242 1019.5162 (K) GDYPLEAVR (M)
1029.5179 1029.5118 (R) EAEAAVFHR (L)
1235.5720 1235.6240 (K) EMIKSGMNVAR (L)
1359.7438 1359.7055 (R) NTGIICTIGPASR (S)
1462.8084 1462.8157 (K) IYVDDGLISLQVK (E)
1473.8158 1473.8099 (K) CLAAALIVLTESGR (S)
1587.7701 1587.7655 (K) DAVLDAWAEDVDLR (V)
1837.9088 1837.9118 (R) RFDEILEASDG1MVAR (G)
1875.8974 1875.8951 (K) FGVEQDVDMVFASF1R (K)
1883.9027 1883.9040 (R) LNFSHGTHEYHAET1K (N)
2435.2986 2435.2822 (R) AATESFASDPILYRPVAVALDTK (G)
PKPDSEAGTA FIQTQQLHAA MADTFLEHMC RLDIDSAPIT ARNTGIICTI GPASRSVEML KEMIKSGMNV
ARLNFSHGTH EYHAETIKNV RAATESFASD PILYRPVAVA LDTKGPEIRT GLIKGSGTAE VELKKGATLK
ITLDNAYMEK CDENILWLDY KNICKWEVG SKIYVDDGLI SLQVKEKGAD YLVTEVENGG SLGSKKGVNL
PGAAVDLPAV SEKDXQDLKF GVEQDVDMVF ASFIRKAADV HEVRKVLGEK GKNIKIISKI ENHEGVRRFD
EILEASDGIM VARGDLGIEI PAEKVFLAQK MMIGRCNRAG KPVICATQML ESMIKKPRPT RAEGSDVANA
VLDGADCIML SGETAKGDYP LEAVRMQHLI AREAEAAVFH RLLFEELARA SSQSTDPLEA MAMGSVEASY
KCLAAALIVL TESGRSAHQV ARYRPRAPII AVTRNPQTAR QAHLYRGIFP VLCKDAVLDA WAEDVDLRVN
LAMNVGKARG FFKKGDWIV LTGWRPGSGF TNTMRWPVP
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6.5 DISCUSSION
The results in this thesis represent the first systematic analysis of the MVN at
the proteomic level during vestibular compensation in rat. A previous study of
changes in protein expression during VC in the guinea pig detected an up-regulation
in the ipsilesional vestibular nuclei in the expression of 3 proteins at 1 week post-UL,
which were almost absent in control animals (Ris et al., 1999). The identities of these
proteins are unknown because N-terminal Edman degradation, rather than mass
spectrometry identification techniques were used. Edman degradation determines the
amino acid sequence of the N-terminal of the protein, which is then used to search
protein sequence databases. However, only two out of the three proteins which
exhibited changes were able to be N-terminal sequenced, and the length of the amino
acid sequences determined for these two proteins (9 and 11 amino acids) were not
long enough to generate a significant hit in the databases searched (Ris et al., 1999).
In addition, Ris and colleagues were assessing changes in guinea pig proteins; the
majority of mammalian protein and gene sequence data identified to date and
available to search online corresponds to rat, mouse and human proteins. The low
level of guinea pig protein sequence data available in these databases is a limiting
factor for proteomic studies using guinea pig.
No changes in protein expression between the ipsilesional and contralesional
MVN at 1 week post-UL in rat were revealed during analysis of the region of the rat
MVN proteome corresponding to region encompassing the 3 protein changes
detected in guinea pig (pi: 5.8-6.1, MW: 58-63 kDa. Ris et al., 1999). This is
unsurprising because it is probably different regions of the vestibular nuclei being
analysed between studies, since it is unclear in the Ris paper from where in the
vestibular nuclei the tissue samples were taken. In addition, the species analysed are
different, and the current study uses a two-step separation technique as opposed to
the single step used by Ris and colleagues.
The results from the present study indicate that there may be changes in the
expression of a number of proteins between the ipsilesional and contralesional MVN
at 1 week post-UL (Fig. 6.4 and 6.5, runs 1-2). However the observed changes in
expression are only consistent between two out of the three repeats of this
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experiment to date. There are a number of possible reasons for the observed
discrepancies between the three experiments including variability in: sample
(biological differences between rats), sample preparation, environmental conditions,
batch of reagents and manual inputs. Because of these limitations in reproducibility
when comparing small numbers of gels, the current experimental protocol utilised an
'all or nothing' approach, investigating qualitative rather than quantitative
differences in protein expression. In protocols using SYPRO Ruby stains,
quantitative changes, assessed by measuring the optical density of spots, are
generally considered significant when the change is observed in three out of four gels
and the change is over threefold (Choe and Lee, 2003). Thus, at least one more
repeat of the current experiment is desirable to establish consistent and quantifiable
changes in protein expression. These experiments are ongoing within the laboratory,
however due to time limitations they cannot be included within the scope of this
thesis.
What the present data demonstrate, is the potential power and utility of a
proteomics approach to the investigation of vestibular compensation and indeed
other forms of brain plasticity. Three of the proteins that showed changes in protein
expression during the first two repeats of the experiment may be of particular interest
to the process of VC. Mitochondrial glutamate dehydrogenase (Fig. 6.4 spot A; Fig
6.6 spot 3) and phosphoglycerate kinase (Fig. 6.5 spot D; Fig 6.7 spot 27) appear to
be up-regulated in the ipsilesional MVN compared the contralesional MVN at 1
week post-UL. These proteins belong to a group defined as intermediary metabolism
enzymes (see Table 6.3) and their presence can be used to determine the metabolic
status of tissues (Lubec et al., 2003); thus an up-regulation of these enzymes on the
ipsilesional side would be indicative of significantly increased metabolic activity,
specifically on the lesioned side of the brain. In the CNS, glutamate dehydrogenase
appears to function in both the synthesis and the catabolism of glutamate
(Mavrothalassitis et al., 1988). An increase in glutamate dehydrogenase expression at
1 week post-UL could be related to a re-modeling or increased efficacy of the
remaining glutamatergic inputs into the lesioned MVN; this in turn may be related to
the increase in firing rate of rostral ipsilesional MVN neurons observed at this time
in vitro (see Chapter 5).
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Spot B as well as the larger spot to its immediate right (Fig. 6.4; Fig 6.6 spots
numbered 2), have been identified as aldolase-C, also known as zebrin, a molecular
marker that reveals a striped zonal organisation of the cerebellar cortex, and whose
distribution appears to correspond to the spatial distribution of mossy fibre afferents
within the cerebellar cortex (Hawkes and Herrup, 1995; Marzban et al, 2003).
Phosphorylation of a protein changes its charge; therefore the same protein in
different phosphorylation states can often be found spotted horizontally across a 2-D
gel. The change in aldolase-C expression between the first two repeats of gels
suggests a change in the phosphorylation state of this protein during compensation.
Altered phosphorylation may be due to changes in the MVN itself or may be due to
changes in the Purkinje cell inputs from the flocculus, since aldolase-C is expressed
in Purkinje cell axons and terminals. Alteration in the phosphorylation state of
proteins after UL, in MVN projecting Purkinje neurones, is of interest as it may
indicate a link between cerebellar cortical plasticity and VC. Indeed, a recent study
showed the importance of protein kinase activity in the flocculus, for the increase in
excitability of neurones that occurs in the MVN after UL (Johnston et al., 2002; see
Sections 2.1.4, 3.6 for discussion).
Figures 6.6-6.7 and tables 6.1-6.2, illustrate proteins present in the MVN which
have been identified by mass spectroscopy. The functions of these identified
proteins are outlined in table 6.3. The generation of this database of proteins
expressed in the MVN will allow for increasingly rapid screening of protein changes
during different stages of compensation, and can be extended to the investigation of
protein changes in other forms of vestibular plasticity such as adaptive changes in the
vestibulo-ocular reflex or recovery from bilateral labyrinthectomy. A number of
recent studies have utilised proteomic techniques to examine mammalian brain
proteomes (Fountoulakis et al., 1999; Gauss et al., 1999), and in 2002 an initial
analysis of the mouse cerebellum proteome was published, with the view to
constructing a web-based database to be used as a resource for comparative
proteomics studies (Beranova-Giorgianni et al., 2002). However, the majority of
proteins identified in the mouse cerebellum and in the rat MVN in the present study,
can be categorised as high abundance proteins, which generally do not include
membrane receptor and signalling proteins, both of which have been implicated in
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the process of VC. This is one of the limitations of a 2-D gel electrophoresis (2-
DGE) approach to proteomics, which will be discussed below.
Limitations of 2-DGE techniques
1) Low abundance proteins
This is an important group of proteins because it encompasses receptors, signal
transduction and regulatory proteins, modifications of which may carry significant
information on the mechanisms of plasticity in the vestibular system. A major
disadvantage of 2-DGE is its inability to visualise low copy number proteins in the
presence of highly abundant proteins. The proteome of a cell can contain at least
10,000-30,000 different proteins (Denslow et al., 2003), however depending on the
2-DGE technique used, only 1000-10,000 proteins can be visualised on a silver
stained gel (Gauss et al., 1999). Only some stained proteins are present at levels
sufficient for mass spectrometric identification and it is likely that most of these are
high abundance proteins. Increasing the amount of protein loaded onto the gel can
increase detection sensitivity. However, with high protein loads, high abundance
proteins can obscure low abundance proteins with similar pi values and MW. This
problem can be combated with the use of multiple overlapping narrow IPG strips in
the first dimension, and with the use of larger gels in the second, but this requires a
significant increase in the quantity of tissue for analysis, which is not practical for the
analysis of small quantities of brain tissue. Thus, abundant protein removal is the
primary requirement of any technique used to concentrate low abundance proteins,
and this is achieved by fractionation. Due to limited quantity of tissue, the current
method uses a two step fractionation procedure, the sucrose buffer removes the most
abundant soluble proteins, and the pellet which is re-solubilised is enriched with
membrane and low abundance proteins. Where greater amounts of protein are
available for analysis, multiple fractionation or affinity purification methods can be
applied to enrich the proportion of the protein of interest (Krapfenbauer et al., 2003).
Kits to affinity purify specific groups of proteins such as phosphoproteins are now
available commercially.
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2) Hydrophobicity ofproteins
Hydrophobic proteins are an important target in the investigation of mechanisms
underlying VC as they are mainly represented by membrane proteins. The initial
problem is the extraction and solubilisation of proteins from the membrane. The
current method addresses this issue with a two-step separation process and the use of
powerful detergents to solubilise integral membrane proteins. However, problems
with the separation process exist once solubilised: hydrophobic proteins are generally
alkaline (pi > 8) (Wilkins et al., 1998), and are therefore not detected on standard 2-
D gels which cover the pH 4-7 range. In the present experiment a wide ranging pH 3-
10 IPG strip is used to visualise a broader range of proteins. A third problem with
hydrophobic proteins is that they are poorly soluble in the aqueous solution used for
isoelectric focusing. Even with the inclusion of Triton X-100 and thiourea to the IPG
rehydration solution to solubilise the membrane proteins, these proteins are designed
to be soluble in lipid bi-layers and not water, therefore migrate poorly into the IPG
gel in the first dimension and the SDS gel in the second. Partial or limited extraction
of these proteins may result, which creates problems for the quantitative analysis of
differences between gels (for review, see Santoni et al., 2000).
3) High and low molecular weight proteins
High and low molecular weight proteins can be poorly represented by proteomic
techniques. These proteins can be excluded from 2-D gels due to difficulties
migrating through the gel matrix, both in the first and second dimension. Further
problems exist with the identification of low molecular weight peptides by MS,
because the peptide mass fingerprint often contains too few peptide fragments for a
significant hit to be generated from gene or protein databases. An alternative to 2-
DGE combines capillary electrophoresis with tandem mass spectroscopy to detect
low abundance and low molecular weight proteins (Javerfalk-Hoyes et al., 1999).
These limitations aside, 2-DGE and mass spectroscopy are the most powerful
techniques to date to study the global expression of proteins in a given tissue. They
are also the only separation process with sufficient resolution, and reliable
identification process, which can identify changes in post-translational modifications.
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For example, phosphorylation changes protein charge and is often indicated by a
horizontal streaking across a 2-D gel (see Fig. 6.6, spots numbed 2: fructose
bisphosphate aldolase C). If there is sufficient protein the amino acid sequence of the
modification can be determined by tandem MS. The ability to determine post-
translational modifications in vestibular tissues is of importance in the study of
mechanisms underlying VC since adaptations of phosphoproteins in particular are
likely to be directly involved in post-lesional plasticity (see Chapter 3 for
discussion).
This study represents the development of a novel technique within our laboratory
to analyse the mechanisms involved in the process of VC. The protocol used in this
study represents a global investigation of changes in protein expression, using basic
tissue extracts and a large pH range to separate proteins. The results indicated that
there may be changes in protein expression and/or phosphorylation in the MVN at 1
week post-UL, however no definite conclusions can be drawn since the third repeat
of the experiment presented different results from the first two. The study indicates
that changes in the MVN are likely to be too subtle to be detected with a global
approach, and an approach targeted at analysing specific classes of proteins
implicated in VC is planned. Here, the proteomic method complements other
techniques used in this thesis: proteins such as membrane receptors implicated in VC
by electrophysiological experiments can be selectively targeted for proteomic
analysis. For example, a pull-down immunoprecipitation column could be created
using subunits of the GABAb receptor to analyse changes in GABAb proteins, and
proteins interacting with the GABAb receptor (the "interactome") during VC.
Affinity columns are commercially available to purify phosphoproteins, which can
then be separated by 2-DGE. Less specifically, the separation of tissue into distinct
fractions (e.g. different molecular weight ranges using molecular weight filters and
centrifugation) and using narrower pH ranges to target and expand the areas of gel
which in experimental runs 1 and 2 suggest changes, will allow clearer visualisation
of proteins of interest. New candidate mechanisms of plasticity indicated by changes
in protein expression can be further investigated by behavioural, pharmacological or
electrophysiological methods.
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Summary
This study involved the development and implementation of a new experimental
technique to study the mechanisms of VC in rat. A proteomics protocol was
established which allowed for wide ranging visualisation of proteins present in the
MVN. A database of proteins present in the MVN, identified by MS was constructed,
which will allow for rapid screening of protein changes during different stages of
compensation, and can be extended to the investigation of protein changes in other
forms of vestibular plasticity such as adaptive changes in the vestibulo-ocular reflex
or recovery from bilateral labyrinthectomy. The study demonstrates that the
proteomic technique can be extended to investigate other forms of plasticity in the
CNS.
Changes in protein expression and/or phosphorylation between the ipsilesional
and contralesional MVNs in rats that underwent VC for 1 week post-UL were
analysed. The results suggest that changes in protein expression and phosphorylation
may be occurring in the MVN at this time; however the changes observed were not
consistent throughout all runs of the experiment therefore more repeats are necessary
before definite conclusions can be drawn. This preliminary study leads the way into
experiments targeted at changes in specific classes of proteins, such as membrane
proteins and phosphoproteins, during VC.
Resume 181
RESUME AND FUTURE EXPERIMENTS
Chapters 1 and 2 introduced the areas of general vestibular system anatomy and
function, and reviewed the current understanding of the underlying causes and
mechanisms of vestibular compensation.
In Chapter 3 it was demonstrated that the significant down-regulation of both
GABAa and GABAb receptor efficacy in rostral ipsilesional MVN neurones was
abolished if animals remained anaesthetised for the 4 hours following UL. In
anaesthetised animals that had been treated with the glucocorticoid agonist,
dexamethasone, the significant down-regulation of GABAa and GABAb receptor
efficacy was restored. These experiments suggest that acute activation of the
hypothalamo-pituitary-adrenal stress axis, the subsequent release of endogenous
glucocorticoids and the activation of glucocorticoid receptors are necessary to induce
the down-regulation of GABA receptor efficacy in rostral ipsilesional MVN
neurones during the early stages of vestibular compensation.
The mechanisms by which glucocorticoids modulate GABA receptor efficacy
following UL are unclear. Corticosteroids can act via both genomic and membrane
receptors to affect GABA mediated transmission. Acting via genomic receptors,
corticosteroids can modulate the transcription of specific GABAa receptor subunits
(e.g. the y2 receptor subunit: Orchinik et al., 1995; Stone et al., 2001). Experiments
to determine whether the down-regulation of GABAa receptor efficacy from 4h post-
UL, is accompanied by changes in GABAa receptor subunit mRNAs that have been
shown to be regulated by corticosteroids, may elucidate the mechanisms underlying
these changes. Corticosteroids have been shown to bind to membrane receptors, and
activate non-genomic signalling mechanisms such as the PKC pathways. Thus,
glucocorticoids may be affecting GABA receptor efficacy via modulation of
intracellular kinase pathways, resulting in changed phosphorylation states of the
receptors. It is not know when the down-regulation of GABA receptor efficacy first
occurs after UL; further experiments are now necessary to establish the exact time
course over which this occurs, which will enable experiments focused at
investigating specific second messenger pathways and molecular events involved in
this process.
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Chapter 4 demonstrated the presence of the enzyme 1 l(3-hydroxysteroid
dehydrogenase type 1 (llp-HSDl, which regenerates active glucocorticoids from
their inert 11-keto forms) in the MVN, flocculus/paraflocculus and nodulus/uvula. It
is the first experiment to specifically investigate 11(3-HSD1 activity in vestibular
related brain tissue. The results suggest that this modulatory enzyme is likely to be
involved in regulating the exposure of these centres to circulating glucocorticoids, by
glucocorticoid metabolism at a cellular level. The results also show that the levels of
11P-HSD1 activity in the MVN and vestibulo-cerebellum remain stable over the 4h
period after UL, disproving the hypothesis that changes in enzyme modulatory
activity may occur in parallel with the deafferentation induced changes in the
properties of the ipsilesional MVN neurones at this time.
In Chapter 5, the mechanisms underlying changes in neuronal activity of
ipsilesional MVN neurones in vitro, during the process of VC, was investigated by
perfusion of brainstem slices from rat with aCSF containing antagonists of the major
neurotransmitters in the VNC. Perfusion of brainstem slices from normal animals
with the cocktail of antagonists, had no effect on the number of neurones detected
per slice, the regularity of firing of these neurones or the mean discharge rate of these
neurones. These results suggest that in normal animals the firing of MVN neurones
in vitro is maintained primarily by the intrinsic pacemaker properties of these
neurones.
At 4h post-UL an increase in excitability of rostral ipsilesional MVN neurones is
observed in normal aCSF, which is maintained in the presence of the
neurotransmitter antagonists. This indicates that the increase in excitability of rostral
ipsilesional MVN neurones at 4h post-UL is maintained primarily by modifications
in the intrinsic pacemaker properties of these neurones. There are a variety of
membrane channels and conductances which could be modified following UL to
maintain this change in excitability: there could be a down-regulation in the number
or efficacy of K+ channels carrying outward current, or an up-regulation of Na+ and
Ca2+ channels carrying inward current. A systematic voltage clamp experiment,
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investigating individual ionic currents before and after UL, is necessary to elucidate
the mechanisms of this increase in excitability.
At 48h and 1 week post-UL, the increase in mean firing rate of rostral
ipsilesional MVN neurones observed in normal aCSF, is lost upon addition of the
neurotransmitter antagonists to the perfusing medium. This indicates that one or
more of the neurotransmitter receptors blocked by the antagonist cocktail, is
maintaining the increase in excitability. The specific neurotransmitter receptors
mediating the increase in excitability should be investigated by repeating the
experiment, firstly using either the excitatory or inhibitory receptor antagonists, and
secondly by breaking the cocktail down into individual receptor components. The
results provide evidence for the theory that the increase in excitability observed in
ipsilesional MVN neurones from 48h post-UL is maintained by an increase in
excitatory input onto these neurones, perhaps from remaining intact sensory systems.
The increase in excitability of ipsilesional MVN neurones in vitro is likely to be
functionally compensatory, as it will help overcome the loss of primary excitatory
inputs from the deafferented vestibular nerve, and the excessive commissural
inhibition from the contralesional MVN in vivo. Thus, different mechanisms are
utilised in the initiation and maintenance of processes involved in VC.
The results also provide evidence for species differences in factors regulating
neuronal excitability of MVN neurones following UL. In rat, recovery of the resting
discharge of deafferented MVN neurones initially appears to be promoted by
modifications of the pacemaker properties of the neurones. This is superseded by
adaptations in the intact sensory and vestibular-related inputs onto these neurones.
The opposite mode of compensation has been proposed for guinea pig: initial
substituting sensory inputs being increasingly replaced by changes in the pacemaker
properties of the deafferented neurones (Vibert et al, 1999b).
Chapter 6 presents the first systematic investigation of the rat MVN proteome
during VC. A novel proteomics protocol was developed and implemented which
allowed for wide ranging visualisation of proteins present in the rat MVN. A
database of proteins expressed in the MVN, visualised by 2-DGE and identified by
MS, was constructed. Further MS experiments are now required to establish a
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comprehensive and complete database of the rat MVN proteome. This will allow
rapid screening of protein changes, identified in future differential 2-DGE
experiments of MVN tissue. The proteomic techniques developed in this study, are
currently being extended to the investigation of proteins present in the
flocculus/paraflocculus complex and the uvula/nodulus, and protein changes in these
areas during VC.
Results from the differential 2-DGE experiments of MVN tissue, indicate that
there may be changes in the expression and/or phosphorylation of a number of
proteins between the ipsilesional and contralesional MVN at 1 week post-UL.
Elowever, no definite conclusions can be drawn yet, because the third repeat of the
experiment did not corroborate the first two; therefore more repeats of the
experiment are now needed. Proteomic techniques provide a powerful complement to
the established methods of investigating VC. For example, one of the proteins
identified which displayed an up-regulation of activity in the ipsilesional MVN
during the first two repeats of the proteomic experiment, was glutamate
dehydrogenase. The results from Chapter 5 indicate that at 1 week post-UL, the
increase in excitability observed in ipsilesional MVN neurones is maintained by an
increased excitatory synaptic input, probably glutamatergic input, onto these
neurones. An increase in glutamate dehydrogenase expression at 1 week post-UL
could be related to a re-modeling or increased efficacy, of the remaining
glutamatergic inputs into the lesioned MVN, leading to the increase in firing rate of
rostral ipsilesional MVN neurons observed at this time in the electrophysiology
experiments.
Continued systematic proteomic analysis of MVN tissue should uncover
molecular mechanisms mediating the post-lesional plastic changes investigated in
this thesis. In addition, analysis of the MVN and vestibulo-cerebellum should reveal
new candidate mechanisms of plasticity, which can inform the design of future
behavioural, pharmacological and electrophysiological experiments. Further
proteomic approaches, targeted at specific classes of proteins implicated by
electrophysiological and systems level studies of VC, should provide significant new
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